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          Zusammenfassung 
Zusammenfassung 
Ziel der vorliegenden Arbeit war es, die Rolle des pro-apoptotischen Proteins Bim am 
endoplasmatischen Retikulum (ER) und an den Mitochondrien zu untersuchen um den 
apoptotischen Signalweg dieses Mitgliedes der Bcl-2 Proteinfamilie näher aufzuklären. 
Für diese Untersuchungen wurden zwei Isoformen von Bim verwendet, zum einen BimL, 
eine lange Version von Bim welches an den Motor Dynein Komplex gebunden ist, zum 
anderen die kürzere Form BimS, welches im Zytosol lokalisiert ist. 
Um eine konditionale Expression von Bim zu erreichen, wurde Myc-markierte humane 
cDNA unter der Kontrolle des Tet-Off Systems in einen adenoviralen Vector kloniert. 
Eine Überexpression von BimL und BimS induzierte in der Prostatakarzinomzelllinie 
DU145 unter Beteiligung der Proteine Bax und Bak apoptotischen Zelltod. Sowohl BimL, 
als auch  BimS  führte in stabil exprimierenden DU145-GFP-Bax und DU145-GFP-Bak 
Zellen zu einer Konformationsänderung und zu einem Zusammenclustern von Bax und 
von Bak. Eine Überexpression des anti-apoptotischen Proteins Bcl-2 in DU145 Zellen 
lokalisiert am endoplasmatischen Retikulum zeigte eine vollständige Hemmung der Bim-
induzierten Apoptose, während Überexpression von Bcl-2 an den Mitochondrien nur eine 
partielle Hemmung herbeiführte. Bim Expression induzierte in DU-145-Bax und in DU145-
Bak überexpremierenden Zellen den Zusammenbruch des mitochondrialen 
Membranpotentials. Dieses wurde ebenso in mit am ER lokalisiertem Bcl-2 in DU145 
Zellen beobachtet. Bcl-2 lokalisiert an den Mitochondrien vermindert dagegen den Verlust 
des mitochondrialen Membranpotentials. Interessanterweise, war aber keines der beiden 
Bim Isoformen in der Lage Zelltod zu induzieren wenn Bcl-2 am ER exprimiert wurde, was 
die Wichtigkeit des endoplasmatischen Retikulums im Bim- vermittelten 
Apoptosesignalweg unterstreicht. 
Um die durch Bim induzierten Prozesse am ER näher zu charakterisieren, wurde die 
Kalzium Freisetzung aus dem ER untersucht. Eine erhöhte zytosolische Kalzium 
Freisetzung konnte durch BimS Überexpression induziert werden und ging zeitlich einem 
Zusammenbruch des mitochondrialen Membranpotentials voraus. Proteinanalysen mittels 
Western Blot zeigten eine Hochregulierung von ER-Stress Proteinen nach Bim 
Überexpression. Die Bim-induzierte DNA-Fragmentierung wurde von einer Cytochrom c 
Freisetzung aus den Mitochondrien und der Prozessierung  und Aktivierung von Caspase-
9, -3 und -8 begleitet. Die Spaltprodukte dieser Caspasen wurden einerseits im Western 
Blot, andererseits durch fluoreszenzmarkierte Peptide,  die an die Spaltform der 
erwähnten Caspasen binden, bestimmt. Mit einem Breitband-Caspase Hemmer konnte 
der Bim-induzierte Zelltod vollständig gehemmt werden, was zeigt, dass Caspasen für die 
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Exekution der Apoptose essentiell sind. 
Durch Verwendung eines spezifischen Hemmers der Initiator Caspase-8 konnte der 
Zusammenbruch des mitochondrialen Membranpotentials nach BimS Induktion gehemmt 
werden, was auf eine wichtige Rolle der Caspase-8 oberhalb des Mitochondriums 
hindeutet. 
Zusammenfassend kann gesagt werden, dass Bim, parallel zum mitochondrialen 
Signalweg, ER-Stress auslöst. Die Ergebnisse lassen darauf schliessen, dass Bim eine 
effektive Apoptose durch die Interaktion des endoplasmatischen Retikulums der 
Aktivierung von Caspasen und der Mitochondrien induziert.  
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Abbreviations 
 
A. bidest Aqua bidestillata 
AIF apoptosis inducing factor 
ANT Adenine Nucleotide transporter 
Apaf-1 apoptosis associated factor1 
APS Ammoniumperoxodisulfate 
Bak Bcl-2 homologous antagonist killer 
Bap31 Bcl-2-associated protein-31 
Bax Bcl-2 associated protein X 
BCA Bicinchonin acid 
Bcl-2 B-cell lymphoma / leukemia-2 gene 
BGHpolyA Bovine growth hormone polyadenylation signal 
BH Bcl-2 homology 
Bik/Nbk  Bcl-2 interacting killer/Natural born killer 
BSA Bovines serum Albumin 
CAPS 3-Cyclohexylamino-1-propansulfon acid 
CARD caspase recruitment domain 
CMV Cytomegalovirus 
ColE1 ori  High-copy number origin of replication for E. coli 
C-Terminus carboxy-terminus 
CVL crude virus lysate 
Cyt c cytochrome c 
Da Dalton 
DEAE Diethylaminoethanol 
DD death domain 
DED death effector domain 
Diablo Direct IAP binding protein with low pI 
DISC death inducing signalling complex 
DMSO Dimethylsulfoxid 
DNA Desoxyribonucleic acid 
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dNTP  2´-Desoxynukleosidtriphosphat 
∆m  mitochondrial membrane potential 
DTT  Dithiothreitol 
E. coli  Escherichia coli 
ECL  Enhanced chemoluminescence 
EDTA Ethylendiamine-tetraactylacid 
ER endoplasmic reticulum 
EtBr Ethidiumbromide 
EtOH ethanol 
FBS fetal bovine serum 
FITC Fluorescein-isothiocyanat 
fmk Fluoromethylketon 
FSC  Forward scatter 
h hour 
HEPES 2-[4-(2-Hydroxyethyl)-1-piperazinyl]-Ethansulfonic acid 
HRP horse radish peroxidase 
HtrA2  High temperature requirement A2 
IAP inhibitor of apoptosis protein 
IRES  Internal Ribosome Entry Site 
JC-1 5,5‘,6,6‘tetrachloro1,1‘,3,3‘tetraethylbenzimidazolyl 
 carbocyaniniodide  
LB-medium  Luria-Browth-Medium 
MEF  Murine embryonic fibroblasts 
min minute 
MOI multiplicity of infection 
MTS  Mitochondrial targeting sequence 
N-Terminus  Amino-terminus 
PAGE  Polyacrylamide gel electrophoresis 
PARP  Poly(ADP-ribose) Polymerase 
PBS  Phosphate buffered saline 
PCMV full length “immediate early” promotor of cytomegalovirus 
PCR  Polymerase chain reaction 
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Pfu  Plaque forming unit 
PI propidium iodide 
PIDD  p53-induced protein with Death Domain 
PminiCMV minimal “immediate early” promotor of cytomegalovirus 
PMSF Phenylmethylsulfonylfluoride 
PTP permeability transition pore 
RAIDD  RIP-associated ICH-1/CED-3-homologous protein with Death 
 Domain 
RING-domain  Really Interesting New Gene 
Rpm rounds per minute 
RT room temperature 
s  Second 
SDS  Sodium dodecylsulfate 
SERCA Sarco(Endo)plasmatic reticulum Ca2+-ATPase 
Smac second mitochondria activator of caspases 
SSC  Side scatter 
TAE-buffer Tris-Acetat-EDTA-buffer 
TEMED N, N, N‘, N‘-Tetramethylethylendiamin 
TM Transmembrane domain 
TNF tumour necrosis factor 
TRE Tetracycline-responsive element 
Tris  Tris-(hydroxymethyl)-aminomethan 
tTA Tetracycline-controlled transactivator 
U  Unit 
UPR unfolded protein response 
V Volt 
v/v  volume / volume 
VDAC voltage dependent anion channel 
Vol.  Volume 
w/v  weight / volume 
XIAP X-chromosome-linked Inhibitor of Apoptosis Protein 
X-Gal 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranosid 
               Summary 
1 Summary 
The aim of this thesis was to investigate the role of the pro-apoptotic BH3-only protein 
Bim, at the endoplasmic reticulum (ER) and the mitochondria and additionally to reveal 
the apoptotic signalling pathway of this Bcl-2 family member. 
For this purpose, a full length human myc-tagged Bim cDNA was cloned into an 
adenoviral vector, which allows for the conditional expression of the transgene under the 
control of a Tet-Off-system. Two different kinds of Bim isoforms were used for these 
investigations. One was BimL, the long version of the Bim protein, which is bound to the 
motor dynein complex of the microtubule and the other one was BimS, the short splicing 
variant, which is localized in the cytosol. 
The enforced expression of each of these two isoforms in the prostate cancer cell line 
DU145, showed the capability of BimL and BimS to induce apoptosis via either Bak or Bax. 
Further, expression of both Bim isoforms in DU145 cells, stably expressing GFP-Bax or 
GFP-Bak, confirmed that Bim induces redistribution and clustering of Bax and Bak. Also, 
both DU145-Bax and DU145-Bak cells showed breakdown of the mitochondrial 
membrane potential upon overexpression of either Bim isoforms. This effect was also 
observed in DU145 cells overexpression the anti-apoptotic protein Bcl-2 at the ER. 
However, targeting Bcl-2 to the mitochondria gave these cells partial resistance to Bim-
induced mitochondrial permeabilization. These findings indicated the employment of the 
intrinsic apoptotic pathway for cell death induction upon Bim signalling. Nevertheless, 
expression of Bcl-2 at the mitochondria partially suppressed Bim-induced apoptosis 
whereas Bcl-2 was targeted to the ER entirely prevented cell death induction by Bim 
underlining the importance of the ER in the Bim-mediated cell death pathway. To examine 
the events at the ER in the Bim pathway, the calcium effluxes from the endoplasmic 
reticulum into the cytosol were assessed. Increased cytosolic calcium levels could be 
detected upon BimS expression and preceded activation of the mitochondria. Further, 
Western blot analysis showed an upregulation of ER stress proteins upon Bim expression. 
Bim-induced DNA-fragmentation was accompanied by cytochrome c release form the 
mitochondria and the processing and activation of caspase-9, -3 and -8. Cleavage 
products of these caspases were detected by Western blot analysis and their activation 
were shown by binding of FITC-labelled substrates against the indicated caspases. In 
addition, the complete inhibition of Bim-induced cell death by a pan caspase inhibitor 
revealed that caspases are crucial for the execution of apoptosis. Inhibition of caspase-8 
by a specific inhibitor did not lead to the breakdown of the mitochondrial membrane 
potential upon BimS overexpression suggesting that capase-8 takes an important place 
upstream of the mitochondria. 
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In conclusion, Bim induces the mitochondrial apoptotic pathway and, in parallel, triggers 
ER stress. It seems that Bim mediates cell death through the interaction of the 
mitochondria, the ER and caspase activation. Induction of a secondary mitochondrial 
activation by an ER-mitochondria cross-talk leads to the amplification of the apoptotic 
death signal. 
           Introduction 
2 Introduction 
2.1 Cell death 
2.1.1 Necrosis 
Cell death occurring passively, in an unregulated and uncontrolled fashion is called 
necrosis (figure 1). This process is initiated when cell damage is too severe to overcome 
and when the cell is not able to activate the energy-dependent apoptotic pathway. 
Necrosis is marked by cell and organelle swelling due to augmentation of the membrane 
permeability. This leads to the release of lysosomes into the extra cellular matrix (Kerr, et 
al., 1994; Wyllie, et al., 1980). Intracellular contents are thrown into the extra cellular 
matrix often causing inflammation in the neighbouring cells. 
 
Figure 1: morphological changes during apoptosis and necrosis 
1) Normal cell 
2) Shrinking of the cell, condensation of the chromatin and membrane blebbing 
3) Nuclear fragmentation and formation of apoptotic bodies 
4) Phagocytosis of the apoptotic bodies 
A) Swelling of the organelles 
B Disruption of the cell membrane 
 (Kerr, et al., 1994) 
 
2.1.2 Apoptosis 
The term apoptosis was established by Kerr (Kerr, et al., 1972). Apoptosis is a selective 
form of cell death that consists of morphological and biochemical changes. It is a highly 
conserved process, from C. elegans to man. It describes a controlled process consisting 
of shrinkage of the cell, blebbing of the plasma membrane, condensation of the chromatin 
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leading to DNA fragmentation and eventually formation of so-called apoptotic bodies 
(Wyllie, et al., 1984) (figure 1). These are eliminated by phagocytosis to avoid 
inflammation (Fadok, et al., 2001). Apoptosis allows elimination of unwanted, aged, 
misplaced or damaged cells. Therefore, apoptosis is a crucial process in embryonic 
development, tissue homeostasis, differentiation, proliferation and immune response 
(Vaux and Korsmeyer, 1999). Developmental cell death occurs in a programmed fashion 
and is referred to as “programmed cell death” (type I cell death). However, this process 
can also be induced by exogenic factors like DNA-damaging agents, UV-irradiation and 
nutrition depletion. Inhibition or abnormal regulation of apoptosis underlies many disorders 
such as cancer and autoimmunity (Bakhshi, et al., 1985). 
 
2.1.3 Autophagy 
In cell death type II or autophagy, cell death occurs by degradation, where the cytoplasm 
or damaged organelles are recycled (Shintani and Klionsky, 2004). Autophagy is defined 
by the formation of the autophagosome, a double- or multi-membrane bound vacuole 
(Dunn, 1990). Fusion with lysosomes results in autophagolysosomes degrading their 
contents. Apart from this function, autophagy is engaged in cellular remodelling during 
differentiation and metamorphosis as well as aging, muscular disorder and 
neurodegeneration (Shintani and Klionsky, 2004). Autophagy might be an attempt to 
protect the cells against mitochondrial permeability transition during oxidative stress or 
mitochondrial calcium overkill (Rodriguez-Enriquez, et al., 2004). 
 
2.2 Apoptotic pathways 
Three main starting points of apoptosis are known, death receptors, mitochondria and the 
endoplasmic reticulum (Nakagawa and Yuan, 2000). These pathways are largely 
independent but can establish crosstalk since there are some junctions along their 
pathways. 
 
2.2.1 The death receptor pathways 
Extra cellular receptors transmit external signals into the cell. Besides signals that lead to 
proliferation and differentiation, cytotoxic signals are taken up by these receptors e.g. to 
eliminate target cells or excess immune cells after an immune response (Ashkenazi and 
Dixit, 1998; Schulze-Osthoff, et al., 1994). Initiation of the extrinsic or death receptor 
pathway (figure 2) occurs upon binding of extra cellular death ligands to the tumour 
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necrosis factor (TNF) super-family of plasma membrane death receptors. Members of this 
receptor family are Fas/CD95, TNFR1, TRAIL receptors DR3, DR4 and DR5. They 
possess a cysteine rich extra cellular domain (Smith, et al., 1994). Upon binding of the 
death ligand, the death receptors form trimers. The intracellular death domain (DD) of the 
receptor recruits adaptor proteins like FADD (Fas Associated Death Domain) or TRADD 
(TNF-receptor associated protein with death domain) (Chinnaiyan, et al., 1995). In turn, 
these adapter proteins bind, with their N-terminal death effector domain (DED), to 
procaspase-8 leading to formation of a complex called death inducing signalling complex 
(DISC) (Muzio, et al., 1996). In this complex, monomeric caspase-8 becomes at least a 
dimer leading to autoprocessing and activation. Activated caspase-8 can proteolytically 
process and activate the effector caspase-3, -6, and -7 to amplify the death signal. 
Furthermore, caspase-8 can cleave Bid, a pro-apoptotic protein, which can initiate the 
mitochondrial apoptotic pathway (Li, et al., 1998; Luo, et al., 1998). Regulation is 
mediated by the caspase-8 inhibitory proteins FLIP (flice inhibitory protein) that exists in 
two splicing variants, the long form FLIPL and the short one FLIPS. They contain two 
DEDs, but they do not have proteolytic activity (Thome, et al., 1997; Thome and Tschopp, 
2001). Both cellular isoforms possess significant anti-apoptotic activity once they are part 
of the DISC. Overexpressed FLIP can block autoproteolytic activation of procaspase-8 by 
binding competitively to FADD (Thome and Tschopp, 2001).  
 
2.2.2 The mitochondrial death pathway 
The intrinsic pathway is regulated by proteins of the Bcl-2 family and is therefore referred 
to as the mitochondrial pathway, because the mitochondria play a central role (figure 2). 
Several stimuli can lead to activation of the mitochondrial cell death pathway such as 
cytotoxic drugs, heat shock, ionising, DNA damage and growth factor withdrawal. These 
stimuli trigger Bax and Bak activation, which subsequently mediate the permeabilization of 
the outer mitochondrial membrane and release of distinct proteins. Among them are 
cytochrome c, Smac/Diablo, apoptosis inducing factor (AIF), endonuclease G and 
Omi/HtrA2 (van Loo, et al., 2002). Released cytochrome c mediates the formation of a 
protein complex called apoptosome, which consists of Apaf-1 (apoptosis protease 
activating factor 1), initiator caspase-9 and (d)ATP (Li, et al., 1997; Liu, et al., 1996; Saleh, 
et al., 1999). Binding of Apaf-1 to cytochrome c increases the affinity of Apaf-1 to ATP, 
which is providing the energy for apoptosome formation (Hu, et al., 1999). During 
apoptosome formation procaspase-9 is activated and, in turn, causes the activation of the 
effector caspase-3 and caspase-7 (Rodriguez and Lazebnik, 1999). Further, cytochrome c 
release is accompanied by a mitochondrial permeability shift, acidification of the cytosol 
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and ion fluxes (Daniel, et al., 2003). Released endonuclease G translocates to the 
nucleus, where it digests DNA caspase-independently (van Gurp, et al., 2003). Moreover, 
activation of released Smac/Diablo results in dimerization. Smac/Diablo contributes to 
caspase activation by restraining inhibitor of apoptosis proteins (IAPs). As implied by the 
name, these proteins inhibit activation of pro-caspases. In his task Smac/Diablo is 
supported by Omi/HtrA2 (van Gurp, et al., 2003). The death receptor signalling pathway is 
connected to the mitochondrial cell death pathway by the BH3-only protein Bid when 
cleaved by caspase-8 (Gross, et al., 1999). This truncated Bid may bind to Bax or Bak 
thereby inducing a conformational change in these proteins and the insertion of them into 
the outer mitochondrial membrane. It also sequesters anti-apoptotic Bcl-2 family proteins. 
This is followed by the permeabilization of the mitochondrial membrane and consequently 
the amplification of the mitochondrial pathway. Despite of this connection the pathways 
function mostly independently form each other (Bouchon, et al., 2000). The anti-apoptotic 
proteins of the Bcl-2 family can block the intrinsic pathway. These proteins can prevent 
cytochrome c release and caspase activation (Kluck, et al., 1997).  
 
 
Figure 2: The mitochondrial and death receptor apoptotic pathway  
The mitochondrial (intrinsic) apoptotic signalling pathway is initiated by cell damaging events, upon which 
pro-apoptotic members of the Bcl-2 family are activated and translocate to the mitochondria to neutralize 
anti-apoptotic proteins. Permeabilization of the mitochondria causes the release of cytochrome c. Released 
cytochrome c associates with Apaf-1 and procaspase-9 in the presence of dATP to form the apoptosome. 
Activated caspase-9 triggers a caspase cascade leading to apoptosis. 
The death receptor (extrinsic) pathway is activated when ligands of the TNF family bind to their receptors 
on the cell surface. Binding of the ligand induces trimerization of the receptor and recruitment of the 
adaptor protein FADD and caspase-8. Within this complex, caspase-8 is activated and in turn cleaves and 
activates casapse-3. The two pathways are mostly independent, but in type II cells the two pathways can be 
linked via cleavage of Bid by caspase-8, caspases-3 or -10. Truncated Bid activates the mitochondrial 
apoptotic pathway. 
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2.2.3 The endoplasmic reticulum pathway 
The endoplasmic reticulum is responsible for the maintenance of the calcium homeostasis 
and is also the major intracellular calcium storage. The uptake of Ca2+ into the lumen of 
the ER is managed by energy-dependent SERCA (sarcoplasmic/endoplasmic reticulum 
Ca2+-ATPase). The release is handled by IP3 (Inositol 1,4,5-Triphosphat (IP3)-regulated 
receptors or ryanodin (RyR) Ca2+ receptors (Berridge, et al., 2000). Furthermore, the ER 
is the main compartment for protein synthesis, folding, targeting and trafficking. The ER 
contains numerous chaperone proteins, a high level of calcium and an oxidative 
environment to carry out these functions efficiently (Rao, et al., 2004). Changes in Ca2+ 
levels or accumulation and aggregation of un- or misfolded proteins lead to ER stress, 
which is gauged by the ER stress sensors IRE1, PERK and ATF6.  To restore normal ER 
function, the unfolded protein response (UPR) is initiated (Szegezdi, et al., 2006). 
Excessive ER stress forces the unfolded protein response to activate diverse pathways 
that eventually lead to apoptosis (Ferri and Kroemer, 2001). Also, prolonged ER stress is 
involved in the pathogenesis of some neurodegenerative disorders that feature misfolded 
proteins (Rao, et al., 2002). ER stress can also be elicited by several agents including 
tunicamycin a specific N-glycosylation inhibitor, Brefeldin A, an inhibitor of the protein 
transport from ER to Golgi and thapsigargin, which blocks Ca2+ uptake by inhibiting the 
SERCA (Lee and East, 2001). The answer to these stresses is the upregulation of ER 
chaperons, including the glucose regulated protein GRP78 also referred to as BiP 
(immunoglobulin heavy chain-binding protein) and the transcription factor CHOP (C/EBP 
homologous protein). They have both anti-apoptotic features and regulate the ER stress 
sensors (Lee, 2005). To relief the ER stress, GRP78/BiP accelerates protein folding in the 
ER lumen (Momoi, 2004). CHOP sensitizes cells to ER stress by downregulation of Bcl-2 
and activation of GADD34 (protein phosphatase 1 (PP1)-interacting protein) and 
ERO1alpha, an ER oxidase (Li, et al., 2006). In summary, these proteins facilitate protein 
folding and prevent aggregation. 
In mice, chaperones present the signal to capase-12, which is on the cytoplasmic site of 
the ER membrane (Szegezdi, et al., 2003). The role of caspase-12 in human is not known 
since it is expressed in a truncated form and is not functional (Nakagawa, et al., 2000). 
Caspase-4 was proposed to fulfil this function in human, but it is still under debate. It was 
shown to be localized at the ER and be activated by ER stress. Its mechanism though, is 
still not fully understood (Hitomi, et al., 2004). Capase-12 is activated upon ER stress, but 
neither upon death receptor nor mitochondrial apoptotic signals (Nakagawa, et al., 2000). 
Apart from the discussion about activation of murine caspases-12 upon ER stress, there is 
also the possible involvement of caspases-3 being involved in Ca2+ homoeostasis. 
Caspase-3 cleaves IP3 receptors in Jurkat cells and thus decreases the activity of the IP3 
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receptor under apoptotic circumstances (Hirota, et al., 1999).  
 
2.3 Calcium mobilization 
Calcium from the ER is not just an ER stress signal it could also be involved in the 
regulation of Ca2+ influx, ER protein folding and chaperone interaction, gene expression 
and regulation of nuclear pore opening. Calcium elevations may be mediated by ER 
proteins, BAP31 (Breckenridge, et al., 2003), or tBid, which enhance transmission of IP3 
mediated Ca2+ signals to mitochondria (Csordas, et al., 2002). Ca2+ released from the ER 
is taken up by the mitochondria and accumulates in the matrix and this may reset in 
cytochrome c release. Ca2+ traverses the outer mitochondrial membrane primarily through 
the voltage dependent anion channel (VDAC). Ca2+ interacts with cyclophilin D, a 
component of the permeability transition pores, to induce their opening of the permeability 
transion pore (Basso, et al., 2005). Calcium overload of the mitochondria has been linked 
to the recruitment of Drp1, that has been implicated in mitochondrial fragmentation 
(Breckenridge, et al., 2003; Rudner, et al., 2002). Consequences of the pore opening are 
the loss of membrane potential and re-release of Ca2+. When the elevated cytoplasmic 
Ca2+ level persists, the permeability transion pore stays open and allows accumulation of 
solutes in the mitochondrial matrix. The entry of solutes leads to the extension of the 
mitochondrial matrix and to rupture of the outer mitochondrial membrane, thereby to 
releasing the intermembrane space content (Green and Kroemer, 2004). Changes in Ca2+ 
levels appear to be regulated by both pro-and anti-apoptotic members of the Bcl-2 family. 
Bax, Bak and Bcl-2 are localized at the outer mitochondrial as well as at the ER 
membrane. At both membranes they regulate fluxes of calcium, meaning the release from 
the ER and the subsequent uptake by the mitochondria, while Bax and Bak support 
calcium release and Bcl-2 and Bcl-xL antagonize it (Garrido, et al., 2006). Bcl-2 was 
shown, however, to diminish calcium levels in the ER and to stimulate accelerated re-
uptake into the ER or into the mitochondria. In this way, the Ca2+ concentration does not 
cross an intracellular threshold after an apoptotic insult. It might be that blockade of Bcl-2 
and Bcl-xL interaction with IP3 (inositol 1,4,5-trisphosphate) receptors helps the effect of 
Bax and Bak (Chen, et al., 2004; White, et al., 2005). IP3 receptors are found on the ER 
membrane, where they regulate the mobilization of Ca2+ stores (Berridge, 2005). Recent 
studies point to a link between the function of cytochrome c and IP3 triggered Ca2+ 
mobilization (Boehning, et al., 2005). Overexpression of Bcl-2 partially prevents rise of 
cytoplasmic Ca2+ levels upon exposure to exogenous ceramide, staurosporin, 
thapsigargin or growth factor depletion (Distelhorst and McCormick, 1996). Moreover, Bcl-
2 targeted to the ER (Zhu, et al., 1996) averted apoptosis stimulated by ceramide, 
irradiation, thapsigargin and the upregulation of Bax and Bad (Annis, et al., 2001; Rudner, 
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et al., 2001; Thomenius, et al., 2003; Wang and Spector, 2001). A model for calcium 
release from the ER is given in figure 3. 
 
 
Figure 3: ER stress and Calcium release 
Apoptotic signals targeting the ER may induce Ca2+ release to regulate mitochondrial activation by 
opening its permeability transition pore (PTP). 
 
2.4 Activation of the mitochondria 
Mitochondria produce ATP, maintain the equilibrium in-between ions and regulate 
apoptosis. As already mentioned (see 1.2.2), upon apoptotic signals mitochondrial 
proteins are release form the intermembrane space into the cytosol. Among these 
proteins are cytochrome c (Liu, et al., 1996), Smac/Diablo (Adrain, et al., 2001), 
Omi/HtrA2 (Suzuki, et al., 2001), AIF (Cande, et al., 2002) and endonuclease G (Li, et al., 
2001). In order to release these proteins the outer mitochondrial membrane needs to be 
permeabilized. 
 
2.4.1 Mitochondrial outer membrane permeabilization 
The mechanisms of mitochondrial outer membrane permeabilization have not yet been 
illuminated in all details. This leaves room for several models. The two most popular ones 
are the permeabilization of the inner membrane by so far enigmatic mechanisms, and the 
insertion of the multi-domain Bcl-2 proteins Bax and Bak into the outer mitochondrial 
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membrane. 
Permeabilization of the inner mitochondrial membrane is achieved by formation of a 
channel spanning through both membranes of the mitochondria (Crompton, 2000). Each 
of these channels, so-called permeability transition pores, has been suggested to consists 
of the voltage-dependent anion channel (VDAC), an outer membrane protein, the adenine 
nucleotide translocator (ANT), in the inner membrane, and cyclophilin D in the matrix 
(Green and Kroemer, 2004). Increased cytosolic Ca2+ or reactive oxygen species promote 
the opening of these more or less functionally defined permeability transition pores. Once 
the pore is open it allows the osmotic driven influx of water, ions and other small 
molecules into the matrix. These activities leading to swelling of the mitochondria, and are 
termed mitochondrial permeability transition (Zamzami and Kroemer, 2001). Now, rupture 
of the outer mitochondrial membrane is induced and eventually the outer membrane is 
permeabilized, spilling the mitochondrial content into the cytosol (Armstrong, 2006). This 
goes along with the loss of the mitochondrial membrane potential. VDAC, the core of the 
permeability transition pore, is regulated by Bax, Bak and Bcl-2 (Chandra, et al., 2005). In 
another model, pro-apoptotic Bax and Bak form pores in the outer mitochondrial 
membrane by oligomerization. But first, BH3-only proteins induce an allosteric 
conformational change in Bax and Bak. Conformational change exposes the N-terminal 
region of Bax and is needed for integration into the membrane (Korsmeyer, et al., 2000). 
Now, Bax is able to translocate to the mitochondria and stably insert into the membrane. 
They form large multimeric pores in the outer mitochondrial membrane. Intermembrane 
space proteins can escape through these pores into the cytosol. In this model, the inner 
membrane and the matrix would not be affected and remain intact. The crucial role of Bax 
and Bak in mitochondrial membrane permeabilization becomes evident by the fact that 
double knockout cells do not undergo outer membrane permeabilization in response to 
apoptotic stimuli (Armstrong, 2006). The pore forming model embarked, when structural 
similarities of pore forming bacterial toxins and multi-domain proteins were found 
(Muchmore, et al., 1996). But not only Bax and Bak are included in this model.  Truncated 
Bid is also believed to form a pore into the outer mitochondrial membrane by 
oligomerization. Therefore it might function like Bax and Bak regarding permeabilization of 
the mitochondria (Henry-Mowatt, et al., 2004). While Bax and Bak induce the release of 
apoptotic factors from the mitochondria, Bcl-2 and Bcl-xL block outer membrane 
permeabilization and thereby avoid the release of these factors (Daniel, et al., 2003). Due 
to interactions between pro- and anti-apoptotic proteins, the binding affinity and the 
stochiometry in-between them is a crucial factor in induction of apoptosis.  
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2.4.1.1 Release of cytochrome c 
It is not exactly known how cytochrome c is translocated through the mitochondrial outer 
membrane, but there is evidence that the Bcl-2 family members are the main regulators of 
cytochrome c release. Bcl-xL, Bax and Bid share similarities in their transmembrane 
domains, which they have in common with bacterial colicin toxins and diphtheria toxins. 
This led to the assumption that Bcl-2 proteins are also able to form pores. On one hand, 
there is the model already described above, implying that Bax forms pores upon 
oligomerization and integration into the outer mitochondrial membrane. On the other hand 
it has been suggesting that Bax and Bak interact with VDAC and thereby stimulates the 
opening of this channel, although the mechanism is not known (Marzo, et al., 1998; Saito, 
et al., 2000). This model is supported by the finding that inactive Bak is associated to 
VDAC, but can be freed by anti-apoptotic proteins that bind to VDAC2 (Chandra, et al., 
2005). Other reports doubt the pore formation of Bax and Bak, although confirming their 
ability to oligomerize. Additionally to these two models, it was shown that the 
fragmentation of the mitochondrial network during apoptosis is an essential event for 
mitochondrial breakdown. Moreover, it was proposed that Bax plays a critical role in 
mitochondrial fragmentation (Karbowski, et al., 2002). Also, it was shown that the 
truncated form of Bid can release apoptotic factors from the mitochondria by forming 
pores at the outer membrane, when the extrinsic apoptotic pathway is activated 
(Zamzami, et al., 2000). Further, it was reported that the pro-apoptotic activity of BH3-only 
proteins induce cytochrome c release without permeability transition (Shimizu and 
Tsujimoto, 2000).  
There are arguments for and against the models mentioned. Most likely, different 
apoptotic stimuli induce distinct mechanisms for permeabilization of the outer 
mitochondrial membrane. 
 
2.4.1.2 Release of pro-apoptotic factors 
Not only cytochrome c is set free upon disruption of the outer mitochondrial membrane. 
Also other apoptosis-inducing factors are liberated from the mitochondria. 
AIF (apoptosis inducing factor) is a flavoprotein, which translocates to the nucleus and is 
participating in chromatin condensation and DNA-fragmentation in a caspase-dependent 
manner (Daugas, et al., 2000; Lorenzo, et al., 1999; Susin, et al., 1999). Its redox activity 
is not important for its apoptotic effect (Miramar, et al., 2001). These data are, however, 
discussed in a highly controversial fashion. 
Endonuclease G is a DNA degrading enzyme important for DNA-repair in mitochondria. It 
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is released from the matrix and migrates to the nucleus and degrades DNA in a caspase 
independent way (van Loo, et al., 2002). 
Omi/HtrA2 (high temperature requirement A2) is a serine protease, which acts as 
chaperone for correction of misfolded proteins or their degradation, but also inhibits IAPs 
(inhibitor of apoptosis proteins). Its mitochondrial signal sequence targets it to the 
intermembrane space, where this targeting-signal is being cleaved off and, the remaining 
protein is transformed into a mature protease. In the cytosol, Omi/HtrA2 facilitates 
caspase-dependent apoptosis, catalytic cleavage of IAPs, and permeabilization of the 
outer mitochondrial membrane (Faccio, et al., 2000; Hegde, et al., 2002; Suzuki, et al., 
2004; Verhagen, et al., 2002; Yang, et al., 2003). Generally speaking, this protein appears 
to exert similar functions as Smac/Diablo (second mitochondria derived activator of 
caspases / Direct IAP binding protein with low pI). In a caspase-independent and Apaf1-
independent fashion, Omi/HtrA2 is able to induce cell death using its serine protease 
activity (Hegde, et al., 2002; Suzuki, et al., 2004). Structural analyses showed that 
cytosolic Smac/Diablo is a symmetric homo-dimer (Chai, et al., 2000). After the release 
from the mitochondria Smac/Diablo binds IAPs in the cytosol. In this way, Smac/Diablo 
regulates IAPs by inhibiting their activity (Vaux and Silke, 2003). Therefore, it amplifies 
caspase activity, since IAPs inhibit the activity of processed caspases (Du, et al., 2000). 
 
2.5 Crosstalk between ER and mitochondria 
The mechanisms and the part of crosstalk between the mitochondria and the endoplasmic 
reticulum are not entirely illuminated. But it seems that cytochrome c induced apoptosis 
activated by ER - mitochondria crosstalk is important for ER stress mediated cell death 
(Momoi, 2004). Moreover, the main signal in ER-mitochondria crosstalk is thought to be 
calcium. After activation of the death receptor pathway and consequent activation of 
caspase-8, BAP31 (Bcl-2-associated protein 31) is cleaved to a p20 fragment. BAP31 is 
an integral ER membrane protein that seems to be a mediator of crosstalk between the 
two organelles and it has pro-apoptotic capacities. It is cleaved and activated by a unique 
isoform of caspase-8 (Breckenridge, et al., 2002). The p20 cleavage product of BAP31 
causes the release of Ca2+ from the ER. Liberated Ca2+ is taken up by the mitochondria 
inducing the recruitment of Drp1. Drp1 mediates the scission of the outer mitochondrial 
membrane, resulting in dramatic fragmentation and fission of the mitochondrial network 
and cytochrome c release (Breckenridge, et al., 2003). Calcium signals from the ER 
regulate the opening of the permeability transition pore. Absorbed Ca2+ in the matrix 
causes at a certain level the opening of the mitochondrial transion pore, which leads to 
loss of the mitochondrial membrane potential and hence to the release of cytochrome c 
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and apoptotic factors. This process is followed by translocation of cytochrome c to the ER, 
where it interacts with IP3 receptors to induce a positive feedback loop (Boehning, et al., 
2003). Recent studies of the ER-mitochondrial communication presented some evidence 
for regulation of the IP3 receptor-mediated Ca2+ release by both pro- and anti-apoptotic 
proteins. Pro-apoptotic factors have been described to facilitate the mobilization of ER 
Ca2+ thereby strengthening the calcium signal propagation to the mitochondria. This may 
lead to Ca2+-dependent mitochondrial membrane permeabilization (Hajnoczky, et al., 
2006). ER membrane proteins also interact with Bcl-2 proteins and thereby influence the 
apoptotic events. Further, it was reported that Bax and Bak induced cytochrome c release 
by interacting with VDAC. With its cytosolic domain BAP31 can interact with procaspase-
8, Bcl-2 and Bcl-xL, but the BH3-only protein Spike can block the formation of the BAP31 
– Bcl-xL complex (Mund, et al., 2003). Another BH3-only protein, Bad, might also be 
involved in ER activation. It is dephosphorylated by calcineurin, a Ca2+/calmodulin 
dependent protein phosphatase and induces the release of pro-apoptotic factors from the 
mitochondria (Wang, et al., 1999). 
 
2.6 Caspases 
Caspases (cysteine-aspartate proteases) are key proteins in the apoptotic process. They 
specifically cleave their substrates following an aspartate residue (Earnshaw, et al., 1999). 
Caspases are synthesized as catalytically inactive pro-caspases i.e. zymogens. They 
need an apoptotic stimulus to be activated by either proteolytic cleavage by other 
caspases or by autocatalysis to become an active enzyme (Cohen, 1997; Shi, 2002). The 
caspase family comprises in human 11 members (13 in mammalian). Based on 
observations made in C. elegans, the first member of this family was described in 1992 as 
the CED-3 homologue interleukin-1-converting enzyme (ICE, later caspase-1) (Cerretti, 
et al., 1992; Thornberry, et al., 1992). According to there structure, several other caspases 
were identified. The amino acid sequence QAC(R/Q/G)G, found in the active site of 
caspases is highly conserved (Alnemri, et al., 1996). The substrate recognition motif 
varies among caspases, making them target-specific substrates (Thornberry, 1997). 
Nevertheless, all caspases cleave at the peptide bond C-terminal of aspartate residues. 
Zymogens consist of 3 domains, one N-terminal pro-domain, followed by one large 
(20kDa) and one small subunit (10kDa), which are separated by linkers. After 
proteolytic cleavage both subunits form heterodimers, made of 2 subunits of each 
proform, with a catalytic site. Caspases can undergo autoactivation or be activated by 
other caspases. 
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2.6.1 Initiator and executioner caspases 
Caspases can be divided into two groups (figure 4), the initiator caspases (caspase-2, -8, 
-9, -10) and the executioner caspases (caspase-3, -6, -7) (Thornberry and Lazebnik, 
1998). These two groups differ in the length and structure of their prodomain. Initiator 
caspases carry a long prodomain with a DED and a CARD (caspase recruitment domain) 
domain and are the link between cell signalling and apoptosis. The CARD domain is 
binding the adapter molecules, the DED cares for the hydrophobic binding of the adapter 
protein (Earnshaw, et al., 1999). Caspases-8 is the main mediator in the extrinsic cell 
death pathway induced by the TNF family members. Binding of death ligands (CD95, Fas) 
leads to trimerization of the death receptors and aggregation of death domains (DD). 
Together with FADD (Fas associated death domain) which recruits procaspase-8 the 
death-inducing signalling complex (DISC) is formed, where caspase-8 is activated (Muzio, 
et al., 1996). Also in the intrinsic cell death pathway the formation of a complex, the 
apoptosome, consisting of procaspase-9 and its adapter protein Apaf-1 is required. The 
pro-domain of the initiator caspase interacts with the adaptor protein leading to 
dimerization and finally to autocatalytic activation (Earnshaw, et al., 1999). Autoproteolytic 
cleavage yields in two small and two large subunits forming an active caspase as a 
homodimer of two heterodimers (Nicholson, 1999). 
The effector caspases share a short pro-domain and act downstream of the apoptotic 
pathway. Initially, they are cleaved by the initiator caspases at a specific asparagin 
residue, followed by autoproteolytic cleavage. Active effector caspases cleave substrates 
escalating the death signal and executing apoptosis (Savill and Fadok, 2000). Caspase-3 
is the main effector caspase that cleaves the majority of the cellular substrates in 
apoptotic cells. Caspase-7 is highly similar to caspase-3 and has comparable substrate 
specificity (Degterev, et al., 2003). They both amplify mitochondrial caspase activation 
signalling (Lakhani, et al., 2006).  
The position of caspases in the pathway is not just defined by their structure and length, 
but also by their subcellular localization (Zhivotovsky, et al., 1999). 
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Figure 4: The caspase family 
There are three major groups of caspases, group 1: initiator caspases, group 2: effector caspases and 
group 3: inflammatory caspases. Caspases are synthesized as pro-caspases with an N-terminal pro-domain. 
The active caspase is a heterotetramer of two large and two small subunits. 
 
2.6.2 Substrates of the caspases 
Caspases target substrates, which are either maintaining the metabolism of the cells or 
proteins involved in the apoptotic machinery (Fischer, et al., 2003). Caspases cleave 
different substrates in a different manner. However, processing of the substrate can be 
directly connected to the morphological changes during apoptosis. In the final steps of 
apoptosis the cell loses its shape. This is indicated by caspases that degrade structural 
proteins, which maintain e.g. the cytoskeleton (Brockstedt, et al., 1998). Among them are 
actin filaments and nuclear lamins, which are cleaved by caspase-6 (Orth, et al., 1996). 
Caspases cleave proteins involved in cell cycle regulation and DNA repair (Cohen, 1997). 
In healthy cells, ICAD (inhibitor of caspase-activated DNase) is in a complex with the 
inhibitor DFF45. Activation requires cleavage of the inhibitor protein by caspase-3 
resulting in active CAD-nuclease which then translocates to the nucleus (Enari, et al., 
1998; Sakahira, et al., 1998). PARP is a nuclear enzyme and is activated upon cleavage 
by caspase-3 at an early stage of apoptosis. It is cleaved into a small, N-terminal fragment 
and a large, C-terminal (catalytical) subunit abrogating its DNA repair and ATPase activity. 
PARP catalyzes the transfer of ADP-ribose polymers to other nuclear proteins, which are 
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in involved in DNA repair and stabilization. If caspases are not active, PARP is 
excessively consuming energy during the apoptotic process and cells end up dying by 
necrosis (Kaufmann, et al., 1993). Thus, it seems that PARP may act as a molecular 
switch between apoptosis and necrosis (Fischer, et al., 2003). 
 
2.7 The Bcl-2 family 
The members of the Bcl-2 (B-cell lymphoma (gene) 2) family are important regulators of 
apoptosis. They transmit external survival or death signals inside the cell. The Bcl-2 family 
members are grouped into two subfamilies of anti-apoptotic and pro-apoptotic proteins 
(figure 5). They all share at least one of the four conserved -helical so-called Bcl-2 
homology (BH) domains (BH1, BH2, BH3, BH4). These domains are conserved motifs 
(Cory and Adams, 2002). The pro-apoptotic proteins involve a subgroup, which comprises 
the BH3-only proteins (Huang, et al., 2002). The anti-apoptotic members share all four BH 
domains, whereas the pro-apoptotic members do not a possess BH4. Instead, they are 
subdivided into the multi-domain group carrying BH1-3 and the BH3-only group. BH1 to 
BH3 are responsible for binding by forming a hydrophobic pocket. They give the proteins 
the ability to form homo- and heterodimers (Borner, 2003). Anti-apoptotic proteins prevent 
permeabilization of the mitochondria, which is on the other hand promoted by the multi-
domain group of the pro-apoptotic proteins. Some of the anti-apoptotic proteins interact 
directly with members of the pro-apoptotic group (Gross, et al., 1999; Rosse, et al., 1998). 
The balance in-between anti-apoptotic and pro-apoptotic proteins decide about life or 
death of the cell. 
Members of the Bcl-2 family can regulate apoptosis in different manner: by forming protein 
channels in mitochondrial membranes or by changing the membrane structure by 
interactions with lipids. They regulated ion fluxes and release of other proteins by the 
permeabilization of the mitochondrial membrane and the endoplasmic reticulum (Sharpe, 
et al., 2004).  
 28 
           Introduction 
 
Figure 5: The Bcl-2 family 
Bcl-2 family members possess at least one of four BH (Bcl-2 homology) domains and are grouped 
according to their ability to inhibit or activate cell death. The pro-apoptotic proteins bind with their BH3 
domain to the hydrophobic pocket formed by the BH1-BH3 domains of the anti-apoptotic proteins. The C-
terminal transmembrane (TM) region is a hydrophobic, single membrane spanning alpha helix that 
mediates localization to intracellular membranes. 
Anti-apoptotic members of the Bcl-2 family 
Pro-apoptotic members of the Bcl-2 family, subgrouped into multi-domain proteins and BH3-only proteins. 
 
2.7.1 The anti-apoptotic proteins 
The anti-apoptotic members of the Bcl-2 family share three or four Bcl-2 homology (BH) 
domains, which are essential for apoptosis (figure 5). Proteins such as Bcl-2, Bcl-xL 
(Boise, et al., 1993), Bcl-w (Gibson, et al., 1996), A1/Bfl-1 (Choi, et al., 1995; Lin, et al., 
1996) and Mcl-1 (Kozopas, et al., 1993) belong to this group. Bcl-2 and Bcl-xL possess all 
four BH domains, where as other anti-apoptotic family members such as Mcl-1 carry only 
BH1 and BH2. The BH-domain serves as binding site for interaction with other proteins. 
BH1, BH2 and BH3 form a hydrophobic groove, which is stabilized by the N-terminal BH4-
domain (Huang, et al., 2002) . This groove represents the binding site for the BH3 -helix 
of the BH3-only proteins (Sattler, et al., 1997). This interaction neutralizes the anti-
apoptotic family members. In healthy cells, the anti-apoptotic proteins primarily might hold 
back Bax and Bak from disturbing intracellular membranes, especially the outer 
mitochondrial membrane (Liu, et al., 2003). Anti-apoptotic proteins can become pro-
apoptotic after N-terminal proteolytic cleavage of the BH4 domain (Cheng, et al., 1997). 
Furthermore, their anti-apoptotic effect seems to depend solely on their BH4 domain, 
since its deletion led to loss of their activity (Huang, et al., 1998). With their C-terminal tail 
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the anti-apoptotic proteins such as Bcl-2, Bcl-w, Bcl-xL and Mcl-1 are able to insert 
themselves into sub cellular membranes, including the outer mitochondrial membrane, the 
endoplasmic reticulum or the nuclear envelope (Cory and Adams, 2002; Duriez, et al., 
2000). High expression of Bcl-2 and Bcl-xL is found in several types of cancer. Bcl-2 is an 
integral membrane protein, even in healthy cells, whereas Bcl-w and Bcl-xL only 
incorporate into membranes after death signals. Bcl-2 and Bcl-xL inhibit apoptosis by 
insertion into the outer mitochondrial membrane, they may maintain the membrane 
integrity (Sharpe, et al., 2004). Bcl-xL was reported to inhibit cytochrome c release (Daniel, 
et al., 2003). There is some discussion about how and if the anti-apoptotic members are 
involved in mitochondrial membrane permeabilization. Structural features seem to make it 
likely that they have pore forming abilities, since they show similarities with several 
bacterial toxins, colchicines A, E1 and diphtheria toxin (Antonsson, et al., 1997; Minn, et 
al., 1997; Schendel, et al., 1997; Schlesinger, et al., 1997). Others say that VDAC is 
involved in the regulation of the anti-apoptotic group members. VDAC is located at the 
outer mitochondrial membrane. Interaction of VDAC and the anti-apoptotic proteins 
causes the exchange of anions between cytosol and the intermembrane space of the 
mitochondria (Heiden, et al., 2000). Moreover, Bcl-2 and Bcl-xL keep pro-apoptotic BH3-
only proteins inactive by binding to them in a complex.  
Bcl-2, Bcl-xL and Bcl-w strongly inhibit apoptosis in response to many, but not all, 
cytotoxic insults. Every cell requires protection by at least one anti-apoptotic family 
member, as they are chief guardians of tissue homeostasis (Cory and Adams, 2002). 
Efficient apoptosis calls for neutralization of several anti-apoptotic proteins and imply that 
not all the anti-apoptotic proteins may have the same function (Adams and Cory, 2007).  
 
2.7.2 The pro-apoptotic proteins 
The pro-apoptotic family members are subdivided in multi-domain proteins and BH3-only 
proteins. Pro-apoptotic proteins Bax (bcl-2 associated protein X) (Oltvai, et al., 1993), Bak 
(Chittenden, et al., 1995) and Bok (Hsu, et al., 1997) contain BH1-BH3 but lack BH4 and 
are therefore also called multi-domain proteins. In healthy cells Bak is held in an inactive 
monomeric state in the outer mitochondrial membrane through its association with VDAC2 
(Cheng, et al., 2003). Bax is a monomeric cytosolic protein, inactive through interactions 
with several proteins (Breckenridge and Xue, 2004). Upon activation they both undergo a 
conformational change. First Bax has to translocate to the mitochondria (Hsu, et al., 1997; 
Wolter, et al., 1997) before inserting into the outer membrane (Goping, et al., 1998), 
whereas Bak stays in the mitochondrial membrane, where they both oligomerize 
(Antonsson, et al., 1997). Their carboxyl-terminus is essential for targeting to 
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mitochondria. One model is that Bax and Bak form pores to release pro-apoptotic factors 
from the mitochondria. The other hypothesis says that they associate with parts of the 
permeability transition pore (Cory and Adams, 2002). But both models agree on 
permeabilization of the outer mitochondrial membrane by Bax and Bak. And both multi-
domain proteins stimulate the release of cytochrome c form the mitochondria using the 
voltage-dependent anion channel (VDAC) (Daniel, et al., 2003). Bax and Bak are 
indispensable for apoptotic signalling, since double knockout experiments showed that 
development and proliferation is not possible without these proteins, either Bax or Bak has 
to be present in order to fulfil the assignment properly (Lindsten, et al., 2000). Cells 
without Bax and Bak are resistant to most apoptotic stimuli (Cheng, et al., 2001). Bax and 
Bak mainly regulate the intrinsic pathway, being localized at the mitochondria, but they 
also operate at the ER (Scorrano, et al., 2003; Wei, et al., 2001). Currently two models are 
discussed: 1. Direct activation, holds that certain BH3-only proteins, termed activators, 
Bim and tBid, can bind to Bax and Bak directly and promote their activation, in this model, 
the remaining BH-only proteins, termed sensitizers, bind only to the pro-survival proteins 
and purportedly act by displacing any bound Bim or tBid, allowing them to directly activate 
Bax and Bak. 2. Indirect activation, on the other hand, suggests that all the BH3-only 
proteins engage only their pro-survival relatives and act by preventing them from 
countering Bax or Bak activation, on this model, Bim and tBid are potent inducers of 
apoptosis simply because they can engage all the pro-survival proteins (Willis and Adams, 
2005; Willis, et al., 2007). In the extrinsic pathway, truncated Bid initiates oligomerization 
of Bax or Bak leading to cytochrome c release from mitochondria (Wei, et al., 2000), since 
cells lacking both of these proteins did not undergo apoptosis after Bid activation. But if at 
least one of these two multi-domain proteins is present, cell death will be initiated (Wei, et 
al., 2001). Interestingly, high levels of anti-apoptotic proteins block Bax oligomerization 
and pore formation, but no Bcl-2 - Bax complex could be detected (Mikhailov, et al., 
2001). The BH3-only group comprise quite a lot of members, such as Bid (Wang, et al., 
1996), Noxa (Oda, et al., 2000), Puma (Nakano and Vousden, 2001; Yu, et al., 2001), Bim 
(O'Connor, et al., 1998), Nbk (Boyd, et al., 1995; Han, et al., 1996), Bad (Yang, et al., 
1995) and some more (figure 5). The BH3 motif is a short sequence of nine amino acids 
and the only commonality of these proteins. The BH3-only proteins function as sensors of 
apoptotic stimuli and are charged to trigger apoptosis (Huang and Strasser, 2000). The 
crucial decision on life or death seems to be fought on these membranes, although most 
family members are recruited to these sites upon apoptotic signal (Adams and Cory, 
2007). In healthy cells the BH3-only proteins are in an inactive state (Huang and Strasser, 
2000). Only upon apoptotic signal they are activated and perform their duty. Distinct 
apoptotic stimuli activate different proteins of this group, which then deliver the death 
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signal to the mitochondria by engaging Bax/Bak or Bcl-2/Bcl-xL (Puthalakath and Strasser, 
2002). For example, Noxa and Puma are induced by transcription with p53 as their 
transcription factor. P53 is activated upon DNA-damage, irradiation and cytotoxic drugs 
(Han, et al., 2001; Lakin and Jackson, 1999). Other proteins of the BH3-only group are 
activated by posttranslational modifications, e.g. Bad, which is dephosphorylated (Harada, 
et al., 1999). Bid is activated by proteolytic cleavage. In its inactive form Bid is a cytosolic 
protein, but once it is cleaved, truncated Bid (tBid), it translocates to the mitochondria (Li, 
et al., 1998). There, it stimulates the permeabilization of the mitochondrial membrane and 
therefore the release of apoptotic factors. Expression of several BH3-only proteins, such 
as Bim, Bad and Bid in Bax/Bak double knockout cells could not induce apoptosis, 
suggesting that BH3-only proteins require Bax or Bak to mediate apoptotic signals (Zong, 
et al., 2001). Most members have additionally a hydrophobic sequence at the C-terminus, 
which helps them to integrate into organelle membranes.  
Bid is activated upon cleavage by caspase-8 after initiation of the extrinsic apoptotic 
pathway (Li, et al., 1998). Normally, Bid is localized as an inactive form in the cytosol. 
After activation, truncated Bid (tBid) translocates to the mitochondria to enhance the 
apoptotic signal (Gross, et al., 1999). Additionally, Bid activates Bax by inducing a 
conformational change, followed by the translocation of Bax to the mitochondria (Eskes, et 
al., 1998). Truncated Bid seems to amplify the perturbation of the mitochondria by forming 
homotrimers in the membrane (Cory and Adams, 2002). Apart from amplification of the 
mitochondrial pathway, tBid can also convey death signals form other organelles. Bid has 
an unique place in apoptosis, since it connects the extrinsic and intrinsic pathway (Daniel, 
2000). The BH3-only protein Nbk/Bik localizes at the ER and not at the mitochondria, it 
mediates the activation of the mitochondria in a Bax-dependent manner (Gillissen, et al., 
2003). Puma and Noxa and Hrk/DP5, are controlled primarily at the transcriptional level. 
Puma and Noxa are expressed upon p53 activation and they were shown to cause outer 
membrane permeabilization. Co-immunoprecipitation studies showed that Noxa binds to 
Bcl-2 and Bcl-xL, but not to Bax (Oda, et al., 2000).  
If the balance between anti-apoptotic and pro-apoptotic Bcl-2 family members is shifted in 
the favour of the pro-apoptotic proteins, they bind to and occupy the anti-apoptotic 
proteins, thereby liberating Bax and Bak (Gogvadze and Orrenius, 2006). 
 
2.7.2.1 Bim 
This BH3-only protein is subject to this thesis and will therefore be introduced in more 
details. While screening for proteins that bind to Bcl-2, a novel protein, named Bim (Bcl-2 
interacting mediator), was discovered (O'Connor, et al., 1998). The only common feature 
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with other known proteins was its BH3 domain, placing it into the BH3-only group of the 
Bcl-2 family. Bim plays a major role in embryogenesis, in the control of haematopoietic 
cell death and as a barrier against autoimmunity (Bouillet, et al., 1999). Originally three 
different Bim splicing variants were found (O'Connor, et al., 1998), but there are also 
additional splicing variants, all encoded by the same gene (figure 6). These various 
isoforms differ in size and apoptotic strength. The best characterized are the three main 
isoforms BimEL, BimL and BimS is constitutively pro-apoptotic and appears to be the most 
toxic, whereas BimEL and BimL are held in an inactive form in healthy cells. Binding to the 
dynein motor complex light chain LC8 (DLC1) of the microtubule sequesters BimEL and 
BimL. In response to cytokine removal, calcium flux, microtubule perturbation (by taxol a 
microtubule polymerizing drug) or cellular damage by UV-irradiation, BimEL and BimL are 
released from the microtubule in a complex with LC8 (Puthalakath, et al., 1999). The LC8-
Bim complex can bind to and antagonize the anti-apoptotic proteins (Borner, 2003) and is 
recruited to the mitochondria. There are controversial reports on BimS about its function 
and expression. Tissue distribution studies for Bim demonstrated expression of BimEL and 
BimL in haematopoietic, epithelial, neuronal and germ cells, while BimS was not detected 
by Immunoprecipitation (IP) or Western blot analysis. It was speculated that BimS is only 
expressed in specific cells that need to be extinguished quickly or that BimS is not 
expressed under physiological conditions (Bouillet, et al., 1999; Puthalakath, et al., 1999). 
On the other hand, there are data showing expression of all three isoforms at similar 
levels in DLD-1 and HSC-2 cells (Adachi, et al., 2005). Besides, colony-forming assays 
and cell death studies illustrated the differences of all three isoforms in their cytotoxicity. 
BimS was found to block colony formation and to stimulate apoptosis in the most effective 
way (O'Connor, et al., 1998).  
 
Figure 6: The three main isoforms of Bim 
Schematic structures of the three main isoforms are shown. BimEL and BimL contain the dynein binding site 
by which they are attached to the microtubule, BimS lacks this region. 
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Bim is regulated by transcriptional induction since upregulation results in an elevated 
amount of Bim-Bcl-xL complexes (Bouillet, et al., 1999) as well as by phosphorylation by 
c-Jun N-terminal kinase (JNK) (Lei and Davis, 2003) and is subject to several types of 
post-translational modifications (Puthalakath, et al., 1999). The BH3-region is essential for 
the interaction of Bim with anti-apoptotic Bcl-2 family members and for most of its deadly 
effect. Its hydrophobic C-terminus enables Bim to localize to cytoplasmic membranes 
(O'Connor, et al., 1998). Furthermore, it cannot trigger cell death in bax/bak double 
knockout cells. Hence, it might be that multi-domain pro-apoptotic proteins are activated 
by their release from anti-apoptotic factors upon BH3-only protein interference (Cheng, et 
al., 2001). Bim seems to act upstream of Bax and Bak, since this BH3-only protein was 
not able to induce neither cytochrome c release nor apoptosis in cells deficient for Bax 
and Bak (Wei, et al., 2001). Being at the microtubule, Bim has the perfect place to serve 
as stress sensor and communicator of stress signal to Bax and Bak. Overexpression of 
Bim highlighted its cytotoxity in several cell types, although it was shown that a few 
molecules of Bim are enough to induce apoptosis even in the presence of increased 
levels of anti-apoptotic proteins (Strasser, et al., 2000). Indeed, Bim possibly is the most 
potent killer of any other Bcl-2 family protein. Also, to date, Bim is not only the sole BH3-
only protein expressing three different splicing products, but all of these main isoforms 
interact with Bcl-2 and Bcl-xL. 
               Materials and Methods 
3 Materials and Methods 
3.1 Cell lines 
Prostate carcinoma sarcoma DU145 cells were purchased from ATCC (Manassas, USA. 
This cell line was isolated from a brain tumour of a patient with metastatic prostate cancer 
by K R. Stone (Stone et al., 1978). The cells carry a mutation for p53 as well as for Bax.  
 
DU145Bax cells were generated as described earlier (Hemmati, et al., 2002) in the 
laboratory using retroviral infection. Briefly, for expression of Bax in the Bax-negative 
DU145 cells we employed the retroviral vector HyTK-Bax (Weinmann, et al., 1997), which 
contains the human Bax-a cDNA under the control of a CMV promoter. Supernatant of the 
virus producing packing cell line Fly-18 (Cosset, et al., 1995) was used to infect DU 145 
cells in the presence of 8mg/ml polybrene (Sigma Chemical Co., Grunwald, Germany). 
Hygromycin (0.5 mg/ml) was added to the cells for selection 48 h later. After 3 weeks of 
selection the cells were subcloned. Bax expression of the clones was determined by 
Western blot analysis as described below. 
DU145Bak cells were generated as described earlier (Radetzki, et al., 2002). Briefly, the 
human Bak cDNA was cloned by PCR amplification from human cDNA using 
electroporation. Stable transfectants were selected in 1mg/ml G418. Mock transfectants 
were generated by the use of the empty pcDNA3 plasmid. 
DU145 EGFP-Bax and EGFP-Bak cells were generated as described earlier (von Haefen, 
et al., 2004) by transfection using Lipofectamine 2000 (Invitrogen Gibco, Karlsruhe, 
Germany). cDNA of Bak and Bax were amplified with PCR. PCR products were digested 
and cloned as BglII/EcoRI fragments into the corresponding sites of the vector pEGFP-C2 
(BD Biosciences Clontech, Heidelberg, Germany) to obtain Bax or Bak that carry the 
EGFP tag at the N-terminus. Stable transfectants were selected by the use of G418 at 1 
mg/ml, subcloned and EGFP-Bak or EGFP-Bax expression of the clones was determined 
by fluorescence microscopy. 
 
Media: DMEM high glucose (4.5g/l) medium supplemented with 10% fetal bovine serum 
(FBS), 100U/ml penicillin and 100µg/ml streptomycin (All from GICO, Karsruhe, 
Germany). 
 
HEK293 cell line is a transformed primary human fetal kidney cell line, which constitutively 
expresses AdE5E1 proteins (Graham et al. 1977). For this reason they were used for 
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adenoviral amplification and titration.  
Media: DMEM high glucose (4.5g/l) medium supplemented with 10% FBS, 100U/ml 
penicillin and 100µg/ml streptomycin. 
 
3.2 Storing stock cells 
For constituting stocks of different cell lines, 1x106 cells in 500µl of pure media were 
supplement with 500µl of a 1:5 DMSO:FBS mix in cryotubes, frozen for 2h at –20°C and 
then stored at –80°C and subsequently stowed in liquid nitrogen. 
 
3.3 Agarose Electrophoresis and extraction of DNA 
The separation of the DNA bands was performed with 1% agarose gels containing 
0.1µg/ml of ethidiumbromid. The agarose gel was run in a BioRad gel chamber with 
1xTBE running buffer.  
DNA was extracted from the agarose gel with QIAEX II gel extraction kit (Qiagen, Hilden, 
Germany). The appropriate DNA-band was cut from the gel and was weighted. The gel 
slice was incubated with 3 times volumes of buffer QX 1 followed by addition of 30µl of 
QIAEX 2 buffer containing silica beads. The mixture was incubated for 10min at 50°C to 
allow the DNA to bind to the beads. Next, the solution was centrifuged at 14000rpm for 30 
sec and the pellet was washed twice with 500µl of PE buffer. The pellet was air-dried and 
the DNA was eluted with water.  
The concentration of the DNA was determined by photometric measurement at 260nm 
while water served as a standard.  
10x TBE: 108g Tris 
 55g boric 
acid 
 7.44g EDTA 
 in 1l aqua 
dest. 
 
3.4 PCR 
DNA was amplified by the polymerase-chain-reaction. The mixture contained 10ng of 
DNA, 1pmol of each primer, 200µM dNTPs, 10x buffer and 1U Taq polymerase in a total 
volume of 20µl (all from Invitek, Berlin, Germany). 
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To create the DNA fragments the following program was used: 95°C for 10min to activate 
the polymerase, 25 cycles of, denaturation of the DNA at 95°C for 60s, annealing at 58°C 
for 60s, elongation at 72°c for 90s. 
 
3.4.1 Primers 
E1A sense: 5’ – GAG ACA TAT TAT CTG CCA CGG AGG – 3’ 
 anti-sense: 5’ – TTG GCA TAG AAA CCG GAC CCA AGG – 3’ 
(Adesanya, et al., 1996) 
 
E4 sense: 5’ – GTA GAG TCA TAA TCG TGC ATC AGG – 3’ 
 anti-sense: 5’ – TTT ATA TGG TAC CGG GAG GTG GTG – 3’ 
(Adesanya, et al., 1996) 
 
Bim sense: 5’ – GGA TCC ATG GCA AAG CAA CCT TCT – 3’ 
 anti-sense: 5’ – ACC TCT TAC GTA ACT ACG AGA TCT – 3’ 
 
All primers were purchased from BioTez GmbH, Berlin, Germany 
 
3.5 Precipitation of DNA 
1:10 volumes of (3.5M) potassium acetate and 2x volume of 100% ethanol was mixed 
with the DNA and incubated at -20°C for 15min. After that, the mixture was centrifuged at 
14000rpm for 30min at 4°C. The pellet was washed 3x with ethanol, dried and finally 
dissolved in water. 1 OD equals to 50mg/ml of DNA. 
 
3.6 Ligation of DNA 
DNA fragments were ligated into plasmids by using T4 DNA ligase. Up to 200ng of DNA 
were incubated with 50ng of the appropriate vector together with 1U of T4 ligase in the 
provided 1x ligase buffer over night at 14°C. 
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3.7 Transformation of bacteria by heat shock 
50µl of heat competent E.coli DH5α bacteria (Clontech, Saint-Germain-en-Laye, France) 
were incubated with 5µl of DNA on ice for 30min. Then, the bacteria-DNA mix was “heat-
shocked” for 90s at 42°C followed by incubation for 5min on ice. 500µl of LB-media was 
added to the mixture and incubated for 1h at 37°C. Finally, the bacteria were smeared on 
an agar plate, containing 50µl/ml ampicilin. The plates were incubated over night at 37°C. 
LB 
Medium: 
10 g Trypton 
 5 g yeast extract 
 5 g NaCl 
 in 1 l aqua dest. 
  
Agar 
plates: 
15 g Agar 
 1 l LB-Medium 
 100 μg/ml ampicillin 
 
3.8 Immunochemistry 
1.5x105 cells were plated on sterile cover slips placed into 6-well plates and infected with 
adenoviral vectors at 25 MOI after 24h. After three times of washing with PBS, the cells 
were fixed with ice-cold 1% paraformaldehyde for 30min. The fixed cells were 
permeabilized with ice-cold 100% methanol for 1min. The cells were again washed with 
PBS and incubated with blocking solution for 30min at RT. The primary antibodies were 
diluted in blocking solution, applied on the cells and incubated over night at 4°C, followed 
by secondary antibodies for 1h at RT. Finally, the slides were washed with PBS and 
mounted in Dako fluorescent mounting medium (DakoCytomation, Glostrup, Denmark) 
and dried at 4°C over night. 
To stain the mitochondria, the cells were incubated with MitoTracker Green (Molecular 
Probes, Leiden, the Netherlands) at 37°C for 1h with a final concentration of 500nM. 
The nuclei were stained with DAPI (Sigma Aldrich, Munich, Germany) at a final 
concentration of 0.5µg/ml. 
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3.9 Western blot analysis 
3.9.1 Preparation of protein samples and determination of the 
concentration 
Cells were harvested by trypsinization and centrifuged at 2000rpm, 4°C for 5min. Pellets 
were washed with ice cold PBS and lysed in an appropriate amount of lysis buffer on ice 
for 30min. After centrifugation at 14000rpm, 4°C for 15min the supernatant was collected 
as protein sample. To separate the cytosolic from the organelle fraction, the pellets were 
resuspended with a hypotonic lysis buffer and immediately centrifuged at 2000rpm, 4°C 
for 5min. the supernatant was kept as the organelle fraction and the pellet was incubated 
in lysis buffer on ice for 30min and treated as described above. To detect cytochrome c 
release, the cells were separated into a cytosolic and mitochondrial fraction by using “mito 
buffer”, a specific lysis buffer. Cell pellets were incubated with the “mito buffer” on ice for 
5min followed by centrifugation at 2000rpm, 4°C for 5min. the supernatant containing the 
mitochondrial fraction was kept and subjected to determination of protein concentration as 
described above. The remaining pellet was incubated with lysis buffer on ice for 30min. 
the pellets were centrifuged at 14000rpm, 4°C for 15min the supernatant was collected as 
protein sample representing the cytosolic fraction.  
The protein concentration was determined using the bicinchoninic acid (BCA) assay 
(Pierce, Rockford, USA). 10µl of protein was mixed with 200µl of BCA solution (reagent A: 
reagent B, 50:1) in a 96-well plate and incubated at 37°C for 30min in the dark. The 
absorption was measured at 620nm. A BSA concentration row served as standard. The 
protein concentration was calculated based on the standard curve. 
 
Lysis buffer 2mM EDTA 
 0.1% SDS 
 1% Triton-X100 
 1mM Na3VO4 
 1mM beta-glycerolphosphate 
 1 tablet protease inhibitor cocktail (“Complete”, Roche 
Diagnostics) 
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Hypotonic buffer: 200mM HEPES pH 7.4 
 10mM KCl 
 2mM MgCl2 
 1 mM EDTA 
 in 100ml 
 to 1ml of buffer add prior to use: 
 7.5µl 100mg/ml digitonin 
 7.5µl 10mM PMSF 
 
3.9.2 SDS-PAGE 
SDS-PAGE (Sodium dodecyl sulfate-polyacrylamide gel electrophoresis) is a method to 
separate  proteins and peptides according to their molecular weight (Laemmli, 1970). The 
anionic detergent SDS denaturates proteins by wrapping its hydrophobic tail around the 
polypeptide backbone, giving the protein a negative charge, which is proportional to its 
length. The reducing agent β-mercaptoethanol in the sample buffer cleaves any disulfide 
bonds between cysteine residues, resulting in a completely unfolded protein. Like this, the 
original conformation and charges of the proteins do not have any influence on how they 
migrate through the gel. The only parameter is their molecular weight. The proteins are 
concentrated at the end of the stacking gel before entering the separating gel. 
Electrophoresis was carried out with a Bio-Rad Mini-PROTEAN® 3 system. Gels were 
prepared with 0.75 mm spacers and 10 or 15 pockets. 
Samples were mixed with 5x sample buffer, boiled for 5min at 95°C and equal amounts of 
protein (25µg) were loaded on a 14% SDS-PAGE gel. Electrophoresis was performed at 
120V for the first 5 minutes and continued with 180V for approximately 1h. 
Separating gel  (14%) aqua dest 
 1.5M Tris/HCl, pH 8.8 
 actrylamide/bisacrylamide solution (29:1; 40%) 
 100µl 10%APS 
 100µl 10%SDS 
 4µl TEMED 
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Stacking gel 2.185ml aqua dest. 
 380µl 0.5M Tris/HCl, pH6.8 
 375µl actrylamide/bisacrylamide solution (29:1; 40%) 
 30µl 10%APS 
 30µl 10%SDS 
 3µl TEMED 
  
5x sample buffer 260 mM Tris/HCl, pH 6.8 
 12.5% mercaptoethanol 
 20% Glycerol 
 2% SDS 
 0.01% Bromphenolblue 
  
5x running buffer 100mM Tris 
 1M glycin 
 
3.9.3 Blotting of the proteins onto nitrocellulose membrane 
Electrophoretically separated proteins were transferred onto 0.2μm nitrocellulose 
membranes (Schleicher & Schuell, Dassel, Germany) by semi-dry blotting using a Bio-Tad 
Trans-blot SD transfer cell (Bio-Rad, Munich, Germany). Membranes and filter paper 
(Schleicher & Schuell GB005, Dassel, Germany) were kept in CAPS buffer for 3min prior 
to use. 3 layers of filter followed by the membrane, SDS-gel and again 3 layers of filters 
were placed on the anode and finally covered with the cathode. Blotting was performed at 
1mA/cm2 for 1h. Homogenous transfer was verified with ponceau S red staining. 
 
Blotting buffer 10mM CAPS, pH 11 
 10% (v/v) methanol 
  
Ponceau 0.1% ponceau-S 
 in 5% acetic acid 
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3.9.4 Immunodetection 
The blotted membranes were blocked for 1h in blocking buffer to avoid unspecific binding 
of the antibodies and to avoid background staining. Next, the membranes were incubated 
with primary antibodies diluted in blocking buffer for 1h at RT. After washing three times 
with blocking buffer, the membranes were incubated for one hour with horseradish 
peroxidase-conjugated secondary antibodies, diluted in blocking buffer. Finally, the 
membranes were washed three times with PBST and protein bands were visualized using 
the SuperSignal West Pico Chemiluminescent Substrate system (Pierce, Rockford, USA). 
This system is based on the chemical reaction of luminol with peroxidase and hydrogen 
peroxide. The light emission emerging of this reaction is captured on film by 
autoradiography. The membrane was incubated in the ECL solution for 3min 
(Luminol:peroxide buffer, 1:1) and exposed to a hyperfilm ECL-film (Amersham 
Biosciences, Buckinghamshire, England) for an appropriate time. 
Blocking buffer 10% casein (Roche, Mannheim, Germany) 
 0.1% Tween 
 in PBS 
  
PBST 0.1% Tween 
 In PBS 
 0.5% SDS 
 
3.9.5 Antibodies 
Primary 
 
 polyclonal rabbit anti-Bim (Cell Signaling Technology, Beverly, MA, USA)  
 clone 7H8.2C12 mouse anti-cytochrome c (PharMingen, Heidelberg, Germany) 
 polyclonal goat anti-Caspase-3 (R&D Systems, Wiesbaden, Germany) 
 polyclonal goat anti-Caspase-9  (R&D Systems, Wiesbaden, Germany) 
 monoclonal mouse anti-Caspase-8 (Cell Signaling Technology, Beverly, MA, USA) 
 polyclonal rabbit anti-Mcl-1 (Santa Cruz Biotechnologies, Heidelberg, Germany) 
 polyclonal rabbit anti-Bak-NT (Upstate, Charlottesville, VA, USA) 
 polyclonal rabbit anti-Bax-NT (Upstate, Charlottesville, VA, USA) 
 monoclonal mouse anti-Bcl-2 (Novocastra Laboratories, Newcastle, UK) 
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 polyclonal rabbit anti-PARP (Cell Signaling Technology, Beverly, MA, USA) 
 monoclonal mouse-anti BiP (PharMingen, Heidelberg, Germany) 
 monoclonal mouse anti-CHOP (Alexis Corp., Lausen, Switzerland) 
 monoclonal rat anti-BAP31 (Apotech, Epalinges, Switzerland) 
 polyclonal rabbit anti-β-Actin (Sigma-Aldrich, Munich, Germany) 
 Alexa Fluor 594 anti-rat IgG (Molecular Probes, Leiden, The Netherlands) 
 Alexa Fluor 488 (Molecular Probes, Leiden, The Netherlands 
 Mito Tracker Green FM (Molecular Probes, Leiden, The Netherlands)   
 
Secondary 
 
 HRP-conjugated anti-mouse IgG (Promega, Mannheim, Germany) 
 HRP-conjugated anti-rabbit IgG (Promega, Mannheim, Germany) 
 HRP-conjugated anti-goat IgG (Santa Cruz Biotechnologies, Heidelberg, Germany) 
 
3.10 The Adenoviral vector 
The shuttle plasmid pHVAd2-TRE is used to insert the gen of interest into the E1 region of 
the adenovirus type 5. It consists of 2.6kb and a multicloning site as described in Bett et 
al., 1994. After modification by Gillissen at al., 2003 this shuttle plasmid additionally 
contains a CMVmini promoter and a BGH-poly A signal. The tTA expression cassette from 
pTet-Off (BD Biosciences Clontech, Palo Alto, USA) was first cloned as XhoI-PvuII 
fragment into pHVAd2 shuttle vector upstream of CMVmini. Bim cDNA fused to an N-
terminal myc tag was cloned into pSL1180 (Amersham Pharmacia Biotech, Freiburg, 
Germany) and then inserted as a BamHI-XbaI fragment into the pHVAd2 vector resulting 
in TRE-myc-Bim. Finally, the Ad5 vector was fused to TRE-myc-Bim by homologous 
recombination of pAd-tTA creating pAd5-myc-Bim-tTA. 
 
3.10.1 Homologous recombination 
Adenoviral vector was completed by homologous recombination of pHVAd1 containing the 
adenovirus genome and the shuttle vector pHVAd2 containing tTA in Escherichia coli 
strain BJ5183 RecBC-sbcB. Transformation of the bacteria was achieved by 
electroporation, after which the bacteria were grown of agar plates containing ampicilin. 
Colonies were picked and grown in liquid LB-media also containing ampicilin and 
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incubated at 37°C over night. The adenoviral vector was isolated from the colonies and 
was verified by digestion with the appropriate restriction enzymes. E.coli DH5α bacteria 
were transformed with the accurate plasmid for multiplication. Finally, the adenoviral 
vector was isolated from the bacteria and used for transfection of HEK293 package cells. 
 
3.10.2 Calcium-phosphate transfection 
10µg of PacI digested adenoviral DNA were mixed with 25µl of 2.5M CaCl2 and adjusted 
with water to a total of 250µl. 250µl of transfection buffer were added drop-by-drop to the 
mix and gently shaken. Upon shaking calcium-phosphate crystals are formed that bind 
DNA. The total of 500µl was incubated for 30min at RT. Different concentrations were 
added to HEK293 cells incubated in 1ml serum free medium. After 1.5h 1ml media with 
20% FBS was added to the cells. Once plaques were visible in cell layer, the cells were 
harvested and the crude virus lysate (CVL) was used for virus amplification. 
Transfection buffer: 8g NaCl 
 370mg KCl 
 250mg Na2HPO4x2H2O 
 5g HEPES 
 in 500ml water 
 pH 6.75 
 sterilize 
 
3.10.3 Amplification of the adenovirus 
HEK293 cells were plated into 50 150cm2 flasks. 24h hours later the culture media was 
discarded and 10ml suspension containing CVL and serum free fresh media was added to 
the cells. After incubation of 1.5h an equal volume of 10ml media with 20% of FBS was 
added to the cells. Once the cells detached from the flask, showing sign of viral infection, 
cells and media were collected and centrifuged. 35ml of CVL and the pellet were kept and 
the rest of the supernatant discarded.  
 
3.10.4 Adenovirus purification 
Before starting the purification, the CVL was thawed and frozen three times. 2.5ml of 
1.25g/cm3 CsCl were poured into an Ultra-Clear centrifuge tube (Beckman Instruments 
GmbH, Munich, Germany) and 2.5ml of 1.5g/cm3 CsCl were slowly added beneath. Then, 
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7 ml of CVL from the virus purification was added onto this CsCl gradient. Next, the 
gradient was centrifuged (Beckmann Optima LE 80-K) at 30 000rpm for 2h. After 
centrifugation 2 bands were visible in the gradient. The virus band (the lower one) was 
harvested using a 1ml syringe and mixed with 1.35g/cm3 CsCl to a final volume of 3ml. 
Then, 3ml of 1.35g/cm3 and subsequently 3ml of 1.25g/cm3 CsCl were carefully added 
creating a gradient. This was followed by over night centrifugation at 30 000rpm resulting 
in a purified virus band on the gradient. The virus was collected as previously with a 1ml 
syringe. 
A NAP-25 column (Amersham Buchler, Braunschweig, Germany) was washed 4 times 
with 5ml of adenovirus suspension buffer. 1ml of the virus, gained from the gradient, was 
applied onto the column. Then, the column was washed with 1.5ml adenovirus 
suspension buffer. Finally, 2ml of adenosuspension buffer was added to the column and 
collected into a fresh tube. The purified virus solution was stored as 50µl aliquots at -
80°C. 
Adenoviral suspension buffer: 135mM NaCl 
 3mM KCl 
 1mM MgCl2 
 100mM Tris/HCl 
 sterilize 
 add 10% glycerol 
 
3.10.5 Virus titration 
A dilution series starting with 1µl, which was cut in half in each step, was pipetted into a 
24well plate using serum free media for dilution. HEK293 cells were plated into a 24well 
plate and infected with the pre-prepared dilution series of the virus by using one well per 
dilution rate in a volume of 500µl. After 1.5h incubation time, 500µl of media containing 
20% FBS was added to the cells. Approximately 14 days after infection the plaques of 
each well were counted. The titer was estimated based on the plaque formation and the 
dilution rate. 
 
3.10.6 Verification of replication competent adenovirus (E1a-PCR) 
For verification of the adenovirus, the E1a region was tested for unwanted recombination. 
During virus amplification in HEK293 cells the E1a region could be inserted into the 
adenoviral vector by homologous recombination and enables the virus to replicate. 
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Therefore the adenoviral DNA was amplified for its E1a region by PCR. Detection of the 
E1a DNA band would make the adenovirus unusable. For purification of viral DNA 1µl of 
the purified virus was mixed with 20µl of proteinase K-Mix and incubated for 90min at 
55°C. 300µl of Phenol/Chloroform/Isoamylalkohol pH 8.0 (ratio 25/24/1) was added to the 
sample. After vortexing the sample was centrifuged for 5min at 14000rpm.  The upper 
phase was transferred into a new tube and mixed with 300µl of chloroform. This step was 
followed by centrifugation for 5min at 14 000rpm. The upper phase containing the DNA 
was transferred into a new tube and the DNA was acquired by precipitation (see 3.4). 
The acquired DNA was tested for E1a positivity by PCR and bands were detected by 
agarose gel electroporation. As a positive control, PCR and gel electroporation were 
performed for the E4 region, which is part of the adenoviral vector. 
Proteinase K-Mix: 5mM EDTA 
 20mM Tris/HCl, pH 8.0 
 0,2%(v/v) SDS 
 0.25µg/µl proteinase K 
 
3.10.7 Infection of the cells with adenovirus 
All media was removed from the cells to be infected and replaced with media without FBS 
containing the adenovirus at the indicated amounts of MOI.  After incubation for 1.5h at 
37°C, the same volume of media with 20% FBS was added to the cells. 
 
3.11 Flow cytometry 
Measurements with FACS (fluorescence-activated cell sorter) allow detection of single 
cells according to different parameters, such as size, granularity and density. Cells floating 
in a sheath liquid are hit by a laser beam (argon ion laser, excitation at 488nm). For each 
cell passing, it is measured how much light is absorbed (forward scatter, shows the 
relative size) and reflected (side scatter, represents the relative density and is proportional 
to the cell granularity). Moreover, different fluorescence emitted by the cells can be 
quantified in different channels (FL1=537nm, FL2=597nm, FL3=650nm) of the flow 
cytometer. 
Evaluation of the obtained data was displayed by using histograms. They show the 
fluorescence intensity versus the cell numbers. 
Flow cytometry analysis were performed with FACScan (Becton Dickinson, Heidelberg, 
Germany) and later evaluated with CellQuest analysis software.  
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3.11.1 Measurement of apoptosis 
One of the typical features of apoptosis is the fragmentation of the DNA, which often 
includes also the disruption of the nucleus. The cell partially loses its DNA since the cell 
membrane is getting permeable during apoptosis. So it is known that apoptotic cells have 
a lower DNA content than normal cells in the G1-phase.  Thus, this DNA can be detected 
as a so-called sub G1 peak and is a marker for apoptotic cells.  
Propidium iodide which intercalates with DNA is used to measure the increased 
fluorescence of its fluorochrome. The intensity represents the DNA-content of the cell. 
After infection with AdBimL or AdBimS 2x105 cells were harvested by trypsinisation at the 
indicated time points. The cells were fixed on ice in a 2% formaldehyde solution for 30min. 
After centrifugation for 5min at 1300rpm 50µl ice cold PBS was added to the each sample, 
followed by 100μl ethanol (-20°C). The samples were kept on ice for 15min. After 
centrifugation for 5min at 1300rpm the cells were resuspended in PBS containing 40µg 
/ml DNase-free RNase A (Roche Molecular Biochemicals, Mannheim, Germany) and 
incubated for 30min at 37°C. Finally, the samples were pelleted and resuspended in 100µl 
PBS containing 50µg/ml propidium iodide (Sigma, Deisenhofen, Germany) and subjected 
to analysis in the FL3-channel. 
 
3.11.2 Annexin-V FITC 
To distinguish apoptosis from necrosis, cells were stained with Annexin-V-FITC (fluorescin 
isothiocyanate) and counterstained with propidium iodide (PI). Annexin-V-FITC binds to 
phosphatidylserine (PS) on the outer side of the plasma membrane. Propidium iodide can 
only enter cells with a disrupted plasma membrane. Thus, PI and Annexin-V positivity is a 
sign for late apoptosis or necrosis, whereas cells positive for Annexin-V, but negative for 
PI are generally defined as early-apoptotic (Vermes et al. 1995, 1997). 
After infection with AdBimL or AdBimS cells were collected at indicated time points. Cells 
were washed twice with cold PBS and resuspended in Annexin binding buffer at 1 x 106 
cells/ml. Next, 2 µl of Annexin-V-FITC (BD PharMingen, Heidelberg, Germany) and 4 µl PI 
(20 µg/ml, Sigma-Aldrich, Munich, Germany) were added to 100 µl cell suspension. 
Samples were incubated for 20 minutes in the dark at room temperature. After incubation, 
100 µl Annexin binding buffer was added. 
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Binding buffer: 10mM HEPES/NaOH pH 7.2 
 140mM NaCl 
 2.5mM CaCl2 
 
FITC conjugated peptide carry the corresponding sequence of the active site of the 
caspase and can therefore bind to the active site. 
 
3.11.3 Measurement of the mitochondrial membrane potential 
Intact mitochondria establish a potential in-between the intramembrane space and the 
matrix created by an electrochemical gradient. Based on this feature of mitochondria 
kationic and lipophilic dyes like JC-1 (5,5´,6,6´-tetrachloro-1,1´,3,3´-tetraethyl-
benzimidazolylcarbocyanin iodide) can accumulate in the matrix. By forming aggregates 
the fluorescence shifts from green to red. Depolarisation of mitochondria is therefore 
accompanied by increased green fluorescence and is measured in the FL-2 channel of 
the FACS. 
2x105 cells were incubated with adenoviral vectors at 25 MOI for the indicated time points. 
Samples were collected by centrifugation and resuspended in 1ml JC-1 solution (2.5µg/ml 
PBS). After incubation for 30min at 37°C samples were centrifuged at 1300rpm for 5min 
at 4°C and washed three times with cold PBS. Finally, the cells were resuspended in PBS 
and immediately analysed. 
 
3.11.4 Caspase activity 
Caspase activity was measured for each caspase individually by using their specific cell 
permeable caspase inhibitors (FLICA, Kit assay, Serotec, Oxford, England). These 
peptides bind covalently to cysteine residues and thereby block the activity of the 
individual caspase. Caboxyfluorescein is attached to the peptide contributing the 
fluorescence. Binding of the peptide to the corresponding caspase leads to an increase of 
the fluorescence, which is identified in the FL1-channel. As for the measurement, 2x105 
cells were harvested after adenoviral infection at indicated time points and resuspended in 
500µl PBS with 30µM final concentration of the peptide. Samples were incubated for 
20min at 37°C and washed 3 times with washing buffer. Finally, the cells were diluted in 
200µl PBS and measured by FACS. 
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3.11.5 Caspase inhibition 
To inhibit the activity of caspases peptide with a specific sequence are used. They are 
bound by the active site of the corresponding caspase. For caspase-3 the DEVD-fmk was 
used, for caspase-9 LEHD-fmk, caspase-8 IETD-fmk (all from Calbiochem, Bad Soden) 
and for caspase-4 LEVD-fmk (Biovision). To block all the caspases a pan caspase 
inhibitor zVAD-fmk peptide was used (Calbiochem, Bad Soden). 
After infection of 2x105 cells with either AdBimL or AdBimS, they were treated with the 
corresponding 20µM caspase inhibitor. The cells were collected at indicated time points 
and prepared for apoptosis measurement as described in 2.6.1 
 
3.11.6 Calcium release 
Thapsigargin is a sesquiterpen-lactone which is extracted form umbellifere Thapsia 
garganica (Ramussen at al., 1978) Thapsigargin is releasing Ca2+ from the ER by 
specifically blocking SERCA (Ca2+-ATPase of the ER) and none of the other Ca2+-
ATPases. Thapsigargin was used as a positive control and subjected to measurement as 
described. 
Fluo-3/AM (Molecular Probes, Leiden, The Netherlands) is an acetoxymethyl ester, which 
can pass the plasma membrane if it is uncharged. Inside the cells esterases transform it 
into a charged molecule. In this state the complex binds Ca2+ ions, accumulates and 
becomes fluorescence.  
Cells were infected with either AdBimL, AdBimS or mock treated and cultured for indicated 
hours. After harvesting 2x105 cells by trypsinization, pellets were resuspended in 500µl 
fresh media with 10% FBS. Additionally, 10µl of 2mM Fluo-3AM in DMSO solution was 
added to each sample. Cells were incubated for 45min at 37°C under vigorous shaking 
and light protection. After the incubation time, samples were centrifuged for 3min at RT 
and washed three times with PBS. Samples were immediately analyzed by flow cytometry 
in the FL-1 channel. 
 
3.11.7 Conformational change of Bax and Bak 
2x105 cells were transduced with adenoviral vectors and collected by trypsinization 16h 
later. After washing with PBS and fixed in 1 ml PBS/0.5% paraformaldehyde (v/v) on ice 
for 30 min. Again the cells were washed with PBS. N-terminal epitope were detected by 
conformation specific anti-Bax-NT or anti-Bak-NT antibody (Upstate, Charlottesville, VA, 
USA). Staining was performed by incubating cells in 1 ml staining buffer (PBS, 1% FCS, 
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0.1% saponin) containing 0.1 mg of the respective antibody on ice for 30 min. Then, cells 
were washed in staining buffer, resuspended in 1 ml staining buffer containing 0.1 mg 
fluorescein-labelled F(ab')2 goat anti-rabbit IgG (H+L) antiserum (Jackson Immuno 
Research, West Grove, PA, USA) and incubated on ice for 30 min in the dark. After a final 
washing with PBS the intracellular staining of Bax or Bak was quantified by flow cytometry 
in the FL1- channel. 
                   Results 
4 Results 
4.1 Cloning of the adenoviral vector 
To clarify the pathway of Bim, full length cDNA of BimL and BimS was amplified by PCR 
cloned into an adenoviral vector. The use of an adenoviral expression system gives the 
advantage to over express the protein of interest at similar levels for each experiment in a 
panel of cell lines. To regulate the expression of these BH3-only proteins, an inducible 
adenoviral vector based on the Tet-Off system was established in the group (Gossen and 
Bujard, 1992). This system comprises all the functional components needed on a single 
adenoviral vector the gene of interest, its inducible promoter, the region of the 
transactivator and its constitutive promoter. The basic adenoviral vector is deleted for the 
E1 and E3 region. The E3 region was replaced by the expression cassette of the tTA-Tet-
Off-transactivator and its constitutive CMV-promoter. To create the pAd1-E1/E3-tTA 
(Gillissen, et al., 2003). The shuttle plasmid pAd2-TRE is used to transfer the gene of 
interest into the E1 region of the adenovirus type 5. Through modifications, it contains one 
TRE-element and one BGH-poly(A) signal (Gillissen, et al., 2003). Myc-tagged human 
cDNA of BimL or BimS was cloned by PCR into the shuttle vector using specific primers 
with BamHI and XbaI for restriction site. Bim was inserted into Ad1-tTA by cotransfection 
of BJ5183 bacteria for homologous recombination of the shuttle vector containing Bim and 
the adenoviral vector. Therefore, both plasmids the shuttle vector and Ad5-tTA were 
linearised with PacI. Homologous recombination in these recombinase proficient bacteria 
resulted in the final adenoviral vectors Ad5-mycBimL-tTA (Ad-BimL) or Ad5-mycBimS-tTA 
(Ad-BimS). Production of the virus was achieved by transfecting HEK293 cells with the 
final adenoviral vector. 
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Figure 7: Inducible Bim expression mediated by Ad5-mycBim-tTA 
A: Genomic structure of recombinant adenovirus Ad5-mycBim-tTA. Ad5 sequences are indicated by black 
dashes. E1 and E3 regions of Ad5 are replaced by mycBimL and mycBimS expression cassette (white boxes), 
respectively and tTA expression cassette (grey boxes), respectively (PCMV: immediate early promoter of 
cytomegalovirus tTA tetracycline-controlled (Tet-Off) transactivator; PTRE: tetracycline-responsive element 
located 5‘ of the minimal immediate-early CMV promoter). 
B: Western blot analysis for BimL and BimS expression. DU145 Bax cells were transduced with Ad5-
mycBimL-tTA or Ad5-mycBimS-tTA and cultured in the presence of different doxycyclin concentrations for 
24h. 
 
4.2 Titration of the adenoviruses 
In order to determine the dose and time dependent effect of both adenoviruses, AdBimL 
and AdBimS, on cell death, DU145-Bax cells were measured for DNA fragmentation after 
indicated time points following infection with AdBimL or AdBimS at MOIs mentioned. Cells 
that were not infected with the adenovirus served as a negative control and did not show 
any sign of apoptosis at any of the time points. Also, when doxycyclin was added to the 
media no apoptotic cells could be detected showing that this agent is not toxic for the cells 
(figure 8). After 24h, DU145-Bax cells, which were infected with either AdBimL or AdBimS 
with the indicated MOIs and grown under off conditions showed the same level of 
apoptosis as the control cells. An apoptotic rate of 4% in the presence of doxycyclin 
demonstrated that doxycyclin suppressed the expression of Bim in case of both AdBimL 
and AdBimS But once doxycyclin was not present in the media, cell death increased with 
rising MOIs of each adenovirus. 25 MOI of AdBimL induced apoptosis in 9% of the cells 
and 25 MOI of AdBimS induced 21% (figure 7A). 50 MOI of adenovirus generated 18% of 
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dead cells after AdBimL overexpression and 34% after BimS overexpression. At 100 MOI 
the number of dead cells was 33% for AdBimL and 51% for AdBimS infected cells. AdBimL 
mediated cell death led to 45% apoptosis with 150 MOI and to 57% in cells transduced 
with AdBimS.   
The 48h time point illustrates the strength of AdBimS, since only 25 MOI of this adenovirus 
provoked 54% of cell death. Increased MOI of 50 ended up with 81% of apoptotic cells 
(figure 8A). 100 MOI and 150 MOI even induced apoptosis in 88% of the cells. To a lesser 
extent BimL overexpression displayed moderately increasing steps in the apoptotic rate 
with 12% upon 25 MOI and with 24% upon 50 MOI. 39% and 53% of the cells were killed 
upon 100 MOI and 150 MOI, respectively. In contrast to AdBimS, the cells infected with 
AdBimL and cultured under off conditions at any MOI rate did not present any noteworthy 
apoptotic rate. Overexpression of BimS under off conditions revealed leakiness of the 
system starting with 50 MOI at 17%, mounting to 22%with 100 MOI and 32% of cell death 
with 150 MOI. 
72h post infection cells visibly showed that the off-system was not able anymore to 
regulate the suppression of Bim properly (figure 8A). AdBimL, under off conditions, 
induced only some cell death of 10-15%. DU145-Bax cells infected with AdBimS under off 
conditions caused apoptosis in the range of 14% up to 60%. Under on conditions, with 25 
MOI of AdBimL 22% of the cells were found to be apoptotic, with 50 MOI 28%, with 100 
MOI 83% and with 150 MOI 89%. AdBimS demonstrated its full power after 72h by killing 
nearly all the cells (90%) regardless of the MOI used with the exception of 25 MOI, where 
it induced 47% of cell death. Of note, cells cultured under off conditions and infected with 
50 MOI, 100 MOI or 150 MOI of AdBimS showed high numbers of dead cells. In 
consideration of these results, all the experiments were performed with 25 MOI for both, 
AdBimL and AdBimS unless mentioned otherwise. To confirm the expression of AdBimL or 
AdBimS Western blot analyses were performed at four different time points (figure 8B). 
DU145-Bax cells were transduced with either AdBimL or AdBimS and harvested at the 
indicated time points. As a control, non-infected cells were used that did not show over 
expression of Bim. DU145-Bax cells, which were transduced with AdBimL and AdBimS 
respectively but grown under off conditions, did not show any Bim expression after 16h. 
Both isoforms were detected for the first time 6h after infection of the cells with the 
adenovirus. Later time points displayed the increasing expression for both splicing 
variants. This Western blot analysis displayed the quick induction of Bim. 
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Figure 8: Dose-response for apoptosis induction by Bim 
A, B, C: Left panel: flow cytometric measurement of apoptotic cells with hypodiploid DNA content. DU145-
Bax cells were infected with AdBimL at different MOI and cultured in the presence (off) or absence (on) of 
doxycyclin for 24h, 48h and 72h (top down). 
Right panel: DU145-Bax cells were transduced with were infected with AdBimS and treated as described 
for were infected with AdBimL. Means +/- SD from three independent experiments. 
D: Western blot analysis of DU145-Bax neo cells. Cells were transduced with AdBimL or AdBimS and 
cultured for indicated hours. Cells were harvested after indicated hours and blotted for BimL and BimS, 
respectively. Actin was used as a loading control. 
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4.3 Bim activates the intrinsic mitochondrial pathway 
4.3.1 Clustering of Bax and Bak 
The multi-domain pro-apoptotic proteins Bax and Bak are known to be involved in the 
signalling cascade of apoptosis. Once activated these proteins oligomerize at the 
mitochondria and ensure that the mitochondria are permeabilized by forming pores at the 
outer membrane. 
One way to visualize Bax and Bak clusters at the mitochondria is to make use of green 
fusion fluorescence proteins. To this end, DU145 cells were stably transfected to express 
the fusion proteins EGFPBax or EGFPBak, respectively. These cells display green 
fluorescence even under non-treated (control) conditions (figure 9A and B). Bak is 
localized to reticular structures since it is associated to the mitochondria (figure 9A). Bax 
on the other hand is a predominantly cytosolic protein, therefore the fluorescence looks 
diffuse (figure 9B). The same pictures present themselves under off conditions, when both 
cell types were infected with the indicated adenovirus, but were cultured in doxycyclin 
containing media. For both, DU145 EGFPBax and DU145 EGFPBak, regardless whether 
they are infected with AdBimL or AdBims, did not show any Bax or Bak clustering. 24h post 
infection with AdBimL or AdBimS under on condition, the fluorescence microscopy 
revealed a punctuated pattern of EGFPBak and EGFPBax. Both isoforms of Bim caused 
clustering of Bak and Bax in consequence of oligomerization of these pro-apoptotic 
proteins. This demonstrates that Bim activates both pro-apoptotic multi-domain proteins. 
The pictures in the last row represent cells treated with 1µg/ml of epirubicin as a positive 
control. Epirubicin is an anthracyclin antibiotic, which acts as a DNA damaging agent by 
inhibiting topoisomerase II. Therefore it triggers the activation of the mitochondrial 
pathway, which is marked by the assembly of Bak and Bax oligomers at the outer 
membrane. DU145 EGFPBax and DU145 EGFPBak cells clearly illustrated clustering of 
Bax and Bak after treatment with epirubicin. 
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Figure 9: Bim induces oligomerization of Bax and Bak in DU145 cells 
A: DU145 EGFP-Bak cells were transduced with AdBimL (left panel) and AdBimS (right panel) and 
cultured for 24h in the presence (off) and the absence (on) of doxycyclin or were treated with epirubicin 
(epi). Pictures were taken with a fluorescence microscope. 
B: DU145 EGFP-Bak cells treated as in A. 
 
4.3.2 Re-expression of Bax and overexpression of Bak in DU145 cells 
Wild type DU145 are deficient for Bax and express only a small amount of Bak. The two 
cell types used in the following experiments originate from these cells. DU145-Bax 
transfectants were generated from mock cells to re-express Bax (figure 10A). Mock 
transfectants were generated in parallel by use of the empty HyTK vector. DU145-Bak 
cells overexpress exogenous Bak but do not express Bax, like the DU145 wild type cells. 
Matching mock transfected cells show a low level of Bak expression (figure 10B). These 
two cell types, one re-expressing Bax and the other overexpressing Bak, gave the 
possibility to investigate the interplay of Bim with these pro-apoptotic proteins separately. 
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Figure 10: Expression of Bax and Bak in DU145 cells 
Western blot analysis of Bax and Bak expression in DU145-Bax and DU145-Bak cells. Non-treated cells 
were harvested and blotted for Bax and Bak respectively. Actin was used as a loading control. 
 
4.3.3 Conformational switch of Bax and Bak 
For further confirmation that Bim activating Bax and Bak, DU145-Bax, DU145-Bak cells 
and their corresponding mock transfected control cells were transduced with AdBimL or 
AdBimS. 16h later, the cells were harvested and stained with conformation specific 
antibody against the N-terminus of Bax (BaxNT) or the N-terminus of Bak (BakNT). Shift 
to the higher fluorescence indicating the conformational change of the protein, was 
determined by flow cytometry (figure 11). First, the cells were examined for a 
conformational change of Bax. DU145 mock cells, which were not infected with the 
adenovirus or were grown under off conditions, did not display Bak activation. Also in the 
corresponding Bax transfectants, no activation could be detected in the control cells or 
those under of conditions. Overexpression of BimL or BimS in mock cells, which are Bax 
negative, showed a similarly low number of cells with BaxNT as the controls, namely 8% 
for BimL and 9% for BimS. After AdBimL expression and under on conditions, in 14% of 
DU145-Bax cells active Bax was measured. In case of AdBimS, 40% of DU145-Bax cells 
were stained for Bax conformational change (figure 11A, upper panel). As a control, 
DU145-Bak and their mock transfectants were investigated for Bax activation, although 
these cells are Bax negative (figure 11A, lower panel). 4-6% of stained cells positive for 
BaxNT were detected when the cells were not infected and 8-16% when they were 
cultured under off conditions. Expression of BimL or BimS in mock cells yielded for both 
BH3-only proteins in 11% of cells positively stained for conformational changed Bax. 
Staining of DU145-Bak cells revealed few positive cells, 13% were found after AdBimL 
and 18% after AdBimS transduction.  
Next, the cells were assayed for a conformational change of Bak. Non-treated DU145 
mock as well as DU145-Bax cells did not demonstrate a conformational change of Bak. 
This was also true for cells, which were infected with either of the adenovirus in the 
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presence of doxycyclin i.e. when the expression was turned off. Only 4-10% of the cells 
presented staining. Upon BimL expression, 13% of DU145 mock cells were detected 
BakNT positive and 20% upon BimS expression (figure 11B, upper panel). 30% of DU145-
Bax transfectants expressing BimL showed exposure of the BakNT epitope, whereas 
expression of BimS presented 51% cells with positive staining. The same procedure was 
performed for DU145-Bak cells (figure 11B, lower panel). 4-11% of DU145 mock and 4-
16% of DU145 Bak cells, which were control treated or expression of Bim was 
suppressed, showed BakNT staining. Under on conditions, determination of activated Bak 
resulted in high rates for both Bim isoforms in these cells. Expression of BimL revealed 
16% of mock cells with Bak conformational change and expression of BimS showed 34%. 
Staining of DU145-Bak cells displayed 47% positive cells upon BimL and 72% upon BimS 
expression. These results confirm that Bim is not only able to activate the multi-domain 
proteins Bax and Bak but can also trigger apoptosis by both proteins, independently from 
each other. 
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Figure 11: Bim induces conformational change of Bax and Bak in DU145 cells 
A: DU145-Bax and DU145-Bak cells were infected with AdBimL (left panel) or AdBimS (right panel) and 
grown under off or on conditions. After 16h the cells were measured for conformational change of Bax. 
Means +/- SD from three independent experiments. 
B: DU145-Bax and DU145-Bak cells were infected with AdBimL (left panel) or AdBimS (right panel) and 
grown under off or on conditions. After 16h the cells were measured for conformational change of Bak. 
Means +/- SD from three independent experiments. 
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4.3.4 Induction of apoptosis by Bim is mediated by Bax and Bak 
As shown previously Bim activated Bax and Bak by inducing their conformational change 
and oligomerization at the mitochondria. The next question addressed was to analyze 
whether this activation of the pro-apoptotic multidomain proteins is functionally linked to 
activation of apoptosis and consequently DNA-fragmentation. For this purpose both 
DU145-Bax and DU145-Bak transfectants were used (figure 12). After adenoviral infection 
with either AdBimL or AdBimS the cells were examined for apoptosis after 48h. Both, BimL 
and BimS induced apoptosis in Bax dependent fashion. Also, Bak overexpressing, but Bax 
negative cells underwent apoptosis (figure 12). In the presence of doxycyclin the 
expression of Bim was suppressed, thus there was no induction of cell death in the Bax or 
Bak transfectants or their mock controls. Whereas all control treated cells showed an 
apoptotic rate of 4-6%, cells under off conditions revealed 14-20% of apoptotic cells. Bim 
is expressed under on conditions, i.e. when no doxycyclin is present in the medium. Bax 
overexpressing cells underwent apoptosis at 58% after AdBimL expression and at 82% 
after AdBimS expression. In the mock cells 18% and 26% of apoptosis was found upon 
overexpression of BimL and BimS, respectively. This might be due to the fact, that these 
mock cells express a small amount of Bak, but are Bax negative.  The same observation 
was made for the DU145-Bak mock cells. These cells too express a small amount of Bak. 
In this case, BimL induced 17% and BimS 22% of apoptosis. Interestingly, the apoptotic 
rate of DU145-Bak cells was similar to the ones obtained in the Bax expressing cells. BimL 
caused 58% of apoptosis and 72% of the same cells died after infection with AdBimS. 
These results suggest that overexpression of Bim can trigger apoptosis via Bax or Bak 
and that both events are independent from each other. Furthermore, both cell types 
DU145-Bax or DU145-Bak and even their equivalent mock cells show in all cases a higher 
apoptotic rate after AdBimS infection as compared to AdBimL. 
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Figure 12: Bim induces apoptosis in a Bax- and Bak-dependent manner 
A, B: Flow cytometric detection of apoptotic cells based on measurement of the cellular DNA content. 
DU145 cells were transduced with AdBimL or AdBimS and cultured in the presence (off) and the absence 
(on) of doxycyclin. Control cells were mock treated and grown in the absence of doxycyclin for 72h. Means 
+/- SD from three independent experiments. 
 
4.4 Activation of pro-apoptotic proteins by Bim leads to the 
breakdown of the mitochondrial membrane potential 
Additionally to the activation of Bax and Bak the integrity of the mitochondrial membrane 
potential can give evidence to the activation of the intrinsic apoptotic pathway. The 
cationic carbocyanine dye JC-1 is a fluorescent marker for mitochondrial depolarization 
during apoptosis. Accumulated JC-1 in the matrix changes its fluorescence emission light 
from green to red. Cells were infected with AdBimL or AdBimS, harvested after 24h, loaded 
with JC-1 and the samples were than analyzed for loss of red fluorescence by flow 
cytometry (figure 13). Non-treated control cells for both DU145-Bax and DU145-Bak 
transfectants and their control transfectants did not show any disruption of the 
mitochondria. The same result was obtained for cells under off conditions. Expression of 
BimL as well as BimS led to the breakdown of the mitochondrial membrane potential. Mock 
showed low mitochondrial membrane potential in 16% of the cells after BimL expression 
and in 34% after BimS expression. BimL induced reduction of the mitochondrial potential in 
32% of DU145-Bax cells and in 63% of the cells after BimS expression. DU145-Bak and 
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the respective mock transfectants displayed a similar rate of apoptosis induction. AdBimL 
induced breakdown of the mitochondrial potential in 12% of the mock transfectants and in 
30% of Bak overexpressing cells. In 32% of the mock transfectants mitochondrial 
breakdown of the membrane potential was detected and in 61% of the DU145-Bak cells 
following BimS expression. Thus, Bim triggers the mitochondrial pathway as shown by the 
decreased numbers of cells with intact mitochondria. Furthermore, BimS induced the 
mitochondrial death pathway more effectively than BimL. Moreover, this occurs via either 
Bax or Bak and this may explain the relatively high rates of mitochondrial membrane 
potential dissipation and cell death in both mock transfectant types. The very low level at 
which these cells express Bak is apparently for BimS to cause disruption of the 
mitochondrial membrane potential and mitochondrial permeabilization. 
 
 
Figure 13: Bim-induced loss of ∆m in a Bax- and Bak-dependent manner 
A, B: Flow cytometric detection of cells with lowered mitochondrial membrane potential. Indicated DU145 
cells were transduced with AdBimL or AdBimS and cultured in the presence (off) and the absence (on) of 
doxycyclin. Control cells were mock treated and grown in the absence of doxycyclin. Measurements were 
performed after 24h. Means +/- SD from three independent experiments. 
 62 
                   Results 
Measurement of the mitochondrial membrane potential can give information about the 
disruption of the outer membrane of the mitochondria. This leads to the release of proteins 
that are normally harboured in the intermembrane space of the mitochondria, into the 
cytosol. Additional confirmation that cytochrome c release did actually occur was obtained 
by immunofluorescence staining of cytochrome c (Figure 14). Mitochondria were stained 
with Mito Tracker Red, cytochrome c was stained in green and the nuclei were made 
visible with DAPI staining.  DU145-Bax and their mock controls were infected with either 
AdBimL or AdBimS and cytochrome c release was determined after 16h. Under off 
conditions no cytochrome c release was visible in neither of the cell types regardless of 
the virus used. The overlay revealed by the yellow colour that cytochrome c is still present 
in the mitochondria. But expression of Bim in DU145-Bax cells caused liberation of 
cytochrome c as can be seen in the overlay. The higher potency of BimS to induce 
apoptosis is obvious under on conditions in the mock cells. Even with a low level of Bak 
expression in the mock transfectants, AdBimS was able to trigger cytochrome c release to 
a noticeable degree. 
 
Figure 14: Bim induces cytochrome c release dependent of Bax 
A, B: Immunofluorescence: indicated DU145 cells were transduced with AdBimL or AdBimS. Cells were 
stained for mitochondria with MitoTracker Red CMXRos, for cytochrome c with anti-cytochrome c followed 
by Alexa Fluor 488-conjugated chicken anti-goat antibodies (green fluorescence) and for the nuclei with 
DAPI staining. Pictures were taken with fluorescence microscope 16h after infection with the 
corresponding adenovirus. 
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4.5 Initiation of the caspase cascade by Bim  
The activation of Bax and Bak and the disruption of the mitochondrial membrane are 
events that take place prior to caspase activation. The following studies aimed to identify 
the caspases involved in the intrinsic death pathway that is induced by Bim. After 
adenoviral expression of AdBimL or AdBimS and treatment with specific or broad spectrum 
caspase inhibitors, the apoptotic rate of the cells was determinates by flow cytometry at 
48h following transduction. In all experiments the cells were incubated with 20µM of 
caspase inhibitor (figure 15). Both mock transfectants and likewise DU145-Bax and 
DU145-Bak, the latter not transduced with the adenoviral vector did not show apoptotic 
signs, the apoptotic rate amounted to a range of 3-6%. When expression of Bim was 
suppressed in these cells, 4-8% underwent cell death. In DU145-Bax cells 2-11% of 
apoptosis was measured, under control or off conditions whereas in DU145-Bak cells 2-
7% of the cells died with evidence of genomic DNA fragmentation. In 12% and 6% of the 
DU145 mock transfectants DNA–fragmentation was detected upon AdBimL or AdBimS 
expression, respectively. Their DU145-Bax counterparts revealed cell death in 33% of the 
cells after transduction with AdBimL in the absence of doxycyclin. AdBimS expression 
induced apoptosis in 41% of these cells. 35% of the DU145-Bak cells cultured under on 
conditions were found to be apoptotic following AdBimL expression, while 41% of the cells 
died when AdBimS was expressed. However, in this setting, both isoforms could only 
trigger 8% of apoptosis in mock cells. 
In a first step, using the broad caspase inhibitor zVAD-fmk all caspases were blocked to 
see if the caspases play functional role in the Bim pathway. Additional treatment with 
zVAD-fmk reduced apoptosis to 3% in DU145-Bax cells transduced with AdBimL as 
compared to Ad BimL expression alone in the absence of doxycyclin. This is 
representative for all non-treated (control) cells and the one under off conditions. In the 
same setting, also the short version of Bim failed to induce cell death, 6% apoptotic cells 
were measured. Overexpression of AdBimL or AdBimS and addition of zVAD-fmk in 
DU145-Bak cells led to a similar outcome with 4% of dead cells. To identify the caspases 
that play a role for Bim triggered cell death caspase inhibitors were employed. The 
caspase-3 inhibitor zDEVD-fmk caused reduction of apoptosis under on conditions in 
DU145-Bax cells after AdBimL expression.  Only 17% of the cells died under these 
circumstances. The same cells overexpressing AdBimS and grown in the presence of 
zDEVD-fmk showed 14% of apoptosis.  Again, a similar result was found in the DU145-
Bak cells: with caspase-3 being blocked, AdBimL could only induce 20% and AdBimS 13% 
of apoptosis. Next, the impact of caspase-9 was examined with the zLEHD-fmk inhibitor. 
Only 10% of the DU145-Bax cells, which were grown in the presence of the inhibitor went 
to apoptosis upon expression of AdBimL and 12% died upon expression of AdBimS. 
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DU145-Bak overexpressing cells behaved the similarly, presenting also 10% of apoptosis 
after infection with AdBimL and 16% with AdBimS. And finally caspase-8 was blocked with 
zIETD-fmk inhibitor, where a similar effect was achieved. 17% and 12% of dead Bax 
expressing cells were detected upon BimL and BimS expression. Their DU145-Bak 
counterparts reacted the same way after BimL or BimS expression, namely with 13% of 
apoptosis. 
In general, it can be said, that the specific caspase inhibitors saved around 50% of the 
cells in both cell types. Thus, the initiator caspases-8 and 9 and the effector caspase-3 
are important for Bax and Bak mediated apoptosis upon Bim expression, especially since 
the pan-caspase inhibitor diminished cell death to the level of not infected cells. 
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Figure 15: Bim-induced apoptosis is caspase dependent 
A: DU145-Bax and DU145 mock cells were infected with AdBimL or AdBimS in the presence (off) and the 
absence (on) of doxycyclin and treated with 20M of the indicated caspase inhibitors. Cells were cultured 
for 48h and measured for hypodiploid DNA content with flow cytometry. Means +/- SD from three 
independent experiments. 
B: DU145-Bak and DU145 mock cells treated as in A. Means +/- SD from three independent experiments. 
 
Apparently, loss of the mitochondrial membrane potential happens within 24h after Bim 
expression (figure 13). Once the outer membrane is broken apoptosis associated proteins 
are released, such as AIF, Smac and cytochrome c. These proteins aim to different 
targets and carry on the apoptotic process. Cytochrome c for example is part of the 
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apoptosome where caspase-9 is activated which in turn leads to the activation of the 
caspase cascade. Thereby, the pro-form of the caspases is cleaved to become an active 
caspase. Since Bim is obviously activating the caspase cascade, cleavage products of the 
caspases should be detectable on the protein level. Hence, total lysates of cells were 
collected at different time points to perform western blot analysis after infection of DU145-
Bax cells with adenoviral Bim. With this time course the generation of the active caspases 
could be followed (figure 16). As a control, DU145-Bax cells were transduced with AdBimL 
or AdBimS and cultured in the presence of doxycyclin for 24h. Western blot analysis 
showed that in case Bim is not expressed, there is no caspase activation, cytochrome c 
release or PARP cleavage in these cells (figure 15A, B, first lane). One of the initiator 
caspases that is activated at early time points of the apoptotic process is caspase-9. Upon 
BimL expression caspase-9 is cleaved after 14h, this time point marks the formation of the 
apoptosome (figure 16A). 10h after transduction of AdBimS activation of caspase-9 could 
be observed (figure 16B). For both isoforms, AdBimL and AdBimS the cleavage products 
could not be detected after 24h, probably due to their degradation. The impact of Bim on 
the main effector caspase-3 demonstrated the same effect. 14h after expression of BimL, 
pro-caspase-3 was processed to its cleavage products of 20kDa and 18kDa. But at the 
24h time point there are no more active caspases detectable by Western blot analyses. 
BimS was more effective by inducing caspase-3 activation already 10h post adenoviral 
infection. Disruption of the outer mitochondrial membrane potential causes the release of 
cytochrome c and is upstream of caspase activation events. According to the results of 
caspase activation, cytochrome c is detectable in the cytosol (cytosolic fraction) after 14h 
for AdBimL and after 10h for AdBimS expression. PARP (poly-ADP-ribose-polymerase) is 
a DNA repair enzyme. It is cleaved upon apoptosis for a substrate of caspases-3/7 and is 
therefore a good marker for this type of caspases mediated cell death.  After expression of 
BimL in Bax positive DU145 cells, PARP is cleaved dominantly after 14h and upon BimS 
expression after 10h. Over time the pro-form of PARP disappears and after 18h and 14h 
respectively, only its cleaved form can be found. The results, gained by this time course, 
indicate that BimS activates the apoptotic pathway faster than BimL. 
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Figure 16: Bim activates proteins of the intrinsic pathway 
A: Western blot analysis for BimL. DU145-Bax cells were transduced with recombinant adenovirus AdBimL 
and cultured for indicated hours in the presence (off) and the absence (on) of doxycyclin. 
B: Western blot analysis for BimS, as in A. 
 
4.6 Role of Bcl-2 in Bim induced cell death 
Bcl-2 is an anti-apoptotic protein and can antagonize the actions of pro-apoptotic proteins, 
although the exact mechanism is still strongly debated (Borner, 2002). Therefore, the next 
step in these investigations was to establish the role of Bim and the potentially involved 
organelles. The following three kinds of Bax re-expressing DU145 cells were used for the 
studies. Cells were transfected stably to express Bcl-2 mutants either at the mitochondria 
(Bcl-2actA) or at the endoplasmic reticulum (Bcl-2cb5). The control cells (neo) were 
transfected with the empty vector and do not overexpress Bcl-2 (figure 17). To target Bcl-2 
to the mitochondria, the membrane anchor was replaced by the mitochondrial insertion 
signal protein actA of Listeria monocytogenes. To achieve localization of Bcl-2 to the ER, 
the rat hepatic ER cytochrome b5 isoform targeting sequence was fused to Bcl-2 instead 
of its C-terminal transmembrane region. The resulting products were transduced into 
DU145-Bax cells. The purpose of these transfectants was to investigate whether Bcl-2, 
being an anti-apoptotic protein would be able to protect the cells from Bim-induces 
apoptosis through a mitochondrial and/or ER pathway. 
 68 
                   Results 
 
Figure 17: Expression of Bcl-2, Bax and Bak expression in DU145-Bax cells 
Western blot analysis of Bcl-2, Bax and Bak expression in DU145-Bax cells. 
 
4.6.1 Bcl-2 targeted to the mitochondria or the ER prevents cell death 
upon certain apoptotic stimuli  
As shown by Western blot analysis, DU145-Bax Bcl-2-transfected cells overexpress Bcl-2 
(figure 17). To confirm that these cells express Bcl-2 at the targeted organelle, 
mitochondria and ER, respectively, immunostaining for subcellular localization was 
performed. The cells were stained for Bcl-2, mitochondria or endoplasmic reticulum and 
examined with a fluorescence microscope (figure 18). After fixation and permeabilization 
the cells were incubated with the primary antibody specific for mitochondria, for the ER or 
for Bcl-2. Addition of the second fluorescent antibody stained the mitochondria and the ER 
red or Bcl-2 green. Nuclei were DAPI stained, and thereby visualized in blue. As for the 
neo control transfected cells there was no staining for Bcl-2 at all, showing that these cells 
do at best express low levels of Bcl-2 and can be used as a control. DU145-Bax Bcl-2actA 
cells reveal in the overlay that Bcl-2actA localized at the mitochondria (figure 18, left 
panel), but was not found at the ER (figure 18, right panel). Vice versa in DU145-Bax Bcl-
2cb5 cells, here Bcl-2cb5 inserted into the endoplasmic reticulum (figure 18, right panel), 
but did not co-localize with the mitochondria (figure 18, left panel). 
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Figure 18: Localization of targeted Bcl-2 in DU145-Bax transfectants 
Cells were stained for mitochondria with MitoTracker Red CMXRos or ER with mouse anti-BAP31 
followed by Alexa Fluor 594-conjugated chicken anti-rat (red fluorescence). Bcl-2 was visualized by anti-
Bcl-2 followed by Alexa Fluor 488-conjugated chicken anti-mouse (green fluorescence). The nuclei were 
stained in blue with DAPI. 
 
The subsequent drugs, known for their involvement in cell death pathways and stimulation 
of different types of cell death were applied to confirm the functionality of cell system used 
in the following experiments. Epirubicin is a DNA damaging agent that inhibits 
topoisomerase II and triggers the mitochondrial apoptotic pathway. Tunicamycin, a protein 
N-glycosylation inhibitor, and thapsigargin, which blocks SERCA, are both causing ER 
stress induced apoptosis. After 72h, the cells were subjected to flow cytometric 
measurement of the cellular DNA content to determine the rate of apoptotic cells (figure 
19). DU145-Bax neo cells showed 77% apoptotic cells after treatment with Epirubicin. 
Induction of ER stress also led to apoptosis in these cells. 74% of dead cells were 
detected after tunicamycin and 37% after thapsigargin treatment and showed partial 
inhibition of apoptosis as compared to the control transfectants. Epirubicin induced in 45% 
of DU145-Bax Bcl-2actA (mito) cells apoptosis by DNA damage. Treatment of DU145-Bax 
Bcl-2actA cells with tunicamycin and thapsigargin respectively induced in 52% and 47% of 
the cells apoptosis by ER stress. The highest inhibition of apoptosis by Bcl-2 was 
achieved in DU145-Bax Bcl-2cb5 (ER) cells. Whereas 50% of the cells died upon 
Epirubicin treatment, tunicamycin and thapsigargin had a minor effect on the cells by 
revealing only 25% and 22% of apoptotic cells. Thus, ER stress inducing agents induced 
much less apoptosis in cells that express Bcl-2 targeted to the endoplasmic reticulum. 
Additionally, these measurements suggested that Epirubicin does not engage to the ER to 
induce apoptosis. 
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Figure 19: Functionality of the DU145-Bax Bcl-2 transfectants 
DU145-Bax mock and Bcl-2 transfectants were treated with epirubicin (1μg/ml), tunicamycin (1μM), or 
thapsigargin (10μM). Apoptotic cells were determined after 72h by measurement of the genomic DNA 
content. 
 
4.6.2 Inhibition of Bim induced apoptosis by Bcl-2 
All three DU145-Bax cell lines were transduced with AdBimL and AdBimS respectively 
(figure 20). 48h post transduction, the apoptotic cells were measured by flow cytometry. 
Non-treated cells and cells under off conditions did not show any pertinent apoptosis 
neither for BimL nor for BimS. In DU145-Bax neo cells AdBimL induced 50% of cell death, 
whereas AdBimS managed to kill 63% of the cells. But when Bcl-2 was present, this anti-
apoptotic protein was able to overcome the induction of apoptosis by Bim. Localized at the 
mitochondria Bcl-2 partially protected the cells against Bim. DU145-Bax Bcl-2actA cells 
died by 31% over BimL and by 45% over BimS expression. In consideration of the DU145-
Bax neo cells, this signifies an inhibition of cell death by approximately 1.5 fold for both 
BimL and BimS. The most significant effect of Bcl-2 was detected in the DU145-Bax Bcl-
2cb5 cells. The apoptotic rate was only 17% for BimL and 15% for BimS. Compared to the 
control cells this means an inhibition factor of 3 times for AdBimL and even 4 times for 
AdBimS. Although Bim induced apoptosis in cells without Bcl-2 expression, as could be 
observed in the DU145-Bax neo cells, Bcl-2 protected the cells from death, especially 
when located at the endoplasmic reticulum. In this experiment as well as in the following it 
should be noted that BimS induced a higher level of cell death as has already be seen in 
the other DU145 cells. Once again the results confirm the current model that BimS induces 
apoptosis more effectively than BimL. 
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Figure 20: Bcl-2 at the endoplasmic reticulum protects cells from Bim-induced 
apoptosis 
B, D: flow cytometric detection of apoptotic cells based on measurement of the cellular DNA content. 
DU145-Bax cells were transduced with AdBimL or AdBimS and cultured in the presence (off) and the 
absence (on) of doxycyclin. Control cells were mock treated and grown in the absence of doxycyclin for 
48h. Means +/- SD from three independent experiments. 
A, C: representative histograms of experiments in B and D. 
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4.6.3 Necrotic cell death 
Since there were almost no apoptotic cells found among DU145-Bax Bcl-2cb5 cells upon 
Bim expression, the possibility of a necrotic cell death had to be ruled out. By double 
staining of the cells with Annexin-V-FITC and propidium iodide (PI), viability of the cells 
can be monitored and necrotic versus apoptotic cells identified. PI is used as a marker for 
the integrity of the cell membrane in PI negative cells. Annexin-V-FITC points at early 
apoptotic cells by binding to phosphatidylserine on the outer side of the membrane. It 
should be noted that in late stages of apoptosis cells may also lose their cell membrane 
integrity and can therefore be double stained. In that case, late apoptotic cells cannot be 
distinguished from necrotic cells. DU14- Bax neo, DU145-Bax Bcl-2actA and DU145-Bax 
Bcl-2cb5 cells were harvested 16h after transduction and were evaluated for double 
positive cells (figure 21). Non-treated cells that were used as a control, showed 5% 
necrosis in DU145-Bax neo, 8% in DU145-Bax Bcl-2actA and 3% in DU145-Bax Bcl-2cb5 
cells. Culture of adenovirally transduced cells in the presence of doxycyclin to inhibit 
induction of BimL or resulted in a similarly low amount of necrotic cells. 5-6% was 
determined in DU145-Bax neo, 8-9% in DU145-Bax Bcl-2actA and 4-5% in DU145-Bax 
Bcl-2cb5 cells. Expression of BimL led to elevated, but not high levels of double positive 
cells. In DU145-Bax neo 21% of double positive cells were measured, in DU145-Bax Bcl-
2actA 14% and in 16% DU145-Bax Bcl-2cb5 cells. The short variant of Bim did not 
particularly change the number of cells stained for Annexin-V-FITC and PI. Quantification 
of DU145-Bax neo, DU145-Bax Bcl-2actA and DU145-Bax Bcl-2cb5 cells revealed 24%, 
20% and 21% of necrotic cells upon Bim expression. 
These data clarified that Bcl-2actA or cb5 expression did not convert the cell death from 
apoptosis to necrosis but maintained viability upon BimL or BimS expression. The most 
relevant result though, was that in DU145-Bax Bcl-2cb5 cells Bim did not induce necrosis, 
nor did it cause apoptosis as could be observed by measurement of DNA-fragmentation 
(figure 20). Bcl-2 localized at the endoplasmic reticulum seems to prevent apoptotic death 
induced by Bim. 
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Figure 21: Bim does not induce necrosis in DU145 cells 
A, C: representative dot plots of experiments presented in B, D. 
B, D: Cells were stained with Annexin-V-FITC, counterstained with PI and measured by flow cytometry. PI 
positivity is a sign of necrosis, whereas cells positive for Annexin-V, but negative for PI are defined as 
apoptotic. DU145 cells were transduced with AdBimL or AdBimS and cultured in the presence (off) and the 
absence (on) of doxycyclin. Control cells were mock treated and grown in the absence of doxycyclin for 
48h. Means +/- SD from three independent experiments. 
 74 
                   Results 
4.7 Disruption of the mitochondrial membrane potential 
The breakdown of mitochondrial membrane potential occurs prior to DNA-fragmentation 
and cell death and marks the activation of the intrinsic mitochondrial apoptotic pathway. 
Permeabilization of the mitochondrial outer membrane results in breakdown of the 
mitochondrial membrane potential. The next question was whether Bcl-2 was able to 
avoid cell death by preventing the breakdown of the mitochondrial membrane potential. 
DU145-Bax neo, DU145-Bax Bcl-2actA and DU145-Bax Bcl-2cb5 cells were incubated 
with AdBimL or AdBimS for 48h and the loss of the mitochondrial membrane potential was 
measured by flow cytometry. 
Control treated cells of all three cell transfectants (neo, Bcl-2actA, Bcl-2cb5) did not show 
loss of the mitochondrial potential in the cells measured. This was still true when the 
expression of Bim was prevented under off conditions in AdBim transduced cells (figure 
22). Under on conditions on the other hand, 62% of DU145-Bax neo cells were detected 
with mitochondrial permeability shift upon BimL and 79% upon BimS expression. 
Overexpression of Bcl-2 at the mitochondria reduced the cells with low mitochondrial 
membrane potential after Bim expression. Only 28% of D145-Bax Bcl-2actA cells were 
found to be affected by AdBimL, whereas 35% of the cells showed loss of mitochondrial 
membrane potential in the case of AdBimS. This indicated that these cells are protected by 
Bcl-2 at the mitochondrial level from Bim induced breakdown of the mitochondrial 
membrane potential. Conversely, in DU145-Bax Bcl-2cb5 cells, where Bcl-2 is associated 
to the endoplasmic reticulum, 54% of the cells had loss of their mitochondrial potential 
upon AdBimL infection. AdBimS caused in 67% of the same cells reduction of the 
mitochondrial potential. Thus, Bcl-2 could only to a minor extent prevent disruption of the 
mitochondria upon Bim expression, when it was targeted to the ER, although it 
dramatically inhibited DNA-fragmentation at the same position. 
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Figure 22: Bcl-2 targeted to the mitochondria prevents loss of ∆m induced by Bim 
A, B: Flow cytometric detection of cells with lowered mitochondrial membrane potential. Indicated DU145 
cells were transduced with AdBimL or AdBimS and cultured in the presence (off) and the absence (on) of 
doxycyclin. Control cells were mock treated and grown in the absence of doxycyclin for 48h. Means +/- SD 
from three independent experiments. 
 
4.8 Caspases are crucial in the Bim pathway 
A connection between Bim and the caspases was already established in Bax or Bak 
expressing cells. Overexpressed Bcl-2 had been shown to save cells from apoptosis. 
Therefore, the question was addressed whether Bcl-2 would have an influence on the 
initiator caspases-8 and -9, and the effector caspase-3, which can be cleaved and 
activated by both initiator caspases. DU145-Bax neo, DU145-Bax Bcl-2actA and DU145-
Bax Bcl-2cb5 cells were transduced with AdBimL or AdBimS and grown under off or on 
conditions. Cells were measured after 36h by flow cytometry for activated caspases using 
a cell permeable FITC labelled tetrapeptide of the corresponding caspase. The caspase 
activity was quantified according to elevated fluorescence. First, caspase-9 was analyzed 
in the Bim-induced apoptosis pathway. All three DU145-Bax transfectants, showed no 
caspase-9 activation upon mock treatment as determined by binding of the LEHD-FITC 
substrate (figure 23). Also, none of the cells showed caspase-9 activation when the 
expression of either Bim isoforms was suppressed by the presence of doxycyclin. 
Transduction of BimL in DU145-Bax neo resulted in 23% of cells with caspase-9 activity. 
In DU145-Bax Bcl-2actA transfectants 14% of cells were found with caspase-9 activation 
and in 8% of the cells with Bcl-2 localized at the ER. The same procedure upon BimS 
expression revealed caspase-9 activation in 44% of the DU145-Bax neo cells, 25% of the 
DU145-Bax Bcl-2actA transfectants and 16% of the DU145-Bax Bcl-2cb5 transfectants. 
As the effector caspase-3 is cleaved and activated by caspase-9, caspase-3 activation 
should occur upon Bim expression. Cells, which were mock treated or transduced with 
AdBimL and then grown under off conditions, did not display caspase-3 activation as 
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determined by binding of fluorescin conjugated DEVD peptide. 39% of DU145-Bax neo 
cells presented caspase-3 activation upon BimL expression. AdBimS induced caspase-3 
activation in 62% of the DU145-Bax neo cells. In cells, where Bcl-2 was targeted to the 
mitochondria, BimL and BimS expression stimulated in 17% and 37% of the cells caspase-
3 activation, respectively. Similar numbers were obtained for DU145-Bax Bcl-2cb5 cells; 
upon BimL expression 22% and upon BimS expression 34% of the cells were determined. 
When caspase-3 is active, it can process caspase-8, which in turn cleaves Bid to tBid. 
Truncated Bid (tBid) can provoke activation of the mitochondria via Bak and Bax, thereby 
creating an amplification loop. To see whether Bim could induce such a feedback loop, 
the activation of caspase-8 was measured by staining with a fluorescin labelled IETD 
peptide. Control treated cells of all three DU145-Bax transfectants were monitored for 
caspase-8 activation and showed no induction of such activation. Likewise, adenovirally 
transduced cells cultured in the presence of doxycyclin did not show caspase-8 activation. 
Transduction of DU145-Bax neo cells with AdBimL resulted in 30% of cells showing 
caspase-8 activation as compared to 14% of DU145-Bax Bcl-2actA cells and 15% of 
DU145-Bax Bcl-2cb5 cells were found. BimS had a much stronger effect on caspase-8 
activation as compared to BimL. 64% of the DU145-Bax neo cells showed caspase-8 
activation. But when Bcl-2 was present at the mitochondria caspase activation found in 
only 36% of the cells and when Bcl-2 was expressed at the ER, 25% of the cells showed 
caspase-8 activation. 
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Figure 23: Bcl-2 targeted to the ER can prevent activation of the caspases upon Bim 
expression 
A, B, C: Flow cytometric detection of cells with increased caspase activation. Indicated DU145 cells were 
transduced with AdBimL or AdBimS and cultured in the presence (off) and the absence (on) of doxycyclin. 
Control cells were mock treated and grown in the absence of doxycyclin. Measurements were performed 
after 36h. Means +/- SD from three independent experiments. 
 
As observed in previous experiments BimS exerted caspase activation in a higher 
percentage of cells (figure 23). Caspase activation for all caspases analyzed could be 
inhibited by both Bcl-actA and Bcl-2cb5 to a similar extent. To summarize these findings, 
BimL and BimS induced activation of caspase-3, -8, and -9, cells were infected with 
adenoviral Bim and treated with several irreversible caspase inhibitors. 48h later the cells 
were harvested and validated for DNA-fragmentation. Control treated DU145-Bax neo 
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cells displayed apoptosis in 3 to 4% of the cells (figure 24). Mock treated DU145-Bax Bcl-
2actA cells showed 4-6% of apoptotic cells and DU145-Bax Bcl-2cb5 cells 2-6%. When 
these cells were infected with AdBimL or AdBimS, but cultured in doxycyclin containing 
media, 5-7% DU145-Bax neo cells were found to be apoptotic, in DU145-Bax Bcl-2actA 4-
8%, and in DU145-Bax Bcl-2cb5 5-11% of the cells. When the expression of BimL was 
turned on DU145-Bax neo cells genomic DNA fragmentation was measured in 52% of the 
cells. Additional treatment with zDEVD-fmk, a caspase-3 inhibitor, diminished the 
percentage of apoptotic cells to 25% establishing the relevance of the effector caspase-3 
in this setting.  When zLEHD-fmk was used to inhibit caspase-9, DNA fragmentation was 
measured in 44% of the cells. Caspase-8 inhibition by the zIETD-fmk inhibitor revealed an 
apoptotic rate of 31%. Caspase-4 has been shown to be located at the ER and was 
suggested to be only involved in apoptosis if the ER pathway is activated.  Treatment with 
the caspase-4 inhibitor, zLEVD-fmk, marginally inhibited apoptosis with only 40% of cells 
showing DNA fragmentation. Finally, treatment with a pan-caspase inhibitor, zVAD-fmk, 
strongly reduced cell death to 10%, indicating that BimL cannot mediate apoptosis without 
caspases. 
Even though apoptosis was decreased in cells expressing Bcl-2actA compared to cells 
with neo control transfectants showing only low Bcl-2 expression, additional caspase 
inhibition could further decrease apoptosis. DU145-Bax Bcl-2actA cells presented an 
apoptotic rate of 31% upon BimL expression, which fell to 22%, when the cells were 
additionally treated with zDEVD-fmk for caspase-3 inhibition. BimL triggered apoptosis in 
27% of the cells in the presence of the caspase-9 inhibitor zLEHD-fmk. When caspase-8 
was inhibited 14% of the DU145-Bax Bcl-2actA cells revealed DNA-fragmentation and 
inhibition of caspase-4 resulted in 23% of dead cells. Addition of the pan-caspase inhibitor 
zVAD-fmk decreased the rate of the apoptotic DU145-Bax Bcl-2actA cells to a level 
compared to the control treated cells, namely 7%. None of the caspase inhibitors had a 
major effect on cells overexpressing ER-targeted Bcl-2, since BimL alone could not induce 
cell death in more than just 16% of the cells. Addition of the caspase-3 inhibitor zDEVD-
fmk led to 13% of cell death in these cells transduced with AdBimL and upon blocking of 
caspase-9 by zLEHD-fmk to 15%. Inhibition of caspase-8 by zIETD-fmk led to DNA-
fragmentation in 9% of the cells and addition of the caspase-4 inhibitor zLEVD-fmk 
resulted in apoptotic DNA fragmentation in 13% of the cells. At last, when the cells were 
treated with the broad spectrum caspase inhibitor zVAD-fmk, 7% of apoptotic cells were 
measured. 
The same settings were used for investigations of caspases involved in BimS mediated 
apoptosis. BimS caused apoptosis in 69% of DU145-Bax neo cells. Once caspase-3 was 
block by the inhibitor, the apoptotic rate was lowered to 44%.  Caspase-9 inhibition still 
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resulted in 62% of apoptotic cells. When the casapse-8 inhibitor was added, BimS induced 
DNA fragmentation in 46% of the cells. Treatment with the casapse-4 inhibitor zLEVD-fmk 
decreased apoptosis to 48%. The pan-caspase inhibitor zVAD-fmk strongly reduced cell 
death to 15% of the cells. DU145-Bax Bcl-2actA cells displayed in 50% of the cells 
apoptotic DNA fragmentation upon BimS expression, showing that Bcl-2 was partially able 
to guard the cells. When casapse-3 was inhibited with zDEVD-fmk, 27% of apoptotic cells 
were observed. In case of additional caspase-9 inhibition, 45% of these cells underwent 
apoptosis. 26% of apoptosis happened in cells exposed to zIETD-fmk to block caspase-8 
and 34% of cells died upon additional caspase-4 inhibition. In the presence of the pan-
caspase inhibitor zVAD-fmk 20% of these cells showed DNA-fragmentation. Protection by 
Bcl-2cb5 was so strong that only 15% of apoptotic cells were detected in AdBimS infected 
cells. There was no relevant reduction in the amounts of apoptotic cells after additional 
treatment with the various caspase inhibitors. 11% of the cells were quantified for DNA-
fragmentation upon BimS expression after addition of the caspase-3 inhibitor.14% of the 
cells underwent apoptosis when they were treated with casapse-9 inhibitor. Inhibition of 
caspase-8 and caspase-4 resulted in 12% and 13% apoptotic cells, respectively. The 12% 
of apoptotic cells detected in cells treated with the broad spectrum caspase inhibitor 
zVAD-fmk showed that the residual apoptosis induced by BimS in Bcl-2cb5 expressing 
cells is caspase independent. 
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Figure 24: Bim acts in a caspase-dependent manner 
A: DU145-Bax cells were infected with AdBimL in the presence (off) and the absence (on) of doxycyclin and 
treated with 20µM of indicated caspase inhibitors. Cells were cultured for 48h and measured for 
hypodiploid DNA content by flow cytometry. Means +/- SD from three independent experiments. 
B: DU145-Bax cells infected with AdBimS and treated as in A. Means +/- SD from three independent 
experiments. 
 
4.8.1 Processing of caspases upon Bim expression 
Caspases were shown to be functionally involved in Bim induced apoptosis. This was 
shown on one hand by measurement of active caspases and on the other hand by the 
impact of inhibition of these caspases on apoptosis execution as measured by DNA 
fragmentation. Thus, detection of caspase subunits by Western blot analysis was used to 
show proteolytic processing of the caspase proforms (figure 25). All three DU145-Bax 
transfectants were transduced with the adenoviral vectors and harvested after 30h. The 
first lane demonstrates that, under on conditions, both Bim isoforms were expressed at 
equal levels in all cell lines. It should be noted that cells, which were infected with the 
adenovirus but kept under off conditions did not reveal Bim expression indicating tight 
conditional expression. Since expression of Bim in DU145-Bax neo cells induced loss of 
the mitochondrial membrane potential, cytochrome c release was analyzed. Cells, which 
were either control treated or grown under off conditions following adenoviral transduction, 
did not show cytochrome c release. In both cases, total cytochrome c was found in the 
mitochondrial fraction, regardless of the cell types and the Bim isoform used. In the 
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cytosolic fraction of DU145-Bax neo cells, cytochrome c could be detected upon both 
BimL and BimS indicating cytochrome c release expression. Expression of Bcl-2 at the 
mitochondria mostly prevented release of cytochrome c into the cytosol upon BimL 
expression. The same result could be found upon BimS expression where a subtle band 
for cytochrome c was seen in the cytosolic fraction. Surprisingly, expression of Bcl-2cb5 at 
the ER inhibited mitochondria from releasing cytochrome c in the presence of BimL and 
BimS, respectively. This indicates a crosstalk of the ER pathway feeding into mitochondrial 
apoptosis signalling. Downstream of cytochrome c release formation of the apoptosome 
and the activation of caspase-9 occur. Uncovering of caspase-9 subunits would indicate 
processing of caspase-3 by the mitochondrial pathway although caspase-3 was also 
shown to cleave the caspase-9 zymogen. BimL expression in DU145-Bax neo cells led to 
processing of caspase-9 as could be observed by the reduced proform. In the same cells, 
BimS also induced cleavage of caspase-9. Detection of decreased pro-caspase-9 in 
DU145-Bax Bcl-2actA cells upon expression of BimL showed that caspase-9 was 
processed even in the presence of Bcl-2. Transduction of these cells with AdBimS under 
on conditions led to the detection of the processed caspase-9 subunit, indicating 
activation of caspase-9. In DU145-Bax Bcl-2cb5 cells, neither expression of BimL nor BimS 
caused cleavage of caspase-9. No reduction of the proform and no cleavage product of 
caspase-9 could be detected upon Bim expression. Bcl-2 localized at the ER might 
interfere with Bim mediated caspase-9 activation in a yet unknown way. According to 
casapse-9 processing, caspase-3 cleavage product was seen upon BimL expression in 
Bcl-2 deficient cells. Processing of caspase-3 proform was found in DU145-Bax neo cells 
upon BimS expression. DU145-Bax Bcl-2actA and DU145-Bax Bcl-2cb5 cells revealed a 
slight occurrence of caspase-3 p20 fragment in case of BimL or BimS expression. To 
enhance the death signal, caspase-3 can process and activate caspase-8 creating a 
positive feedback loop. No matter whether Bcl-2 was overexpressed in the cells or not, 
expression of BimL or BimS resulted in the appearance of a processed caspase-8 
intermediate. This might indicate that the amplification loop was initiated independently of 
the Bcl-2 status or that caspase-8 processing is initiated upstream of a Bcl-2 inhibitable 
event. Finally, cleavage of PARP was examined as it is cleaved by caspase-3 upon 
apoptotic stimuli. DU145-Bax neo cells transduced with AdBimL revealed PARP cleavage 
under on conditions. In the same settings, upon expression of BimS only the cleavage 
product of PARP could be detected indicating massive caspase-3 activation. Despite the 
expression of Bcl-2actA, BimL as well as BimS expression induced PARP cleavage to an 
extent comparable to the DU134-Bax neo controls. Furthermore, BimL and BimS triggered 
PARP cleavage under on conditions in DU145-Bax Bcl-2cb5 cells, although to a lesser 
extent. This indicates that caspase activation leading to PARP processing via caspase-3 
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like caspases occurs within the ER pathway downstream of Bcl-2 inhibitable events. 
 
 
Figure 25: Bcl-2 partially suppresses processing of caspases 
A: Western blot analysis for indicated pro-apoptotic proteins. DU145-Bax cells were transduced with 
AdBimL and cultured for 30h in the presence (off) and the absence (on) of doxycyclin. Cell lysates were 
blotted for the indicated proteins with the appropriate antibodies. 
B: DU145-Bax cells were transduced with AdBimS, and treated as in A. 
 
4.9 Caspase-8 is involved in BimS induced apoptosis 
Although the extrinsic death-receptor initiated pathway was not investigated with regard to 
Bim mediated apoptosis, it is possible that caspase-8 is important in the Bim pathway 
since it was reported that caspase-8 is involved in ER stress induced apoptosis (Chandra, 
et al., 2004). 
DU145-Bax neo, DU145-Bax Bcl-2actA and DU145-Bax Bcl-2cb5 cells were incubated 
with AdBimS for 24h and cells with low mitochondrial membrane potential were measured 
by flow cytometry (figure 26). DU145-Bax neo cells mock treated or grown under off 
conditions did not show cells with low mitochondrial membrane potential. Expression of 
BimS led to 60% of cells, which had loss of their mitochondrial potential and 58% were 
detected when these cells were treated with casapse-8 inhibitor. DU145-Bax Bcl-2actA 
cells, which were either not infected with the adenovirus AdBimS or were infected, but 
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cultured in the presence of doxycyclin showed 4-6% of cells with low mitochondrial 
membrane potential. 46% of these cells were detected with mitochondrial permeability 
shift upon BimS expression. Additional inhibition of caspase-8 reduced the effect by half. 
Similar data was obtained in cells, where Bcl-2 is targeted to the ER. Here, 7% of cells 
showed mitochondrial membrane potential loss when control cultured or transduced with 
AdBimS in the presence of doxycyclin. BimS induced breakdown of the mitochondrial 
membrane potential in 58% of the cells. This number was reduced to 32% when caspase-
8 was blocked. Thus, BimS mediates cell death through caspase-8 in a Bcl-2 dependent 
way. According to these data, no difference could be detected with respect to caspase-8 
inhibition in BimS induced mitochondrial permeabilization whether Bcl-2 was expressed at 
the mitochondria or at the ER. The fact that inhibition of caspase-8 did not influence the 
breakdown of the mitochondrial membrane potential might suggest that Bcl-2 is upstream 
of caspase-8 activation. 
 
 
Figure 26: BimS mediates caspase-8 activation 
DU145 cells were transduced with AdBimS and cultured in the presence (off) and the absence (on) of 
doxycyclin or were additionally treated with capase-8 inhibitor for 24h. Control cells were mock treated 
and grown in the absence of doxycyclin. Means +/- SD from three independent experiments. 
 
4.10 BimS induces calcium release into the cytosol 
The main calcium store in the cell is the endoplasmic reticulum. Ca2+ is pumped from the 
cytosol into the lumen of the endoplasmic reticulum by the SERCA (sarcoplasmic 
endoplasmic reticulum calcium ATPase). ER stress causes the depletion of calcium from 
the store. Cytosolic Ca2+ is mostly absorbed by the mitochondria through their Ca2+ 
uniporters. The positively charged calcium ions disturb the mitochondrial membrane 
potential. At a certain threshold, accumulated Ca2+ in the matrix triggers the opening of the 
permeability transition pore, which results in swelling of the matrix, the loss of the 
membrane potential and finally in the destruction of the outer mitochondrial membrane. 
Consequently, apoptosis inducing factors are released form the mitochondria, such as 
cytochrome c, Omi/Htr2 and Smac/Diablo. Since Bcl-2 can antagonize the apoptosis 
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promoting effect of Bim, it was investigated whether Bcl-2 is inhibiting apoptosis (see 
3.5.2) by avoiding ER stress and interfering with Ca2+ release. Considering that a leak of 
calcium from the ER is one of the first events of the apoptotic process, even upstream of 
mitochondrial activation upon ER stress, Ca2+ fluxes were measured Bim expression. 
Cytosolic Ca2+ was measured by using Fluo-3AM, which binds to Ca2+ ions resulting in 
increased fluorescence. Time course experiment of Bim expression showed that Bim can 
be already found 8h after infection with the adenoviral vector and is increasing with time 
(figure 27). So, cytosolic Ca2+ elevations were determined at 8h, 16h and 24h by flow 
cytometry. As a positive control for ER tress, thapsigargin was used. This agent inhibits 
SERCA, and induces an unfolded protein response and increased Ca2+ levels in the 
cytosol. DU145-Bax neo, DU145-Bax Bcl-2actA or DU145-Bax Bcl-2cb5 cells were 
infected with either AdBimL or AdBimS or treated with thapsigargin and subjected to flow 
cytometric measurement (figure 27). Control cells with low Bcl-2, which were control 
treated or were transduced with AdBimL but grown under off conditions did not show any 
sign of calcium leak at any of the indicated time points. Turning on AdBimL expression did 
not result in major changes in these results. Even after 24h, only 10% of the cells were 
detected with elevated Ca2+ levels, implying that BimL cannot trigger Ca2+ release. The 
same cells were infected with AdBimS and displayed another picture. In DU145-Bax neo, 
mock treated and cells under off conditions did not show increased release of Ca2+ at any 
time points. But under on conditions, AdBimS provoked after 16h calcium fluxes in 19% of 
the cells. This number increased to 30% when the cells were exposed to AdBimS for 24h. 
Treatment of the cells with thapsigargin only, proved that ER stress could be induced in 
these cells. 8h after addition of thapsigargin, 15% of the cells were found to have released 
Ca2+. 16h later, 36% and at 24h 44% of the cells were affected. 
Overexpressed Bcl-2actA targeted to the mitochondria did not change the situation for the 
cells. Cells, which served as a negative control or in which the expression of either of the 
Bim isoforms was kept suppressed in the presence of doxycyclin, did not show Ca2+ 
fluxes. Expression of BimL did not have an impact on the cells in respect to Ca2+ release. 
BimS on the other hand, triggered Ca2+ release from the ER in DU145-Bax Bcl-2actA cells. 
8h post infection nothing had happened yet, another 8h later though in 17% of these cells 
higher amounts of Ca2+ were measured. Cells, which were collected 24h after 
transduction with AdBimS showed 20% of cells with calcium release. Once these cells 
were treated with thapsigargin as a positive control, they showed high release rates of 
42% at 8h, 55% at 16h and finally 58% at 24h. DU145-Bax Bcl-2actA cells seemed to be 
more sensitive for the ER stress agent. The fact, that these cells are transfectants might 
be the answer for this phenomenon. Finally, DU145-Bax Bcl-2cb5 cells were investigated. 
Since these cells express Bcl-2 at the ER, they should be protected against ER stress and 
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therefore should not release Ca2+. Mock treated cells and cells, which were infected with 
either of the adenovirus but grown in the presence of doxycyclin, could not be monitored 
for Ca2+ fluxes. Indeed, neither of the Bim variants could induce Ca2+ release at any of the 
indicated time points under on conditions. Bcl-2 targeted to the ER was able to protect the 
cells from ER stress generated by BimS. Moreover, even thapsigargin was not strong 
enough to break through the protective wall of Bcl-2. After the longest incubation time of 
24h with thapsigargin, 20% of the cells were detected with elevated Ca2+ levels, revealing 
the functionality of the cells. These results point to a link between BimS and Bcl-2 at the 
ER, which has yet to be identified. 
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Figure 27: Ca2+-fluxes from the ER upon Bim expression   
A, C: representative histograms of Ca2+ release measurement after 24h. 
B, D: DU145-Bax cells were transduced with AdBimL or AdBimS and cultured with doxycyclin (off) or 
without doxycyclin (on) for indicated time points. As a positive control the cells were treated with 10µM 
thapsigargin (thaps). Increased cytosolic Ca2+ levels were measured by flow cytometry. Means +/- SD from 
three independent experiments. 
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4.10.1 Bim induces upregulation of ER stress proteins 
According to the results obtained so far, it was speculated that Bim might associate with 
the endoplasmic reticulum where it would induce a stress response and initiate apoptosis. 
Therefore, detection of ER protein levels associated with ER stress responses might give 
some insights into the mechanisms by which Bim mediates apoptosis. Total lysates were 
collected 16h post infection with either AdBimL or AdBimS and subjected to Western blot 
analysis (figure 28). 
 
 
Figure 28: Bim induces upregulation of ER proteins 
A: Western blot analysis of the expression of ER associated proteins. DU145-Bax cells were transduced 
with AdBimL and cultured for 30h in the presence (off) and the absence (on) of doxycyclin. Cell lysates were 
blotted for the indicated proteins and developed with the appropriate antibodies. 
B: DU145-Bax cells were transduced with AdBimS, and treated as described in A. 
 
Detection of BimL (figure 28A) after transduction of AdBimL of all three cells lines 
confirmed that BimL was expressed under on conditions at comparable levels. None of the 
cell lines, which were mock treated or grown in the presence of doxycyclin, did show any 
BimL expression. Additionally, DU145-Bax neo, DU145-Bax Bcl-2actA and DU145-Bax 
Bcl-2cb5 were examined for Bcl-2 expression. Only cells that stably express Bcl-2, namely 
DU145-Bax Bcl-2actA and DU145-Bax Bcl-2cb5, revealed Bcl-2 expression. Since Bim 
activates Bax directly or indirectly expression levels might be changed upon Bim 
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expression, especially in cells, which express Bcl-2 and might neutralize Bim. But 
Detection of Bax revealed that it was equally expressed, no matter which cell type was 
examined. Moreover, cells under on conditions showed the same Bax level as cell under 
control or off conditions. For the same reason Bak expression was examined. AdBimL 
induced upregulation of Bak in DU145-Bax neo cells under on conditions. While BimL 
expression also resulted in upregulation of Bak in DU145 BaxBcl-2actA cells, Bak proteins 
levels remained the same when Bcl-2 was targeted to the ER. CHOP is a transcription 
factor induced during ER stress and promotes apoptosis. BimL expression triggered 
upregulation of CHOP in all three cell transfectants, indicating that BimL may have caused 
ER stress. The slightly elevated CHOP level detected under off conditions was most likely 
set off by the adenovirus. Another ER stress protein is BAP31which is a resident integral 
membrane protein of the endoplasmic reticulum. It regulates the export of other integral 
membrane proteins to the downstream secretory pathway. ER stress and other apoptotic 
stimuli lead to generation of a p20 fragment, preferably cleaved by caspase-8. Also 
BAP31 was found to be up regulated, but only in DU145-Bax neo and DU145-Bax Bcl-
2actA cells, whereas in DU145-Bax Bcl-2cb5 cells no such upregulation could be 
determined upon BimL expression. BiP/GRP78, another ER stress protein, is involved in 
protein folding and assembly, targeting misfolded protein for degradation, ER Ca2+- 
binding and controlling the activation of trans-membrane ER stress sensors. Further, due 
to its anti-apoptotic character, it is a component of the unfolded protein response. Upon 
BimL expression higher amounts of BiP were detected in all three cell transfectants. Cells, 
which were transduced with AdBimL in the presence of doxycyclin, presented a slightly 
stronger band than the corresponding control cells. This could be explained by a potential 
stress of infection with the adenovirus. The anti-apoptotic protein Mcl-1 is known to bind to 
Bim with high affinity, although its preferred binding partner is the BH3-only protein Noxa. 
Influence or binding of Bim to Mcl-1 cannot be ruled out, but nevertheless total Mcl-1 was 
equal in all three cell lines. Even expression of BimL did not influence Mcl-1 amounts. -
Actin detection was used as a loading control. 
Detection of the same proteins was performed upon BimS expression. Transduction of 
AdBimS in all three transfectants under on conditions proved that AdBimS was equally 
expressed in all of them (figure 28B). Bcl-2 could not be found in DU145-Bax neo cells, 
but was present in the transfectants. Also the short version of Bim did not induce changes 
in the total amount of Bax expression. The cells expressed similar levels whether they 
were treated or not. Its multi-domain relative Bak on the other hand was upregulated in 
cells without Bcl-2 and also in cells, where Bcl-2 was localized at the mitochondria under 
on conditions. Control cells and cells, which were grown in the presence of doxycyclin 
showed unchanged Bak levels. In DU145-Bax Bcl-2cb5 cells expressing BimS no 
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difference could be determined. The protein band for Bak in BimS transduced cells in the 
absence of doxycyclin was alike to the ones observed under control conditions. BimS 
expression resulted in up regulation of CHOP in cells where Bcl-2 was absent. But Bcl-2 
targeted to the mitochondria or the ER could not prevent induction of this ER protein 
under on conditions for BimS expression. Detection of BAP31 showed that up regulation 
occurs in DU145-Bax neo cells upon BimS expression and when Bcl-2 is localized at the 
mitochondria. Just as for BimL, no upregulation of BAP31 could be monitored in cells that 
express Bcl-2 at the ER. BiP displayed a higher expression in all three cells types upon 
BimL or BimS expression under on conditions, regardless of the Bcl-2 status. AdBimS 
transduced cells showed a minor upregulation of the ER stress proteins CHOP and BiP 
under off conditions. Expression of BimS did not influence Mcl-1 on its expression level. All 
samples were quantified for equivalent expression. -Actin detection served as a loading 
control for the Western blot analysis. 
             Discussion 
5 Discussion 
5.1 Bim mediates apoptosis in Bax- or Bak-dependent manner and 
is antagonized by Bcl-2 
The main function of Bax and Bak is to disrupt mitochondrial membrane integrity in order 
to release cytochrome c and other pro-apoptotic factors. It was proposed that they 
mediate this release either by binding to and modifying mitochondrial channel proteins 
such as VDAC or ANT (Marzo, et al., 1998) or by direct pore formation (Antonsson, et al., 
1997; Eskes, et al., 1998). However, the activation of these two pro-apoptotic proteins is 
still controversial. Two different models have been discussed, the direct activation and the 
indirect activation. The direct activation model proposes that a subgroup of the BH3-only 
proteins called “activators” can activate Bak and Bax, whereas the remaining BH3-only 
proteins, called “sensitizers”, neutralize the anti-apoptotic proteins (Willis, et al., 2007). 
The indirect activation model suggests that Bak and Bax are held in check by being bound 
to anti-apoptotic proteins. BH3-only proteins displace Bak and Bax from the anti-apoptotic 
proteins to achieve their activation (Willis and Adams, 2005). But no interaction of Bak 
with BH3-only proteins could be detected. Also, Bax did not bind to BimEL and BimL in co-
immunoprecipitation studies (Marani, et al., 2002; O'Connor, et al., 1998; Yamaguchi, et 
al., 2003). Even though BimS was found to weakly bind to Bax it might not be the 
physiological truth, since this BimS-Bax complex existed in detergents that alter Bax 
conformation. Additionally, a BimS mutant that was not able to bind to Bax anymore but 
could still interact with anti-apoptotic proteins and induce as much apoptosis as the wild 
type (Willis and Adams, 2005; Willis, et al., 2007). And finally, the ability of Bcl-2 or Bcl-xL 
to inhibit apoptosis induced by Bid, Bim or Bad correlates with their ability to bind BH3-
only proteins but not Bax and Bak (Cheng, et al., 2001). For these reasons it is more likely 
that the indirect activation of Bax and Bak by the BH3-only proteins is the main process. 
Therefore, the investigations described in this study focused in the first part on clarification 
if Bax and Bak were redundant when Bim is overexpressed. With the help of an antibody 
specific for an epitope at the N-terminus of Bax or Bak the conformational change was 
examined. Conformational change of Bax and Bak became evident when elevated 
fluorescence was measured. Conformational change of Bax could be detected in DU145-
Bax cells upon BimL and BimS expression, respectively (figure 11). According to the 
specific Bak antibody BimL as well as BimS induced Bak activation in DU145-Bak cells as 
confirmed by the measurement of the conformational change of Bak. Whereas monomeric 
Bax is translocated from the cytosol to the mitochondria, Bak already resides at the 
mitochondria. Nevertheless, both proteins undergo conformational change and 
oligomerize at the mitochondria, which seems to be based on the activation by Bim.  
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DU145 cells stably expressing EGFP-Bax or EGFP-Bak were used to detect clustering of 
these two pro-apoptotic proteins. Non-treated DU145 cells, which stably expressed either 
of both fusion proteins, indicated the localization of Bax and Bak. In DU145 EGFP-Bax 
cells the fluorescence of the fusion protein appeared diffuse being concordant with the 
cytosolic localization. EGFP-Bak on the other hand presented a string-like pattern, 
pointing to its association at the mitochondria (figure 9). When DU145 EGFP-Bax cells 
were transduced with adenoviral BimL or BimS clustering of Bax could be observed by the 
punctuated pattern. Expression of either of the two Bim isoforms in DU145 EGFP-Bak 
cells also led to clustering of the fusion protein, noticeable by the EGFP spots. These 
results show that Bim induces activation of pro-apoptotic the multi-domain proteins 
leading to conformational change and clustering of these proteins, which might represent 
oligomerization. 
Although it is not possible to conclude direct or indirect activation of Bax and Bak from this 
study, it can be said that Bim induces Bax and Bak activation. Bax and/or Bak are needed 
for execution of apoptosis. Several investigations with bax/bak double knockout cells 
clarified that without these two proteins apoptosis will not occur (Armstrong, 2006; 
Lindsten, et al., 2000; Wei, et al., 2001). Expression of BimL resulted in apoptosis in 
DU145-Bax and DU145-Bak cells, but not in the DU145 mock cells, confirming that 
induction of apoptosis needs Bax or Bak. BimS joined in on this effect, by inducing cell 
death in cells expressing Bax or Bak, but not the control cells. Indeed, a higher rate of 
apoptosis was measured upon BimS expression. Activation of Bax and Bak upon Bim 
expression ultimately led to apoptosis determined by measurement of DNA-fragmentation. 
A high percentage of DU145-Bax cells were found to be apoptotic after transfection with 
AdBimL and AdBimS, respectively. DU145-Bak cells showed similar rates of apoptosis 
upon BimL or BimS expression. These results demonstrate that BimL as well as BimS are 
able to kill in a Bax- and Bak-dependent manner. 
After establishing the role of Bax and Bak in the Bim induced apoptotic pathway, the focus 
of this study turned to the relation of Bim to the mitochondria and the ER. The primary 
objective to use the DU145-Bax targeted Bcl-2 cell system was to assess whether Bim 
would activate the mitochondria or the ER to induce apoptosis. In transfectant cells Bcl-2 
was targeted to the mitochondria by exchanging the C-terminal insertion sequence for an 
equivalent mitochondrial signal of (DU145-Bax Bcl-2actA) or to the ER by a 
transmembrane sequence (DU145-Bax Bcl-2cb5). DU145-Bax cells transfected with an 
empty vector served as a control (DU145-Bax neo). In the absence of Bcl-2 
overexpression both BimL and BimS induced apoptosis in DU145-Bax neo cells, indicating 
their ability to activate Bax. However, in the presence of Bcl-2, Bim was at least partially 
blocked in its actions and therefore revealed its preferred pathway. Bcl-2 localized at the 
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mitochondria reduced the apoptotic rate upon BimL expression. A similar inhibitory effect 
of Bcl-2 was found for the apoptotic rate induced by BimS. Even though the mitochondria 
were protected by Bcl-2 from being permeabilized, Bim was able to induce cell death by 
other mechanisms. Overexpression of either Bim isoforms in DU145-Bax cells with ER 
localized Bcl-2 did not end in apoptosis. The anti-apoptotic function of Bcl-2 prevented 
Bim-induced activation of ER mediated apoptosis. These results implicate that Bim might 
aim to the ER on its pathway once it is activated by an apoptotic stimuli. This 
consideration is supported by the report that Bim translocated to the ER in murine 
myoblast cells (C2C12) upon tunicamycin treatment. There, Bim stimulates the activation 
of ER stress induced apoptosis, which could be prevented by overexpression of Bcl-xL 
(Morishima, et al., 2004). Furthermore, Bim has been reported to respond to cell death 
downstream of ER stress and to be induced in response to ER stress. Additionally, it was 
shown that Bim targeted to the ER initiated apoptosis and can therefore act as a specific 
death signal in response to ER stress (Morishima, et al., 2004). Other studies reported 
that ER targeted Bcl-2 may sequester Bim, preventing it from interacting with other 
members of the Bcl-2 family (Egle, et al., 2004). This possibility was also stated by other 
reports, saying that Bim binds and inhibits ER localized Bcl-2 to regulate cell death and is 
therefore capable of regulating this anti-apoptotic protein at the ER (Kim, et al., 2004). It 
should be mentioned that Bcl-2 targeted exclusively to the ER is more restricted in its anti-
apoptotic actions compared to Bcl-2 predominantly expressed at the mitochondria, 
suppressing cell death induced by ER stress agents and by c-Myc. 
The secondary outcome of the overexpression of Bim in the DU145-Bax Bcl-2 system was 
the ability of membrane associated Bcl-2 to antagonize the killing effect of Bim. Whereas 
Bcl-2 targeted to the mitochondria only partially reduced Bim-induced apoptosis, 
localization of this anti-apoptotic protein at the ER almost completely cell death upon Bim 
expression. Similar results were found in other cell lines with different apoptotic stimuli. It 
was reported that Bcl-2 targeted to the mitochondria or the ER could protect cells from 
apoptosis depending on the cell death stimuli (Zhu, et al., 1996). Furthermore, it was also 
shown that Bcl-2 located at the ER was able to block cytochrome c release upon ER 
stress inducing agents (Hacki, et al., 2000). 
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5.2 Bim activates the mitochondrial apoptotic pathway 
Mitochondria play a key role in executing the intrinsic pathway, but are also involved in the 
extrinsic pathway that leads to apoptosis in response to intracellular stress signals. There 
two types of cells; in cell type I the cell death signal is propagated by caspase cascade 
initiated by the activation of large amounts of capsase-8 at the DISC following followed by 
the rapid cleavage of caspase-3 which in turn cleaves vital substrates in the cell. In type II 
cells no DISC is formed; instead caspase-8 cleaves the pro-apoptotic protein Bid to tBid 
leading to activation of the mitochondrial cell death pathway (Krammer, 2000). The 
permeabilization of the outer mitochondrial membrane marks the initiation of the intrinsic 
pathway followed by formation of the apoptosome and the activation of the initiator 
caspase-9. In the extrinsic pathway the mitochondria are stimulated by the activation of 
caspase-8 and subsequent cleavage of Bid. Moreover, rupture of the mitochondria can be 
amplified through caspase-3, caspase-8 and the cleavage of Bid in a feedback loop. The 
main event of mitochondrial activation is the loss of the membrane potential and 
consequently the release of cytochrome c and different pro-apoptotic factors. 
Mitochondria appear to undergo several changes in membrane structure and morphology 
before releasing cytochrome c. All these changes appear to influence the release of 
cytochrome c. Several studies indicate that transient openings in the mitochondrial 
permeability transition pore are important for this event. Bcl-2 family proteins may activate 
several processes in the mitochondria and ER during apoptosis, for example the 
reorganization of proteins within the intermembrane space before their passage across 
the outer mitochondrial membrane (Breckenridge and Xue, 2004). There are several 
models for how cytochrome c is released from the mitochondria. Most of them concentrate 
on the mechanism by which the outer mitochondrial membrane is permeabilized. The first 
model claims that non-specific pores at the inner mitochondrial membrane open to cause 
osmotic swelling of the mitochondrial matrix. This is followed by disruption of the outer 
membrane and the release of pro-apoptotic factors and cytochrome c (Petit, et al., 1998). 
Model number two says that the members of the Bcl-2 family regulate cytochrome c 
release. The anti-apoptotic proteins such as Bcl-2 and Bcl-xL were found to prevent efflux 
of cytochrome c from the mitochondria by inhibition of Bax or Bak function or by binding of 
BH3-only proteins (Jurgensmeier, et al., 1998; Kluck, et al., 1997; Yang, et al., 1997). In 
contrast, Bax and Bak stimulated the opening of VDAC and allowed cytochrome c to pass 
(Shimizu, et al., 1999). Thus activation of Bax or Bak appears to be a predominant 
gateway to mitochondrial activation. The third model proposes a mitochondrial 
permeability transition-independent mechanism of cytochrome c release. The release may 
occur by modulation of the mitochondrial volume leading to swelling of this organelle.  In 
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this scenario the mitochondria remain intact and maintain their membrane potential 
(Gogvadze and Orrenius, 2006). In the fourth model caspase-2 is the main player 
mediating cytochrome c release. Caspase-2 was shown to be associated with the 
mitochondria (Susin, et al., 1999) and to disrupt the inner mitochondrial membrane (Von 
Ahsen, et al., 2000). Interestingly, caspase-2 does not need its catalytic activity for this 
function (Robertson, et al., 2004). Although it was not attempted in this study to verify one 
or possible combinations of any of the models mentioned, cytochrome c efflux was 
investigated in respect to BimL and BimS. Immunostaining of cytochrome c in DU145-Bax 
cells revealed a leak of cytochrome c upon Bim expression (figure 14). Infection with 
AdBimL, staining of cytochrome c and the mitochondria showed in the overlay that 
cytochrome c had been released from the mitochondria. In mock cells, which are Bax 
negative there was no sign for cytochrome c depletion upon BimL expression. In general, 
the same patterns were observed upon BimS expression. But there were more cells 
detected with cytochrome c depleted mitochondria. In the overlay, the strength of BimS 
became visible as it also induced cytochrome c release in some of the DU145 mock cells. 
This was confirmed by Western blot analysis, where cytochrome c could be detected in 
the cytosolic fraction upon expression of both Bim variants in DU145-Bax cells (figure 16). 
Release of cytochrome c occurred early, already 14h post infection with AdBimL 
cytochrome c could be detected in the cytosol. The cytosolic fraction of DU145-Bax cells 
was found to contain cytochrome c 10h post infection with AdBimS. This rapid activation of 
the mitochondria shows an effective mode of action of Bim and might with regard to the 
time course of protein expression indicate that lower amounts of BimS as compared to 
BimL suffice to trigger the mitochondrial pathway. 
The mitochondrial (intrinsic) pathway consists of release of cytochrome c and the 
breakdown of the mitochondrial membrane potential. Release of cytochrome c triggers the 
binding of dATP to Apaf-1 and the formation of the apoptosome, followed by the activation 
of caspase-9. Activation of caspase-9 was shown by Western blot analysis and flow 
cytometric measurements (figure 23, 25). In this study it could be observed that 
transfection of Bcl-2 and targeting of Bcl-2 to the mitochondria blocked the loss of the 
mitochondrial membrane potential (figure 22), suggesting that Bim induces the 
mitochondrial pathway. DNA fragmentation was also partially inhibited by Bcl-2 (figure 20). 
It can be concluded that the signals leading to mitochondrial activation are at least 
partially mediated upstream of the mitochondria and can be inhibited by anti-apoptotic 
proteins such as Bcl-2, e.g. targeted to the ER. This was found to be the case for release 
of cytochrome c but not for loss of the mitochondrial membrane potential. 
It was shown by Western blot analysis that Bcl-2 blocked the Bim induced leak of 
cytochrome c from the mitochondria. When Bcl-2 was targeted to the mitochondria, only a 
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small amount of cytochrome c was released to the cytosol upon Bim expression (figure 
25). A similar effect was achieved when Bcl-2 was present at the ER indicating that ER-
mediated apoptosis may lead to secondary activation of the mitochondrial pathway. Both 
isoforms were blocked in their actions by Bcl-2 and this prevented the release of 
cytochrome c. Whether Bcl-2cb5 inhibited the effect of Bim by directly binding to this BH3-
only protein or whether it blocked the multi-domain proteins Bak and Bax to become 
activated and therefore inhibited the pore formation at the mitochondrial membrane could 
not be clarified at this point. Of note, no protein interaction were studied here that might 
have elucidated the mode of BimL or BimS induced Bak/Bax activation. 
There are data describing that cytochrome c release occurs before loss of the 
mitochondrial membrane integrity (Goldstein, et al., 2000). Others claim that cytochrome c 
can be released independently from breakdown of the mitochondrial membrane potential 
and activation of the caspases (Bossy-Wetzel, et al., 1998). Further it was reported that 
this process is conducted by the permeability transition pore and can be inhibited by 
overexpression of Bcl-2 (Susin, et al., 1996). It was also proposed that, without 
cytochrome c, apoptosis is attenuated and, consequently, the apoptosome is not 
obligatory for stress-induced apoptosis, but only acts as a caspase amplification system 
that is more important in certain cell types than others (Li, et al., 2000; Von Ahsen, et al., 
2000).  
In a next step, investigations concentrated on the question whether Bim-induced 
mitochondrial activation was dependent of Bax, Bak and inhibited by Bcl-2. In Bax 
negative mock transfectant cells, no cells were detected with mitochondrial permeability 
shift. Then again, in DU145-Bax cells, BimL induced breakdown of the mitochondrial 
potential, and BimS even twice as much. Approximately the same numbers were found in 
Bax-deficient DU145-Bak cells and their mock transfectants. Apart from the intensity, both 
isoforms were able to activate the mitochondrial pathway. In DU145-Bax re-expressing 
and DU145-Bak cells Bim induced breakdown of the mitochondrial membrane potential. In 
cells, which were either Bax negative or with low Bak expression, no cells could be 
determined with a mitochondrial shift, suggesting that Bim induces disruption of the 
mitochondria by activation of Bax or Bak. However, some reports say that Bax and Bak do 
not play a redundant role in activation of the mitochondria and cannot substitute for each 
other. BH3-only proteins were shown to induce apoptosis either via Bax or Bak. Nbk was 
found to kill cells in an only Bax-dependent manner (Gillissen, et al., 2003). Nbk is not the 
only BH3-only protein that is restricted to either Bax or Bak, also other members of this 
group depend on one of these two pro-apoptotic proteins to induce apoptosis. Therefore it 
was interesting to discover that Bim does not favour one of these two multi-domain 
proteins but is equally activating Bax and Bak to cause mitochondrial perturbation.  
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Studies with Bcl-2 targeted to the ER verified that it protects the mitochondria from a 
distance. There are established data suggesting that it can inhibit disruption of 
mitochondrial membrane potential (Annis, et al., 2001), release of cytochrome c from 
mitochondria (Hacki, et al., 2000), and oligomerization of Bax (Thomenius, et al., 2003). It 
has been demonstrated that Bax and ER targeted Bcl-2 do not interact during apoptosis, 
although ER-Bcl-2 inhibited apoptosis (Annis, et al., 2001). In another study, Bcl-2 at the 
ER was able to inhibit the oligomerization of a Bax mutant, which was constitutively 
localized on the mitochondria (Thomenius and Distelhorst, 2003). Since Bcl-2 localized at 
the ER and mitochondrial Bax are spatially separated, it is unlikely that they interact. 
However, the data obtained in this study together with the data generated by other groups 
showed that the mitochondrial cell death pathway induced by Bim could be prevented by 
Bcl-2. There is also evidence that BH3-only proteins may directly affect the mitochondria 
(Sugiyama, et al., 2002). These findings propose an alternative model in which Bcl-2 lies 
upstream of BH3-only proteins and impede them in activating Bax and inducing apoptosis. 
This model is also supported by recent reports that ER-targeted Bcl-2 prevents the 
mitochondrial localization of the BH3-only protein Bad (Thomenius and Distelhorst, 2003). 
Expression of Bim in cells with mitochondria-localized Bcl-2 showed a decreased level of 
DNA-fragmentation (figure 20). The following investigation was supposed to answer the 
question whether the protection of the mitochondrial membrane potential by Bcl-2 was the 
reason for the reduced rate of apoptosis. 48h post infection with AdBimL high loss of the 
mitochondrial membrane potential was observed in the DU145 Bax neo cells. Bcl-2 
targeted to the mitochondria reduced this effect by more than half, showing that Bcl-2 was 
able to protect the cells from BimL induced activation of the mitochondrial pathway. On the 
other hand, Bcl-2 localized to the ER could not save the mitochondria form losing their 
membrane potential. In these cells BimL induced a mitochondrial permeability shift almost 
as much as in cells without Bcl-2. Expression of BimS had a similar but stronger effect. 
Nearly all DU145-Bax neo cells infected with AdBimS were detected with mitochondrial 
permeability shift. Targeting Bcl-2 to the ER resulted in loss of the mitochondrial 
membrane potential for the majority of the cells. At first glance, this result raised doubts 
since there was no enhanced DNA fragmentation measured in these cells. But a possible 
solution came from other reports that some cells remain viable after permeabilization of 
the outer mitochondrial membrane (Holinger, et al., 1999). Therefore breakdown of 
mitochondria might not be necessary or sufficient for apoptosis (von Ahsen, et al., 2000). 
Only Bcl-2 at the mitochondria could protect the cells from losing their mitochondrial 
integrity upon BimS expression. It seems that the localization of Bcl-2 is important for its 
inhibitory effect, but the single fact of overexpressing Bcl-2 was not enough to fully 
neutralize Bim-mediated apoptosis induction at the mitochondria. 
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It was reported that Bcl-2 or Bcl-xL can block mitochondrial membrane permeabilization 
induced by ectopically expressed BH3-only proteins or by Bax and/or Bak (Gross, et al., 
1999). Therefore, it is possible that the apoptotic pathway is divided in two processes. 
Activation of pro-apoptotic proteins results in an initial release of approximately 10% of the 
cytochrome c from the intermembrane space followed by caspase activation. The second 
mechanism depends on the permeability transition leading to matrix swelling and 
consequent remodelling of the mitochondria, whereby all the cytochrome c is dumped 
(Bernardi and Azzone, 1981). These findings may underline the importance of the ER in 
the Bim pathway in the present study. Even though the mitochondria lost their membrane 
potential upon Bim expression (figure 22) in cells where Bcl-2 was targeted to the ER, 
these cells did not undergo apoptosis upon Bim expression (figure 20). It seems that the 
ER has to be accessible for Bim in order to induce apoptosis. If the ER is protected by 
Bcl-2, Bim can activate alternative pathways such as the mitochondrial cell death pathway 
as is indicated by the loss of the mitochondrial membrane potential, but this does not 
seem sufficient to lead to cell death. Further it might also support the model of the 
mitochondrial remodelling. This model implies that the permeabilization of the outer 
mitochondrial membrane does not lead to complete depletion of cytochrome c but 
requires the remodelling of the inner membrane. The structural reorganization of the 
mitochondria seems to be dependent of the permeability transition following activation of 
pro-apoptotic proteins to guarantee that cytochrome c release during apoptosis is quick 
and absolute. Studies have demonstrated that pro-apoptotic Bcl-2 family members 
remodel the mitochondrial structure (Scorrano, et al., 2002). The fact that Bcl-2 localized 
at the mitochondria did not completely inhibit apoptosis might support the theory that there 
are some alternative pathways and more importantly that the ER is available for Bim. 
Whereas Bcl-2 solidly prevented loss of the mitochondrial membrane potential, it did not 
inhibit apoptosis in the same strong way upon Bim expression. This could be another hint 
that the ER is an important station for Bim to fulfil its apoptotic function and that it does not 
rely exclusively on mitochondria as it is proposed for other BH3-only proteins. 
Interestingly, transfected and targeted Bcl-2 could, at least partially, inhibit mitochondrial 
cell death but the processing of the caspases was merely blocked. Although this result 
was obtained by two different methods, the question needed to be answered how these 
caspases could be activated if cytochrome c release is prevented. It should be expected 
that caspase activation is completely blocked if there is no cytochrome c release. But it 
can be speculated that overexpressed Bcl-2 is able to inhibit cytochrome c release but 
nevertheless small amounts of cytochrome c could reach the cytosol, which is enough to 
activate the caspases to a certain extent. Small amounts of cytochrome c are not 
detectable in Western blots. And, as already mentioned the assumption that only a small 
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amount of the cytochrome c resides in the intermembrane space and most of it is found in 
the matrix (Bernardi and Azzone, 1981) might lead to the idea that permeabilization of the 
outer membrane and the liberation of few of these molecules is sufficient to activate the 
caspase cascade. For these reasons it is plausible that overexpression of Bcl-2 cannot 
fully inhibit cytochrome c release. 
It should also be taken to account that in the case of BimS, inhibition of caspase-8 led to a 
partial protection of the mitochondria when Bcl-2 was overexpressed in the cell, 
regardless of its localization. Addition of the caspase-8 inhibitor reduced the number of 
cells with a mitochondrial permeability shift by half (figure 26). It was reported that 
caspase-8 can be recruited to the ER (Ng, et al., 1997) and can also be found at the outer 
mitochondrial membrane (Chandra, et al., 2004). Bcl-2 localized at the mitochondria 
diminished the amount of cells with lowered mitochondrial potential although BimS was 
present. Additional treatment with the caspase-8 inhibitor boosted this effect, only small 
amounts of cells were detected, which had lost the mitochondrial membrane potential. 
Based on these findings it could be speculated that BimS directly or indirectly activates 
caspase-8 to induce the breakdown of the mitochondrial membrane potential. Caspase-8 
does not seem to be a target for BimL as inhibition of this caspase did not have an effect 
on mitochondrial activation (figure 26), but it can not be ruled out that caspase-8 is 
involved in its pathway through an amplification loop, e.g. through cleavage of Bid to tBid. 
Further aspects of caspase-8 and Bim will be discussed below. 
 
5.3 Activation of caspases upon Bim expression 
Various caspases are activated in different manner at different points of the apoptotic 
pathway, but nevertheless, activation of the caspases marks a crucial step in apoptosis. 
Mitochondrial membrane permeabilization and release of pro-apoptotic factors including 
cytochrome c, is involved in the activation of the caspases. However, there are debates 
about whether permeabilization of the outer mitochondrial membrane itself relies on or 
can occur independently of caspase activity (Breckenridge and Xue, 2004). 
Intermembrane space proteins are released at different time points following the apoptotic 
stimulus and some depend on caspases. This finding suggests that decisions are made 
upstream of mitochondria on whether and which pro-apoptotic factor is released form the 
intermembrane space (Breckenridge and Xue, 2004). 
Emphasis of investigations in this thesis was put on caspase-3, caspase-9 and caspase-8. 
Caspase-9 is the key initiator caspase of the mitochondrial pathway and is recruited by 
APAF-1 into the apoptosome. Active caspase-9 cleaves thereby and activates caspase-3. 
Caspase-8 is essential for the death receptor pathway and mediates the mitochondrial 
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amplification loop. Caspase-3 represents the main downstream effector caspase and can 
be activated by either caspase-9 or caspase-8.  
The activation of the three mentioned caspases was measured indirectly by detection of 
their cleavage products by use of Western blot analyses. The initiation of the caspase 
cascade was observed in DU145-Bax and DU145-Bak cells, presenting the capability of 
Bim to mediate cell death through both Bax and Bak (figure 16). DU145-Bax cells 
transfected with ER-targeted Bcl-2 showed resistance to caspase processing upon Bim 
expression (figure 23). These results were consistent with the measurements of DNA-
fragmentation, where it was shown that these cells do not undergo apoptosis upon Bim 
stimulation in consequence of inhibition of the ER-mediated death pathway by Bcl-2cb5. 
Based on this finding it was concluded that the first station of Bim on this pathway is the 
ER, from where the death signal is transported to other compartments (figure 20). Further 
confirmation was achieved by flow cytometric measurements. Both, activation and 
inhibition of caspase-9, -3 and-8 were measured. To measure caspase activation, a FITC 
labelled caspase specific peptide substrate was used that binds to the activated enzyme. 
In all DU145 transfectants, an activation of the caspases could be measured (figure 23). 
The only exception was DU145-Bax Bcl-2cb5 cells, where none of the caspases were 
activated due to inhibition by Bcl-2cb5. The inverse picture was seen using caspase 
inhibitors individually for each of the three caspases. The apoptotic rate was dramatically 
reduced once the caspase inhibitor zVAD-fmk was added to the cells infected with AdBimL 
or AdBimS (figure 24). Lesser levels of inhibition were exerted by zDEVD-fmk and zIETD-
fmk inhibition with zLEHD-fmk inhibition showing the least effect. 
These inhibition studies of caspase-9 revealed that caspase-9 participates in Bim induced 
apoptosis in DU145-Bax and DU145-Bak cells (figure 15). Addition of zLEHD-fmk reduced 
apoptosis in both cell lines upon BimL expression by approximately one third. Upon BimS 
expression and treatment with caspase-9 inhibitor almost four times less apoptosis was 
measured in DU145-Bax as well as DU145-Bak cells. Yet, presence of Bcl-2 interfered 
with caspase-9 activation in principle, so that use of zLEHD-fmk did not show any major 
effect, no matter at which organelle Bcl-2 was localized. Measurement of caspase-9 
activity upon Bim expression confirmed these data. Whereas cells without Bcl-2 showed 
elevated activation of caspase-9, Bcl-2 at the mitochondria diminished active caspase-9 
by half. Bcl-2 targeted to the ER restrained the activation of caspase-9 even more. 
Compared to DU145-Bax neo, only one third of the cells were detected with activated 
caspase-9. These data suggest that both Bim variants seem to induce caspase-9 
activation to the same extent. Caspase-3 is cleaved and activated by caspase-9 in the 
mitochondrial pathway. Therefore, this caspase should be a part of the Bim induced 
apoptotic pathway. Bax-dependent cell death was reduced in half of the cells when they 
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were, additionally to the adenovirus, treated with the caspase-3 inhibitor. Similar effects 
were found in DU145-Bak cells upon Bim expression and addition of zDEVD-fmk. 
Caspase-3 activity was also determined in context to Bcl-2 overexpression. Roughly, for 
both Bim isoforms cells overexpressing Bcl-2 resulted in a 50% reduction of the caspase-
3 activity as compared to cells with no Bcl-2 overexpression. These results do not 
necessarily mean that caspase-3 has a bigger role than caspase-9 in respect to Bim. 
Higher caspase activation rates and stronger inhibition of apoptosis with zDEVD-fmk 
could be the result of an amplification loop. Caspase-8 connects the extrinsic and intrinsic 
pathway via Bid and can amplify the mitochondrial activation. Therefore, involvement of 
caspase-8 in the Bim pathway was also investigated. DU145-Bax cells treated with 
zIETD-fmk to inhibit caspase-8 presented upon expression of either of the Bim isoforms 
the same apoptotic rate as the ones treated with zDEVD-fmk. The same experiments in 
DU145-Bak revealed comparable apoptotic rates as detected in the DU145-Bax cells. 
Hence, it can be said that caspase-8 has a role in Bim induces apoptosis. So far in the 
work presented, both Bim splicing variants had a similar impact on cells except that BimS 
was more important in induction of cell death related events. Measurement of casapse-8 
activation though, suddenly presented a difference between the two isoforms, which might 
have a differential impact on their pathway. Expression of BimL in DU145-Bax neo cells 
showed only a small quantity of cells with caspase-8 activity. Even less cells were 
detected with caspase-8 activity when Bcl-2 was present regardless of the localization. 
Expression of BimS in DU145-Bax neo cells demonstrated more than double as much 
cells with active caspase-8 as induced by BimL. But much less Bcl-2 transfectants with 
caspase-8 activation were observed when expressing BimS. These results gave the first 
clue that caspase-8 has a role in BimS induced apoptosis, which does not seem to be 
case for BimL. In consideration of reports that caspase-8 is located at the mitochondria 
and might have a great influence on mitochondrial activation, it was investigated whether 
inhibition of caspase-8 would have an effect on the loss of the mitochondrial integrity 
induced by Bim. Transduction of AdBimS in DU145-Bax neo cells led to 61% of cells with 
lowered mitochondrial membrane potential which did not change when zIETD-fmk was 
added to the cells. But overexpression of Bcl-2 and inhibition of caspase-8 prevented, 
however, the cells from loss of the mitochondrial membrane potential. In this constellation 
the caspase-8 inhibitor reduced the cells detected for mitochondrial permeability shift by 
half, no matter whether Bcl-2 was targeted to the mitochondria or the ER. Therefore, it 
may be assumed that Bcl-2 participates in the mechanism of caspase-8 activation initiated 
by BimS. Additional clues were given by the report that activation of caspase-8 might be 
achieved by a cytochrome c dependent way. It was proposed that caspase-6, an effector 
caspase like caspase-3, is the only caspase with the ability to activate caspase-8 after 
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cytochrome c release. In this case, caspase-8 would not need interaction with FADD and 
no formation of the DISC to be processed (Cowling and Downward, 2002). But as already 
discussed above no cytochrome c release could be detected by Western blot analysis in 
cells overexpressing Bcl-2, which makes this theory less likely, unless the minor part of 
cytochrome c kept in the intermembrane space would be enough to trigger this pathway. 
To make this point clear, further investigations especially about caspase-6 as the activator 
of caspase-8 would be necessary, but were not done in this work. 
Detection of processed caspase-9, -3 and -8 by Western blot analysis revealed that these 
caspases are activated upon both BimL and BimS expression independently of the Bcl-2 
expression level (figure 25). One possibility for the activation of these caspases despite of 
the presence of Bcl-2 could be a Bcl-2 insensitive feedback loop, where caspase-9 is 
activated, which in turn leads to activation of caspase-3. This effector caspase on the 
other hand is able to activate caspase-8. The other explanation could be taken from the 
proposition that only about 15% of the cytochrome c is located in the intermembrane 
space and the rest resides in the matrix (Bernardi and Azzone, 1981). Given that the inner 
mitochondrial membrane might not be permeabilized upon Bim expression, this small 
amount of cytochrome c might be able to induce caspase-9 activation and thereby trigger 
the activation of caspase-3 and -8. It should be noticed, that for the same time point (30h) 
there was more cleavage product detected for caspase-8 in cells transduced with AdBimL 
than for cells expressing BimS. It could be speculated that due to the strength of BimS and 
the fact that it is not post-translationally modified, active caspase-8 is already degraded at 
this time point. 
All the results of the caspase investigations point to the conclusion that Bim requires 
mostly caspase-9 and -3 to execute apoptosis.  BimS additionally seems to involve 
caspase-8 into these steps of cell death induction. Interestingly, blocking caspase-8 did 
not affect the activation of the mitochondrial and therefore the breakdown of the 
mitochondrial membrane potential by BimS. BimS induced permeabilization of the 
mitochondria could, however, be partially inhibited by usage of the caspase-8 inhibitor. 
DU145-Bax cells containing Bcl-2actA and also cells with Bcl-2cb5 showed a reduced 
number of cells with mitochondrial membrane potential loss. It seems that at this very 
early part of apoptosis induction BimS is able to activate an alternative, parallel apoptotic 
pathway where caspase-8 is activated upstream via the ER to trigger secondary activation 
of the mitochondrial pathway. 
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5.4 BimS causes ER stress and calcium release 
The unfolded protein response is mediated through three ER transmembrane receptors, 
pancreatic ER kinase (PKR)-like ER kinase (PERK), activation transcription factor 6 
(ATF6), and inositol-requiring enzyme 1 (IRE1). In healthy cells, all three ER stress 
receptors are maintained in an inactive state through binding to the ER chaperone 
BiP/GRP78. On accumulation of unfolded proteins, BiP dissociates from the three 
receptors, which leads to their activation and triggers the unfolded protein response. The 
unfolded protein response provides protection form cell death by reducing the 
accumulation of unfolded proteins and restores normal ER functioning (Schroder and 
Kaufman, 2005). However, when ER stress is excessive and prolonged cell death 
mechanisms are activated. Several mechanisms have been proposed for ER-induced cell 
death, including direct activation of proteases, kinases, transcriptions factors and Bcl-2 
family proteins. Several investigations of ER stress induced apoptosis were performed in 
murine systems focusing on caspase-12, which is specifically cleaved upon induction of 
ER stress (Nakagawa, et al., 2000). There is no evidence of functional caspase-12 in 
human, although its mRNA was detected, but due to a frame shift mutation and disruption 
by a stop-codon and it is enzymatically inactive (Saleh, et al., 2004). Human caspase-4 
was proposed to take the place of murine caspase-12 in humans in ER stress mediated 
cell death (Hitomi, et al., 2004). Caspase-4 was predominantly found at the ER 
membrane, but also at the mitochondria, which might imply additional ER-independent 
functions. Processing of caspase-4 was observed after exposure to ER stress inducing 
agents such as thapsigargin and tunicamycin in human neuroblastoma cells but not upon 
inducers of mitochondria-dependent dell death such as UV-irradiation and DNA damaging 
agents. However, caspase-4 knock down in HeLa cells had little effect on apoptosis 
induced by ER stress, implying that the importance of this caspase in ER stress is cell 
type dependent and so not sufficiently understood. In the investigations presented here, 
expression of Bim and inhibition of caspase-4 did not fundamentally block DNA-
fragmentation (figure 24), questioning its suggested role, at least in Bim induced 
apoptosis. When Bcl-2 was not present, expression of BimL and treatment with caspase-4 
inhibitor a minor reduction in cell death was observed. In the same settings with BimS a 
similarly decreased apoptotic rate was measured. In cells, where Bcl-2 was targeted to 
the mitochondria, the caspase-4 inhibitor to an only minor extent diminished apoptosis, 
when these cells were transduced with AdBimL or AdBimS. These results reveal that 
caspase-4 is not the key caspase in ER stress-induced apoptosis, its inhibition helped to 
decrease cell death, but not in a major way. In the presence of Bcl-2 the effect of the 
caspase-4 inhibitor was even smaller, probably because overexpressed Bcl-2 anyhow 
partially inhibited apoptosis. When Bcl-2 was targeted to the ER, no effect of the caspase-
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4 inhibitor could be detected, neither upon BimL nor BimS expression. This was not 
surprising since these cells did not show relevant apoptosis induction or show by analyses 
of DNA-fragmentation upon Bim expression. Further studies are needed to clarify a 
potential role of caspase-4 in Bim induced ER stress. The influence of capase-4 inhibition 
on mitochondrial membrane potential loss and detection of caspase-4 cleavage products 
could give some insight on participation of caspase-4. A potential candidate for the role as 
the mediator of ER stress induced apoptosis is caspase-8. It is thought to act as initiator 
caspase at the ER and to contribute to mitochondria-ER crosstalk. It was found to localize 
to the outer mitochondrial membrane in an active state. Caspase-8 localized at 
mitochondria may activate caspase-3, which then processes caspase-9 and thus might 
contribute to the amplification loop. As another substrate of casapse-8, Bap31 (Bcl-2 
associated protein 31) was identified. It was observed in a regulatory complex at the ER 
with Bcl-2 and caspase-8 (Ng, et al., 1997). Cleavage of this integral ER protein generates 
a p20 fragment that has pro-apoptotic features. The p20 fragment, which remains in the 
ER membrane, may mediate mitochondrion-ER crosstalk through a Ca2+-dependent 
mechanism (Chandra, et al., 2004). It causes the release of Ca2+ from the ER, which is in 
turn taken up by mitochondria and triggers the release of cytochrome c and caspase 
activation (Rao, et al., 2004). Overexpression of Bax or Bak led to Ca2+ efflux from the ER, 
Ca2+ influx into the mitochondria resulting in cell death, that can be prevented by Bcl-2 
(Nutt, et al., 2002). The expression of Bcl-2 decreased the amount of Ca2+ that could be 
released from intracellular stores, regardless of the mode of store depletion, the cell type 
or the species from which Bcl-2 was derived. The response to ER stress agent 
thapsigargin revealed that Bcl-2 increased the permeability of the ER membrane. Bcl-2 is 
said to inhibit apoptotic mechanisms downstream of cytochrome c, probably at the level of 
the ER (Foyouzi-Youssefi, et al., 2000). The ER-mitochondria crosstalk might be used for 
mitochondrial amplification of ER initiated apoptosis. Considering the findings described, 
the following pathway might apply for BimS: Active caspase-8 in the outer mitochondrial 
membrane cleaves and activates Bap31 to p20, upon which Ca2+ is released from the ER. 
Liberated Ca2+ is absorbed by the mitochondria causing their permeabilization, which 
might lead to apoptosis. Several studies have demonstrated that members of the Bcl-2 
family also integrate into the ER membranes, where they regulate the transfer of ER Ca2+ 
to mitochondria and ER stress signals (Oakes, et al., 2006). Whereas anti-apoptotic 
members of the Bcl-2 family can prevent alteration of Ca2+ homeostasis, pro-apoptotic 
members promote Ca2+ mobilization from the ER to mitochondria during apoptosis, 
perhaps by regulating of the activity of the ER inositol trisphosphate receptor. This might 
be important for the mitochondrial permeability transition pore opening and 
intermembrane space protein release (Breckenridge and Xue, 2004; Mathai, et al., 2005; 
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White, et al., 2005). 
Considering the data obtained in this thesis, the just mentioned process does not seem to 
be main pathway, but lead to an amplification and acceleration of the death signal. For 
further investigations about the role of Bim in ER stress, Bim should be expressed in the 
presence of the caspase-8 inhibitor and subsequent detection for Bap31 should not show 
the p20 fragment. This would be a further clue that at least BimS mediates apoptosis by 
inducing ER stress. This hypothesis is supported by the finding that upon BimS expression 
DU145-Bax neo and DU145-Bax Bcl-2actA cells showed upregulation for Bap31, but not 
in the cells, that express Bcl-2 at the ER (figure 28). This confirms that Bcl-2 is able to 
inhibit induction of ER stress when it is localized at the ER. Further, this is in line with the 
finding that DU145-Bax neo and DU145-Bax Bcl-2actA cells displayed Ca2+ release upon 
BimS expression (figure 27). Surprisingly, Western blot analysis of these cells transduced 
with AdBimL presented under on conditions the same picture as described for BimS. It 
might therefore be speculated that BimL does also target the ER, leading to upregulation 
of Bap31, but fails to induce ER stress and thus also calcium release. The slight induction 
of Bap31, which was detected under off conditions might come from the transduction of 
the cells with the adenovirus. Supplementary clues that this hypothesis of BimS but not 
BimL acting through the ER pathway were given by data showing that capase-8 is 
activated upon BimS expression but not in cells infected with AdBimL (figure 23). 
Moreover, perturbation of the mitochondria could be diminished by capase-8 inhibition 
when BimS was expressed in the cells, which was not the case upon BimL expression 
(figure 26). Overexpression of the p20 Bap31 fragment triggered Ca2+ release and 
sensitized mitochondria for caspase-8 induced apoptosis (Breckenridge, et al., 2003). 
Activation of the ER and the mitochondria might nevertheless be partially caspase-8 
independent, although the mechanisms described for Bim so far, relies on caspase 
activation.  Caspase-8, Bap31 and Bcl-2 or Bcl-xL that were found to form a complex (Ng, 
et al., 1997). Formation of this complex can be blocked by the BH3-only protein Spike 
(Mund, et al., 2003).  
Another ER stress-induced cell death modulator is CHOP, a transcription factor induced 
during ER stress (Kaufman, 1999; Wang, et al., 1996). Lack of CHOP provides partial 
resistance to ER stress-induced apoptosis (Zinszner, et al., 1998). CHOP promotes ER 
stress mediated apoptosis by repressing Bcl-2 gene expression, which increases the 
proportion of pro-apoptotic proteins in the cell and facilitates their activation. How CHOP 
induces apoptosis though, is unclear. While capable of inducing apoptosis and 
contributing to cell death in several scenarios involving ER stress, CHOP is not essential 
for cell death induced by ER stress (Harding, et al., 2003). Overexpression of CHOP has 
been shown to induce apoptosis, which was linked to the activation and mitochondrial 
 105
             Discussion 
translocation of Bax. Vice versa, overexpression of Bcl-2 could block CHOP induced 
apoptosis (McCullough, et al., 2001). This could not be confirmed by overexpression of 
Bim in DU145 cells. Under on conditions, both BimL and BimS induced upregulation of 
CHOP independently of the Bcl-2 status. A further ER protein involved in ER stress is the 
chaperone protein GRP78/BiP (immunoglobin heavy chain binding protein). It maintains 
ER function, facilitates protein folding and protects cells from toxic insults, hence has anti-
apoptotic abilities. BiP is localized inside the ER lumen, but it is also found on the cell 
surface, especially in prostate cancer cells (Mintz, et al., 2003). BiP functions as a main 
regulator of the unfolded protein response by binding to and preventing the activation of 
all three stress sensors IRE1, PERK, ATF6 (Kaufman, 1999). Upon ER stress these 
sensors are released form BiP and become activated. Additionally, BiP inhibits apoptotic 
signals at least in part by blocking caspase activation (Rao, et al., 2002). All in all, BiP has 
protective function against cytotoxic insults, it can protect cells against apoptosis caused 
by disturbance of ER homeostasis. Detection of BiP by Western blot analysis 
demonstrated increased levels of this protein upon expression of both Bim isoforms. No 
differences were found in-between cells with or without Bcl-2 overexpression. The strong 
expression of BiP might indicate that this protein is induced and regulates ER stress 
induced by Bim. BiP is also believed to regulate ER Ca2+ storage (Lievremont, et al., 
1997). Measurement of elevated cytosolic calcium revealed that the short form of Bim 
induced calcium release form the ER in a time dependent manner. DU145-Bax neo 
transduced with AdBimS showed increased calcium levels making regulation of calcium 
fluxes by BAP31 in this setting unlikely. Within 8h the cytosolic Ca2+ levels increased 
considerably upon BimS expression in these cells. Bcl-2 localized at the mitochondria 
partially interfered with BimS induced calcium leak. Noticeable, but still less calcium fluxes 
were measured in DU145-Bax Bcl-2actA cells increasing slightly in the same time frame. 
It was therefore not surprising that DU145-Bax Bcl-2cb5 cells, which express Bcl-2 at the 
ER were resistant to BimS induced calcium release Consequently, when the ER was 
blocked by Bcl-2, BimS was not able to promote leakage of calcium from this organelle. 
Expression of BimL did not induce calcium release in none of the three cell transfectants 
at any time point. Taking in account that BiP can block ER signalling proteins, Ca2+ 
release and caspase activation, the long variant of Bim might not be able to counteract. In 
various tumour cells, among them prostate cancer cell line DU145, which were used in the 
present studies, highly augmented BiP expression was determinated (Arap, et al., 2004; 
Misra, et al., 2005). The ability of BimS to induce stronger caspase-8 activation as 
compared to BimL might lead to calcium release from the ER. The second reason might 
be the strength of BimS to induce apoptosis in comparison to BimL, which was constantly 
evident throughout the investigations. Therefore, BimS might be able to overcome a 
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putative protective effect of BiP.  
Bcl-2 family members including Bcl-2 Bcl-xL, Bax, Bak and Nbk have been shown to 
associate with the ER, suggesting that Bcl-2 family proteins operate at the ER to regulate 
calcium homeostasis and apoptotic cell death (Breckenridge, et al., 2002; Ng, et al., 
1997). 
 
5.5 Concluding remarks 
Although further investigations must be conducted to elucidate the molecular basis and 
interactions of BimL and BimS, the following scenario is supported by the data provided in 
this study: A cell death signal activates BimL resulting in its release from the microtubule 
and translocation to the ER. There it activates an ER-associated apoptosis signal that 
results in activation of Bak and Bax. It is unclear whether this occurs at the mitochondria 
or the ER. At the mitochondrion Bak and Bax mediate loss of the mitochondrial membrane 
potential and the release of cytochrome c. The liberation of cytochrome c activates the 
apoptosome and triggers the activation of caspase-9, which mediates the cleavage of 
caspase-3. It could not be clarified whether ER and mitochondrial events happen 
sequentially or represent two separate pathways. Although is was recently shown by cell 
survival assays that Bim is the most critical initiator of ER stress induced apoptosis 
(Puthalakath, et al., 2007), the mechanism of ER/mitochondria crosstalk is nevertheless 
enigmatic.  
BimL can be antagonized by Bcl-2, although this anti-apoptotic protein cannot entirely 
block the induction of apoptosis. The prevention of cell death by Bcl-2 seems to depend 
on its localisation. Expressed at the mitochondria, Bcl-2 could only partially inhibit 
apoptosis. While cytochrome c release from mitochondria was inhibited by both Bcl-2actA 
and Bcl-2cb5, only Bcl-2actA interfered with loss of the mitochondrial membrane potential. 
The reason for this might be that BimL still manages to induce mitochondrial activation to a 
certain extent, which is reflected in the reduced but yet detectable DNA-fragmentation. 
When Bcl-2 resides at the ER, BimL was not able to conduct apoptosis, suggesting that 
ER-stress induced apoptosis is parallely activated to the mitochondrial apoptosis pathway.  
BimS seems to mainly use the same pathway as BimL by activation of the mitochondrial 
cell death pathway. Just as for BimL, Bcl-2 expression at the mitochondria can prevent 
activation of the mitochondrial apoptosis pathway and therefore apoptosis. But there is 
one dramatic difference between the pathway of BimL and BimS. According to the findings 
made in this project, caspase-8 is the chief helper of BimS. Upon activation, BimS not only 
induces the activation of the multi-domain proteins Bak and Bax but additionally also of 
caspase-8, whether this might be in a direct or indirect way. Only upon BimS expression 
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IETD-fmk could inhibit loss of the mitochondrial membrane potential. Moreover, BimS 
induced a higher percentage of cells with caspase-8 activation as shown by binding of 
fluorescing IETD peptide substrate. Localization of Bcl-2 at the ER fully blocked BimS 
mediated apoptosis. Activation of the ER apoptosis signal seems to be triggered 
simultaneously to the activation of the mitochondrial apoptotic events. Bcl-2 seems to 
grant survival at this position even against such a strong killer as BimS. By targeting the 
ER, BimS causes the depletion of the calcium stores causing ER stress as an additional 
apoptotic pathway to its activation of the mitochondrial cell death pathway. BimL does 
activate caspase-8 only in a small number of cells although it induces upregulation of the 
ER stress proteins such as BiP, CHOP and Bap31. ER stress is said to be followed by 
calcium release and subsequent uptake by the uniporters of the mitochondria. Uptake of 
calcium into the mitochondria causes swelling of the matrix and can lead to disruption of 
the membranes. Active capase-8 was found by others to be integrated into the outer 
mitochondrial membrane, where it assists on permeabilization of the mitochondria 
(Chandra, et al., 2004). Additionally, it is also possible that caspase-8 activates Bid by 
cleavage to tBid, which can not only trigger the activation of the multi-domain pro-
apoptotic proteins Bak and Bax but can also form pores at the outer mitochondrial 
membrane enhancing the disruption of these organelles. Therefore, BimS might have 
three possibilities or any combinations of those to induce and most importantly to ensure 
cell death once it is activated. Based on the results obtained in the present study, the 
following model is proposed: 
 
 
Figure 29: Model for Bim induced apoptosis 
 
Although some steps of Bim induced apoptotic pathway were illuminated, there are still a 
lot of questions to be answered. For example, if other anti-apoptotic proteins such as Bcl-
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xL are also able to inhibit the pathway of Bim or how Bim causes ER stress. Further it 
would be interesting to know, by which mechanism BimS induces the release of Ca2+ from 
the ER and the activation of caspase-8. The ER might mark the point where BimL and 
BimS follow different pathways. BimL might activate Bax and Bak already at the ER and 
not later at the mitochondria which then leads to the permeabilization of the mitochondria 
followed by the release of cytochrome c and finally to apoptosis. BimS does not only 
activate Bax and Bak just like BimL, but also induces a leak of calcium from the ER, which 
is taken up by the mitochondria and enhances the death signal. It can be speculated if this 
additional step of calcium mobilisation might be the reason for the potency of BimS. 
One reason for the strength of BimS might lay in the fact that it is not bound and therefore 
not regulated by the dynein motor complex of the microtubule. An incoming death signal 
might activate BimS directly, whereas BimL would have to be released from the 
microtubule.  Another explanation could be taken from the report that BimS is subjected to 
any post-translational modification, but is directly active after expression as opposed to 
BimL and BimEL (Weber, et al., 2007). Finally, the structure of BimS could be responsible 
for its strong killing ability. It was speculated that the intensity by which a BH3-only protein 
induced the apoptotic pathway is depending on its affinity to anti-apoptotic proteins. No 
such data are, however, at presence available comparing BimS and BimL. Binding assays 
revealed that Bim and Puma, which are both strong killers, had high affinity to all anti-
apoptotic family members and could neutralize all the anti-apoptotic proteins, whereas the 
less potent BH3-only proteins had a more restricted binding spectrum (Chen, et al., 2005). 
On the other hand, Noxa only bound to Mcl-1 and Bfl-1/A1 and turned out to be a weak 
killer, Nbk neutralized Bcl-w, Bcl-xL, but not Bcl-2 or Mcl-1. Therefore it was suggested 
that limited targeting of anti-apoptotic proteins correlates with the apoptotic strength of the 
BH3-only proteins (Chen, et al., 2005). Such a mechanism might therefore also explain 
the higher potency of BimS to induce apoptosis as compared to BimL. The exact interplay 
with the anti-apoptotic proteins needs further extensive investigations and cannot be 
explained at this point. Further, it can be speculated that higher induction of apoptosis by 
BimS might be due to the additional amplification of the death signal by the release of 
calcium from the ER. As presented in this study, BimS did not only upregulate ER stress 
proteins but also triggered elevated cytosolic calcium levels. Calcium released by the ER 
is known to be absorbed by the mitochondria (Szalai, et al., 1999), which in turn 
contributes to mitochondrial permeabilization and the release of cytochrome c and other 
apoptotic factors. 
The data presented in this thesis can promote Bim as a physiologically relevant target in 
tumour therapy.
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